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We shall not cease from exploration 
And the end of all our exploring  
Will be to arrive where we started  
And know the place for the first time 
T.S. Elliott, “Little Gidding” 
  
   
 
Chapter 1 
Perinatal brain damage and its relationship with preterm birth, 
asphyxia and intrauterine infection, a review of the literature 
 
1. Clinical background 
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2.2. Fetal cardiovascular control 
3 The effects of endotoxins on the brain 
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1. Clinical background 
1.1. Epidemiology of brain damage 
Despite the improvements in obstetric care, the number of children suffering from perinatal 
brain damage has not decreased over the past two decades. On the contrary, epidemiological 
data show an increase in the number of children affected by cerebral palsy, likely associated 
with the improvements in survival of very premature infants due to achievements of neonatal 
care (Hagberg et al, 1993). The prevalence for moderate or severe encephalopathy was 3.8/1000 
live births in a large Australian study with various causes of newborn encephalopathy. Major 
risk factors were maternal thyroid disease, prolapse of the umbilical cord, moderate or severe 
antepartum bleeding, and a birth weight below the third percentile (Badawi et al, 1998). 
Depending on the localisation of the brain damage these children can develop spastic paresis, 
choreo-athetosis, ataxia, and disorders of sensomotor coordination (Berger and Garnier, 1999). 
Later in life, they are at risk for developing disorders of visual and auditory systems and 
impairment in intellectual ability, which are associated with cerebral palsy (CP) (Volpe, 1995). 
Cerebral palsy is a complex of symptoms characterized by the aberrant control of movement or 
posture that appears in early life and can lead to costly life-long disability (Grether and Nelson, 
1997). These features are not the result of recognized progressive disease. Subtypes of spastic 
CP are categorized depending on the different types of motor disability, hemiplegia, 
quadriplegia or diplegia. The risk of CP is strongly associated with gestational age. The risk 
among very preterm neonates is one in 20 survivors whereas the risk is less than one per 1000 
survivors in children weighing more than 2500 gram at birth (Nelson and Grether, 1999). 
An important type of brain lesion associated with CP is periventricular leukomalacia (PVL), a 
cerebral lesion characterized by foci of necrosis in the white matter in the adjacent area of the 
lateral ventricles which occurs in 7% to 26% of neonates with birthweights under 1500 g 
(Levene et al, 1983; Trounce et al, 1988). Forty-seven to 80% of these infants develop aberrant 
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neuromuscular tone and posture and often cognitive impairment. (Fawer et al, 1985; Stewart et 
al, 1987). 
White matter damage in preterm infants is named periventricular leukomalacia, but in the 
majority of cases, other parts of the brain are also affected including subcortical and callosal 
white matter as well as the internal capsule (Leech and Alvord, 1974; Golden et al, 1997; Gilles 
et al,1998). Gray matter areas like the cerebral cortex, thalamus and basal ganglia can also be 
damaged (Golden et al, 1997; Inder et al, 1999, Hagberg et al, 2002). 
Even though perinatal care has improved, the morbidity of children with perinatal brain damage 
has not changed. The impact on both children and family is considerable and the ensuing care 
demands a high level of commitment and co-operation between various therapists. Until now, no 
effective strategy has been developed to cure this disease or to prevent it. 
 
For years it was believed that adverse circulatory events during child birth were the main origin 
of CP (Volpe, 1998). This hypothesis is supported by the fact that most white matter damage 
occurs in the so-called watershed areas, which are areas between the main cerebral arteries 
(Takashima and Tanaka, 1978; Nakamura et al, 1994). Furthermore, in the cortex, sulci are more 
damaged than gyri because of the hairpin bend the penetrating blood vessels are forced into as 
they cross the border from grey to white matter (De Reuck et al, 1984). Likewise, the 
susceptibility of oligodendroglial progenitors to oxidative stress, excitotoxicity and in vitro 
ischemia (Oka et al, 1993; Fern et al, 2000; Hagberg et al, 2002) underlines this hypothesis. 
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1.2. Asphyxia and hypoxia in relation to brain damage 
When discussing the pathophysiology of fetal-neonatal brain damage, the imprecise term 
asphyxia, meaning “pulseless” is often used as a synonym for hypoxia-ischemia of the brain. 
The American College of Obstetricians and Gynecologists advised that asphyxia should be 
regarded severe enough to cause hypoxic ischemic encephalopathy in case of: 1) umbilical 
artery or metabolic acidosis pH<7.00, 2) an Apgar Score of 0 to 3 for more than 5 minutes, 3) 
neonatal neurological sequelae, such as seizures, coma or hypotonia and, 4) multiple organ 
failure (ACOG 1995). 
Asphyxia is usually caused by an acute reduction in the uterine or umbilical circulation which in 
turn can be caused by abruptio placentae, uterine hypertonia, placenta praevia, vena cava 
occlusion syndrome, hypotension or compression of the umbilical cord (Jensen and Berger, 
1991). Estimates suggest that between 2 and 4 /1000 full term newborn infants suffer asphyxia 
at or shortly before birth. Approximately 15 to 20% of such asphyxiated infants that suffer from 
hypoxic-ischemic encephalopathy, will die during the newborn period, and of the survivors 25 
% will exhibit permanent neuropsychologic deficits (Vannuci and Perlman, 1997). 
Fetal cardiovascular response to hypoxia 
Between 80 and 100 days of gestation, the immature sheep fetus reacts with either no change 
(between 80 and 90 days gestation) or an increase (between 90 and 100 days gestation) in fetal 
heart rate, and fetal blood pressure usually remains unaltered from baseline in response to a 1 
hour episode of acute hypoxaemia (Boddy et al, 1974; Iwamoto et al, 1989; Iwamoto, 1989). 
The absence of a hypertensive response in the immature sheep fetus may be related to a fall in 
the combined ventricular output. Although heart rate can sometimes increase, the reduced stroke 
volume usually favours a fall in ventricular output (Iwamoto et al, 1989).  In contrast, the same 
hypoxemic episode in fetuses older than 120 days of gestation induces invariably a transient fall 
in fetal heart rate and a gradual increase in fetal arterial blood pressure (Boddy et al, 1974; 
Iwamoto et al, 1989; Iwamoto, 1989; Cohn et al, 1974; Giussani et al, 1994).   
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Hypoxia also leads to an activation of the sympathetic-adrenergic nervous system and thus 
increased production of catecholamines. Catecholamines are released from the adrenal medulla 
because of increased sympathetic activity and the direct effect of hypoxia on the gland. During 
hypoxemia other factors such as renin and angiotensin II are also increased, inducing increased 
peripheral resistance (Dawson, 1994). Due to this, and the stimulation of the baroreceptors, 
increased peripheral vasoconstriction occurs, leading to redistribution of cardiac output in 
favour of the central organs (brain, heart and adrenals) away from the periphery such as the 
gastrointestinal tract, renal, pulmonary, cutaneuous and skeletal muscle beds (Cohn et al, 1974; 
Peeters et al, 1979; Reuss et al, 1982; Yaffe et al, 1987). If the asphyxic insult persists, the fetus 
is unable to maintain this circulatory centralisation, and both cardiac output and extent of 
cerebral perfusion fall (Hanson, 1997). 
Prior to 110 days of gestational age, there are no changes in vascular resistance or blood flow in 
the fetal carcass (taken to mean muscle and skin of the limbs and trunk), but reduced vascular 
resistance allowing blood flow to increase in the cerebral, myocardial and adrenal circulations 
(Boddy et al, 1974; Iwamoto et al, 1989; Iwamoto et al, 1989).  In contrast, at gestational ages 
over 110 days, a similar degree of fetal hypoxaemia leads to pronounced vasoconstriction in the 
carcass, the gastrointestinal tract, the spleen, the kidney, and the lungs, shunting blood flow 
away from the peripheral circulations towards the cerebral, myocardial and adrenal vascular 
beds (Cohn et al, 1974; Sheldon, 1979; Jensen and Berger, 1993).  
The fetus reacts to a severe lack of oxygen with several reflexes, which are rapid in onset and 
via endocrine responses, which develop more slowly. Receptors leading to this response are the 
baroreceptor and chemoreceptor. 
Both baroreceptors and chemoreceptors are located in the carotid and aortic arch. Stimulation of 
baroreceptors results in bradycardia via vagal efferent pathways. Denervation of the aortic and 
carotid bodies in fetal sheep does not only abolish fetal bradycardia and hypertension upon 
hypoxia, but also attenuates peripheral vasoconstriction (Itskovitz et al, 1991), although the 
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increase in carotid blood flow, observed in intact fetuses at the onset of acute hypoxaemia 
(Giussani et al, 1993) is not changed. These effects are attributed to interruption of carotid 
chemoreflex, rather than baroreflex, signals due to the relative timings of the fetal bradycardia 
and hypertensive responses to acute hypoxaemia: in the intact fetuses the initial episode of 
bradycardia finished before any significant elevation in fetal arterial blood pressure was detected 
(Giussani et al, 1993).  
Data from several studies demonstrate the importance of the fetal carotid chemoreceptors in 
initiating fetal heart rate and peripheral vasoconstrictor responses to acute hypoxaemia. Before 
120 days gestation, fetal tachycardia in response to acute hypoxaemia may result not only from 
immaturity of the chemoreflex pathways but also from differential rates of maturation of 
sympathetic and parasympathetic nervous system chronotropic control, with sympathetic 
innervation dominating (Nuwayhid et al, 1975; Assali et al, 1977). Establishment of sympathetic 
innervation of the fetal heart is known to occur between 85-100 days in the sheep (Rawashdeh et 
al, 1988). Therefore, prior to ca. 120 days, the relative influence of cholinergic mechanisms is 
less than later in gestation, and the balance of cholinergic and adrenergic inputs is such that 
there is no fetal bradycardic response during hypoxaemia (Walker et al, 1979; Iwamoto et al, 
1989, Iwamoto, 1989). However, in fetuses older than 120 days, fetal bradycardia at the onset of 
acute hypoxaemia is produced by carotid chemoreflex-mediated increases in efferent vagal 
activity (Giussani et al, 1994; Giussani et al, 1993), resulting in relative dominance of 
cholinergic over adrenergic stimulation of the pacemaker centres of the heart (Walker et al, 
1979). 
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Fetal cerebral response to hypoxia 
When hypoxia occurs, cerebral oxygen delivery decreases and partial pressure of carbon dioxide 
increases, causing vasodilatation of the cerebral vascular bed and cerebral hyperperfusion. With 
lower oxygen delivery, cerebral oxygen consumption is maintained by an increase in cerebral 
extraction of oxygen delivered to the brain (Rudolph, 1984). Also, brain blood flow to 
phylogenetically older structures such as the brainstem, pons, medulla oblongata is increased 
compared to cortical flow (Peeters et al, 1979; Lou et al, 1985; Jensen and Berger, 1991; de 
Haan et al, 1997; Johnson et al, 1997). Depending on the extent of the oxygen deficit and the 
maturity of the fetus, cerebral perfusion can reach two to three times the original rate of blood 
flow. 
Complete arrest of uterine perfusion is found to cause an initial reduction of blood flow to the 
brain  (Jensen et al, 1987). If the lack of oxygen continues, the anaerobic energy reserves of the 
heart become exhausted. Cardiac output and mean arterial blood pressure fall (Rudolph and 
Heymann, 1976) and if blood pressure reaches values below 25 mm Hg, cerebral autoregulation 
is lost and a further reduction of cerebral blood flow ensues (Lou et al, 1979), which affects the 
parasagittal region of the cerebrum and the white matter most of all (Berger and Garnier, 1999). 
Brief umbilical occlusions, mimicking uterine contractions during labour, resulted in acidosis 
with hypotension and severe asphyxia combined with selective neuronal damage in the fetal 
sheep brain after a maximum of 4 hours (de Haan et al, 1997). Fetal asphyxia, induced by 
reduction of uterine blood flow, is associated with increases in cerebrospinal fluid levels of 
hypoxanthine and xanthine, both substrates in the formation of oxygen free radicals, in the 
recovery phase with microscopically detectable brain damage (de Haan et al, 1993). 
Cerebral response in the immature fetus 
It has been suggested that immature fetuses are more susceptible to asphyxia since they have a 
limited ability to increase blood flow to the white matter through vasodilatation (Szymonowicz 
et al, 1990) due to immaturity of cardiovascular development. Cardiovascular changes in 
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response to hypoxemia show a specific development during fetal maturation. Before 110 days 
gestation in fetal sheep, hypoxemia for one hour, induced by giving the ewe a hypoxic gas 
mixture, leads to an increase in fetal heart rate and a small fall in arterial blood pressure (Boddy 
et al, 1974; Dawes, 1984; Iwamoto et al, 1989). After 110 days gestation there is still a rise in 
heart rate for an hour but with a transient increase in arterial blood pressure (Boddy et al, 1974; 
Cohn et al, 1974) and an increase in fetal heart rate variability (Dalton et al, 1977; Parer et al, 
1980, Giussani et al, 1994). The immature fetus can survive a prolonged period of asphyxia, but 
this capacity to survive exposes the fetus to profound hypotension and hypoperfusion. A 
secondary period of significant cerebral hypoperfusion and reduced oxygen delivery that occurs 
post-asphyxia, might contribute to the patterns of cerebral injury seen in the human preterm 
fetus (Bennet et al, 1999). Keunen and co-workers investigated whether neuronal damage results 
after total umbilical cord occlusion of increasing duration in midgestation fetal sheep. In 
immature sheep of midgestational age (85 to 90 days), a prolongation of the duration of total 
umbilical cord occlusion up to 20 minutes resulted in a progressive increase in the severity of 
asphyxia but not in neuronal damage (Keunen et al, 1997). Brief umbilical occlusions in 
immature fetuses at 90 days gestation lead to bradycardia and fetal demise with ongoing 
occlusions (Keunen and Hasaart, 1999). 
Energy metabolism 
When the brain is deprived of oxygen, aerobic metabolism will be replaced by anaerobic 
metabolism. This will result in lower levels of adenosine triphosphate (ATP) leading to a lower 
membrane potential (Palmer et al, 1990). Excitotoxicity, toxic glutamate receptor activation, is a 
key mediator of central neuronal loss consequent to hypoxic-ischemic insults (Choi and 
Rothman, 1990). During hypoxia-ischemia, as cellular energy reserves and Na+ gradients fall, 
increased release and impaired uptake of glutamate mediate a toxic buildup of extracellular 
glutamate, leading to overstimulation of glutamate receptors and consequent neuronal cell death. 
Excitotoxicity can be exacerbated by decreased cellular energy stores since normal brain 
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functioning is not only oxygen dependent but also relying on glucose because neuronal 
interactions require a source of energy. Excitotoxicity leads to increased Ca 2+ influx, which can 
activate cytotoxic intracellular pathways. 
The prolonged availability of extracellular glutamate during hypoxia-ischemia is transduced by 
neuronal membrane receptors into potentially lethal intracellular ionic derangements, in 
particular, intracellular Na+ and Ca 2+ overload. Excitotoxic neuronal cell death, which tends to 
occur by necrosis, correlates well with measures of total Ca 2+ influx, and removal of 
extracellular Ca 2+ attenuates glutamate-induced neuronal death. 
 
Sustained elevations in intracellular Ca 2+ can initiate "toxic cascades," which are capable of 
ultimately killing the cell (Figure 1). These cascades include activation of catabolic enzymes, 
such as proteases, phospholipases and endonucleases. Endonuclease activation can be triggered 
by influx of large amounts of Ca 2+, which may lead to DNA breakdown during hypoxia-
ischemia. Increased intracellular Ca 2+ also activates a variety of protein kinases. In particular, 
Ca 2+/calmodulin kinase (CaMK) and the classical Ca 2+-dependent isoforms of protein kinase C 
(PKC) can modify the function of many ion channels, including NMDA and AMPA/KA 
receptor-gated channels and voltage-gated Ca 2+ channels. 
An especially important deleterious consequence of Ca 2+ overload following excitotoxic 
glutamate receptor activation is formation of free radical production, which is linked to elevated 
Ca 2+ in several ways: (1) Ca 2+-dependent activation of phospholipase A2, with liberation of 
arachidonic acid and further metabolism, leading to "by-product" free radical production and 
lipid peroxidation; (2) stimulation of NMDA receptors, leading to activation of NO synthase and 
the release of NO, which can then generate highly reactive peroxynitrite; and (3) uncoupling of 
mitochondrial electron transport, enhancing mitochondrial production of free radicals. 
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It is likely that excitotoxicity may be an important trigger for mitochondrial free radical 
production in ischemia-reperfusion injury. Supporting the idea that free radicals are important 
downstream mediators of excitotoxicity, treatment with free radical scavengers can attenuate 
NMDA or AMPA receptor-mediated neuronal death (Siegel et al, 1999). 
Once the hypoxic period is over, a phase of reperfusion starts 6 to 12 hours after the hypoxic 
event, leading to another wave of neuronal cell damage, probably due to the release of oxygen 
radicals and synthesis of NO. Also apoptosis is thought to play a role in this secondary neuronal 
cell damage (Berger and Garnier, 1999). 
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Figure 1. Mechanisms contributing to neuronal injury during ischemia-reperfusion (published 
with permission from Siegel et al, 1999). 
Several pathways believed to contribute to excitotoxic neuronal injury in ischemia. mGluR, 
metabotropic glutamate receptor; NMDA-R, N-methyl-d-aspartate receptor; GluR, 
AMPA/Kainate type of glutamate receptors; PL, phospholipids; PLA2, phospholipase A2; DAG, 
diacylglycerol; PLC, phospholipase C; PKC, protein kinase C; G, G protein; PIP2, 
phosphatidylinositol 4,5-bisphosphate; IP3, inositol 1,4,5-trisphosphate; NO, NO; O2, 
superoxide radical; H2O2, hydrogen peroxide; VSCC, voltage-sensitive Ca2+ channel. 
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1.3. Neuropathological features of hypoxic-ischemic encephalopathy 
Some basic varieties can be recognized in the features of brain lesions. Maturity of the fetus and 
the nature of the insult are major factors that determine if and what degree of brain lesions will 
arise. 
There are essentially six forms of hypoxic-ischemic brain lesion (after Berger and Garnier, 
1999): selective neuronal cell damage, status marmoratus, parasagittal brain damage, 
periventricular leucomalacia, intraventricular or periventricular haemorrhage and focal or 
multifocal ischemic brain lesions (Volpe, 1995, Gilles et al, 1983). Selective neuronal necrosis 
is the most common variety of hypoxic-ischemic encephalopathy and may coexist with other 
features of brain damage as well (Keunen and Hasaart, 1999). With increasing immaturity, 
oligodendrocytes may become more vulnerable than neurons (Volpe, 1992). The predilection 
sites of selective neuronal loss are the cerebral cortex, hippocampus and the cerebellum. The 
neuronal loss is predominantly localized in the areas of vascular border zones in the depth of the 
sulci. Neuronal loss in the basal ganglia and thalamus is frequently observed after repeated 
episodes of hypoxia-ischemia. 
In mature fetuses, selective neuronal cell damage is most frequently found in the cerebral cortex, 
hippocampus, cerebellum and the anterior horn cells of the spinal cord (Streicher et al, 1968; 
Larroche, 1977; Norman, 1978; Rorke, 1982; Friede, 1989; Volpe, 1995). This cell damage 
usually starts after 10 minutes of ischemia in the mature fetus (Williams, 1992). However, 
immature lambs tolerate severe asphyxia extremely well with respect to neuronal damage 
(Keunen et al, 1997, Keunen et al, 2000). Within the cortex, the border zones between the major 
cerebral arteries are the worst affected. Neuronal damage is often more marked than damage to 
oligodendrocytes, astroglia and microglia, which are mostly more resistant to hypoxia (Volpe, 
1995). Status marmoratus only affects 5% of children with hypoxic-ischemic lesions since 
hypoxia mainly affects basal ganglia and the hypothalamus. In the perinatal period these 
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children often have seizures but the extent of the disease is not fully developed before 8 months 
after birth. Microscopically there is loss of neurons and hypermyelination. The increased 
amount of myelinated astrocytes give the affected structures, especially the putamen a marble 
appearance (Friede, 1989; Rorke, 1982; Rorke, 1992). 
 
Since several years, the assumption that asphyxia during the perinatal period is the major cause 
of non-progressive impairment such as CP has been challenged by epidemiological studies 
which reveal only approximately 8-20% of all CP can be attributed to perinatal events (Blair and 
Stanley, 1993). The past years, more and more attention is drawn to the association between an 
increased risk of perinatal brain damage and preterm birth. 
 
1.4. Preterm birth 
Preterm birth, defined as birth before 37 weeks of gestation, is a leading cause of perinatal 
mortality and morbidity worldwide, affecting 5% to 10% of all births (van den Berg and 
Oeshsli, 1984). Preterm neonates have a significantly higher risk of death than term neonates 
(Rush et al, 1976; Kessel et al, 1984; Main and Main, 1986) and survivors are at risk for short-
term and long-term morbidity including necrotising enterocolitis, bronchopulmonary dysplasia, 
retinopathy, intracerebral hemorrhages, periventricular leukomalacia and neurological 
developmental disorders. Among those infants born before 30 weeks who survive, 
approximately 25% will have a major disability. Another 10% will have some disability and an 
additional 30% will have cognitive, perceptual and behavioural problems that could interfere 
with school performance (Hall et al, 1995; Schothorst and van Engeland, 1996; McCarton et al, 
1997). 
Prevention of preterm birth is the single most important challenge to modern obstetrics today. 
Progress in this area has been hampered by lack of understanding of the basic mechanisms 
responsible for premature labour and delivery (Gomez et al, 1995). 
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Preterm premature rupture of the membranes (PPROM) is associated with about one third of 
low birth weight deliveries. PPROM has been reported to be the third most important factor 
leading to perinatal death after amniotic fluid infection and abruptio placentae. Factors 
associated with PPROM include PPROM in a prior pregnancy, histologic chorioamnionitis, 
abnormal bleeding, polyhydramnion, incompetent cervix, smoking, and selected vaginal 
microorganisms in the current pregnancy (Harger et al, 1990; Gibbs et al, 1992). 
Several clinical and laboratory studies have shown that many preterm deliveries result from 
premature activation of cells in the cervix, decidua, and fetal membranes in response to local 
mediators of maternal or fetal stress, ascending genital tract infection, and/or decidual 
hemorrhage. Supposed mediators include peptide hormones (e.g. corticotropin releasing 
hormone (CRH) and/or inflammatory-cytokines (e.g. interleukin-1, -6,and –8 (IL-1, IL-6 and 
IL-8)) which induce the production of oxytotic factors (e.g. prostanoids and endothelin) capable 
of instigating cervical change and/or membrane rupture (Fidel et al, 1994; Lockwood, 1995). IL-
1ß has been shown to exist in abundance in uterine decidua and seems to be a potent stimulus 
for prostaglandin E2 biosynthesis in human amnion (Romero et al, 1992; Romero et al, 1994). 
Recently, evidence was gathered that interruption of the oxygen supply during birth only 
accounts for 6% of spastic CP and that other factors, more specifically ante partum etiologies 
are probably more relevant (Nelson and Grether, 1998). Maternal fever and /or a clinical 
diagnosis of chorioamnionitis without a recognized infection in the neonate often lead to lower 
Apgar scores and other signs of neurologic depression, sometimes with seizures and a need for 
resuscitation and respiratory support. Apparently, exposure to an infection can mimic birth 
asphyxia (Nelson and Willoughby, 2002; Damman and Leviton, 1997). 
 
             
 
 
24        Chapter 1 
1.5. Preterm birth and intrauterine infection 
Intrauterine infection (IUI) is recognized as an important initiator of preterm labour and PPROM 
(Gomez et al, 1997). Intrauterine infection with associated maternal and fetal inflammatory 
responses may account for up to 30% of preterm birth (Gibbs et al, 1992). Three lines of 
evidence support a role for infection in the onset of preterm labour: (1) the administration of 
bacteria or bacterial products to animals results in either abortion or labour (2) systemic 
maternal infections such as pyelonephritis, pneumonia, malaria and typhoid fever are associated 
with the onset of labour and (3) localized intrauterine infection is associated with preterm labour 
and delivery (Gomez et al, 1997). 
Chorioamnionitis is often defined according to the presence of fever, maternal or fetal 
tachycardia, uterine tenderness, malodorous amniotic fluid, and maternal leukocytosis (Nelson 
and Willoughby, 2000). These signs often have a relationship with maternal sepsis but are not 
sensitive indicators for infections with non-purulent agents common in the genital tract such as 
mycoplasma and ureaplasma. Also, epidural analgesia may cause maternal fever, (Lieberman et 
al, 1997) however, whether epidurals produce fever in the absence of chorioamnionitis has been 
questioned (Dashe et al, 1999). 
Intrauterine infection can be classified into two broad categories according to the location of the 
microorganisms: intra-amniotic and extra-amniotic infections (Gomez et al, 1997). The gold 
standard for the diagnosis of intrauterine infection is a positive microbiologic culture for 
microorganisms. The two techniques that have been used for microbiologic studies are 
transabdominal amniocentesis and transcervical retrieval, either by needle puncturing of the 
membranes or by aspiration through an intrauterine catheter. The transcervical retrieval is 
associated with an unacceptable risk of contamination with vaginal flora. 
There are several pathways for bacterias to spread to the amniotic cavity and fetus: (1) 
ascending from vagina or cervix (2) hematogenous dissemination through the placenta (3) 
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retrograde seeding from the peritoneal cavity due to invasive procedures. The most common 
route is the ascending route. 
One of the processes leading to intrauterine infection is the following (after Gomez et al, 1997): 
1. An overgrowth of facultative organisms or the presence of pathologic organisms in the 
vagina or cervix. Bacterial vaginosis may be an early manifestation of this overgrowth. 
2. After bacteria gain access to the intrauterine cavity they reside in the decidua. This localized 
inflammatory reaction leads to deciduitis and further extension to chorionitis. 
3. This infection may invade the fetal vessels (choriovasculitis) or advance through the amnion 
(amnionitis) into the amniotic cavity leading to intra-amniotic infection. 
4. Once in the amniotic cavity, the bacteria can gain access to the fetus by different ports of 
entry. Aspiration of the amnion fluid may lead to congenital pneumonia. Otitis, 
conjunctivitis and omphalitis are infections caused by bacteria spreading from infected 
amniotic fluid. Seeding from these sites to the fetal circulation may lead to bacteremia and 
sepsis. 
Vaginal pathogens including Neisseria gonorrhea, Chlamydia trachomatis, Trichomonas 
vaginalis and bacteroides species, as well as bacterial vaginosis and asymptomatic bacteriuria 
are found in greater frequency in women destined to deliver preterm with or without antecedent 
PPROM (Gibbs et al, 1992). 
 
Several cytokines have been studied such as IL-1, IL-6, IL-8, IL-15 in response to infection with 
various results. The presence of IL-15 mRNA and peptide in the amniochorion and decidua and 
its increased presence in the amnion fluid during preterm labour suggests a possible role for IL-
15 in preterm labour. 
Some of the intra-amniotic cytokines that link intrauterine infection with preterm delivery 
(Romero et al, 1989; Mazor et al, 1995) now seem to be of fetal origin (Eschenbach, 1997). 
Indeed, fetal umbilical vein pro-inflammatory cytokine levels, but not maternal serum values, 
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seem to correlate with the presence and severity of amnion inflammation and umbilical 
vasculitis (Salafia et al, 1997). 
In 41 pregnancies complicated by PPROM, fetal plasma interleukin-6 (IL-6) levels obtained via 
cordocentesis were significantly higher in the 24 infants who had a positive amniotic fluid 
culture than in the 17 infants whose amniotic fluid was sterile (Romero et al, 1998). In 
pregnancies that resulted in preterm labour, IL-6 levels were significantly higher in those that 
led to spontaneous delivery within 48 hours than in those that ended later. Maternal plasma IL-6 
concentrations did not correlate with either the procedure-to-delivery interval or fetal or 
amniotic IL-6 levels. 
These observations support the hypothesis that a fetal inflammatory response precedes imminent 
preterm delivery. Cytokines in the amniotic fluid and fetal or neonatal circulation, as a humoral 
characteristic of the fetal inflammatory response, seem to increase the risk for neonatal brain 
injury and long-term disability. Recent observations support the hypothesis that morphologic 
characteristics (fetal vasculitis) are also associated with an increased risk for perinatal brain 
damage (Damman and Leviton, 1997). 
Rupture of the membranes is not a prerequisite for intra-amniotic infection, since bacteria are 
capable of crossing intact membranes (Galask et al, 1984). Bacteria can be present in the 
amniotic fluid (Romero et al, 1993) in combination with endotoxins in the neonatal blood 
without previous rupture of the membranes (Okumura et al, 1999). Children with lower Apgar 
scores and neurologic signs of depression have an increased incidence of bacteria in the 
amniotic fluid in the absence of prolonged rupture of the membranes (Nelson and Willoughby, 
2002). 
It seems logical that bacterial infection would initiate preterm birth by causing an inflammatory 
reaction within the uterus and effectively switching on labour at an earlier stage. Bacteria do not 
directly synthesise prostaglandins (Bennet et al, 1992) but they do release phospholipases which 
may liberate arachidonic acid from intracellular lipid pools thus increasing the amount of 
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prostaglandins. An important mechanism by which bacteria might activate inflammatory 
mediators within the uterus is endotoxin. 
 
1.6. Endotoxins 
The term endotoxin was used for the first time in 1894 by Richard Pfeiffer who observed that a 
heat stable toxic material bound to the membrane of Vibrio Cholerae was released only after the 
cells disintegrated. He called the material endotoxin, to distinguish it from filterable material 
released by bacteria (Pfeiffer, 1894). 
Few, if any, other microbial products have been as extensively studied as bacterial endotoxins. 
Endotoxin is a molecular complex of lipid and polysaccharide; therefore a frequently used term 
is also lipopolysaccharide (LPS). 
Gram-negative bacteria are coated by highly toxic and chemically stable endotoxins which are 
partially shed when bacteria are destroyed by antibiotics in the bloodstream of the patient (Goto 
and Nakamura, 1980). The function of the outer membrane of Gram-negative bacteria is to act 
as permeability barrier. The outer membrane is impermeable to large molecules and 
hydrophobic compounds from the environment. Endotoxin is located on the outer face of the 
membrane, where it mediates contact with the environment. It is essential to the function of the 
outer membrane, and as a structural component of the cell, it may play several roles in the 
pathogenesis of Gram-negative bacterial infections. First, it is a permeability barrier that is 
permeable only to low molecular weight, hydrophilic molecules. This prevents penetration of 
the bacteria by bile salts and other toxic molecules from the gastrointestinal tract. It is also a 
barrier to lysozyme and many antimicrobial agents. Second, it impedes destruction of the 
bacterial cells by serum components and phagocytic cells. Third, LPS plays an important role as 
a surface structure in the interaction of the pathogen with its host. For example, LPS may be 
involved in adherence (colonization), or resistance to phagocytosis that determine the course and 
outcome of an infection. Since antibiotics have no effect on LPS (Spink et al, 1948), this toxic 
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mediator persists in the circulation of an affected patient and is associated with a high mortality 
and morbidity. 
Romero and co-workers showed that early spontaneous birth with PPROM was more likely 
when endotoxin was detected. Endotoxin also stimulates the synthesis of inflammatory 
cytokines including IL -1β and TNF-		
	

al, 1987).  Upon release from the bacterial outer membrane, LPS activates monocytes and 
macrophages to produce inflammatory cytokines such as TNF-α, Il-1 and IL-6, which serve as 
endogenous mediators of inflammation. Endotoxins have different effects on macrophages, they 
can either result in activation of monocytes and macrophages and thus cause septic shock or 
they can lead to refractoriness to subsequent challenge with high concentrations of this toxic 
product, which is also known as endotoxin tolerance (Dobrovolskaia and Vogel, 2002). 
The incidence of sepsis has increased as a result of improvement in the survival of patients with 
multiple trauma, cancer and AIDS. As a result, much time and effort has been put in the 
detection of LPS. The assays have been greatly improved and simplified over the past years thus 
making the determination of endotoxin rapid and easy. Until recently, suspected samples were 
tested on rabbits. Rabbits are sensitive to endotoxin and if a suspect sample of saline injected 
into a rabbit caused a fever, then it was contaminated. Unfortunately this method was expensive 
and slow, taking up to 48 hours to obtain a result. A Limulus amoebocyte lysate (LAL) assay, 
produced by extracting blood from a crab, can take as little as 45 minutes. A suspect sample is 
mixed with reconstituted LAL and allowed to rest in a small tube. After 45 minutes the tube is 
inverted and if a clot has formed it will stick to the top of the inverted tube, thus rendering the 
sample positive. 
However, the absence of measurable amounts of circulating endotoxin (at specific timepoints) is 
not absolute proof of the absence of bacterial participation in sepsis. Detection might be 
impossible due to the endotoxin release kinetics (short peaks), insensitive measurement 
techniques or very high (local) potency of the endotoxins even at extremely low non-detectable 
   
 
                                                                                                                   Review of the Literature      29 
concentrations. (Redl et al, 1993). In addition, the sepsis may be caused by fungi or Gram 
positive organisms. Figure 2 (after Baron et al, 1996) illustrates the basic structure of endotoxin. 
 
Figure 2. Structure of LPS 
 
The structure of endotoxin molecules from Salmonella and E. coli is known in detail. Although 
all endotoxin molecules are similar in chemical structure and biologic activity, some diversity 
has evolved with differences in potency and toxicity. 
The molecular complex can be divided into three regions (Fig. 1): (1) the O-specific chains, 
which consist of a variety of oligosaccharide residues, (2) the core polysaccharide which is the 
basic structure of the macromolecule, and (3) lipid A, composed usually of a glucosamine 
disaccharide with attached long-chain fatty acids and phosphate (Baron et al, 1996). The 
polysaccharide portions are responsible for antigenic diversity, whereas the lipid A part 
represents toxicity. Dissociation of the complex has revealed that the polysaccharide is 
important in solubilizing the toxic lipid A component, and in the laboratory it can be replaced by 
carrier proteins (e.g., bovine serum albumin) (Baron et al, 1996). 
The more pertinent toxic effects include pyrogenicity, leukopenia followed by leukocytosis, 
complement activation, depression in blood pressure, mitogenicity, induction of prostaglandin 
synthesis, and hyperthermia followed by hypothermia. These events can culminate in sepsis and 
lethal shock. However, not all effects of endotoxin are necessarily detrimental; several induce 
responses potentially beneficial to the host, assuming the stimulation is not excessive. These 
include: 
1. mitogenic effects on B lymphocytes that increase resistance to viral and bacterial infections 
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2. induction of gamma interferon production by T lymphocytes, which may enhance the 
antiviral state, promote rejection of tumor cells, and activate macrophages and natural killer 
cells 
3. activation of the complement cascade with the formation of C3a and C5a 
4. induction of the formation of interleukin-1 by macrophages and interleukin-2 and other 
mediators by T lymphocytes. 
These potential beneficial effects of "nontoxic" endotoxin derivatives might create treatments 
for diseases caused by a deficiency in the immune response. For example, the toxicity of 
endotoxin is largely attributed to lipid A. The toxicity of lipid A is markedly reduced after 
hydrolysis of a phosphate group or deacylation of one or more fatty acids from the lipid A 
molecule. These relatively nontoxic lipid A derivatives may be useful in reducing the severity of 
bacterial sepsis in which bacterial endotoxin produces a life-threatening clinical course as was 
demonstrated in a double blind randomized clinical trial (Astiz et al, 1995). Recently, it was 
shown that alkaline phosphatase (AP) was able to dephosphorylate LPS. To test whether LPS-
dephosphorylation can be used for intervention during sepsis, the effects of Salmonella LPS and 
its dephosphorylated counterpart monophosphoryl lipid A on macrophage activation were 
studied. When mice received AP immediately after the LPS challenge, the survival rate was 
100%, over 57% in the control group. Thus the enzymatic removal of phosphate groups from 
LPS by AP represents a crucial detoxification reaction, which may provide a new strategy to 
treat LPS-induced diseases like sepsis (Bentala et al, 2002). 
 
Endotoxin, which has first been identified in the intestinal tract, accumulates mainly in the liver, 
and can affect a range of cell and host proteins. 
Two major theories exist with respect to the way LPS is recognized by the host. One theory 
assumes that cell-associated structures bind LPS and transduce signals for gene expression. The 
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other theory suggests that LPS binding proteins facilitate insertion into the membrane which 
leads to intracellular signalling. 
Toll like receptors which are innate immune receptors have been first identified in Drosophila. 
Ten homologs have recently been identified and are named Toll-like receptors (TLR). The first 
human TLR, which is known as TLR4 (Lemaitre et al, 1996), was cloned several years ago. 
Kupffer cells, granulocytes, macrophages, platelets, and lymphocytes all have a cell receptor on 
their surface called CD14, which binds endotoxin. Endotoxin binding to the CD14 receptor on 
macrophages is enhanced by interaction with a host protein made in the liver (i.e., LPS-binding 
protein). Targeted gene deletion studies show that knock-out mice lacking CD 14 (Haziot et al, 
1995) or have a defective gene that encodes for TLR-4 (Poltorak et al, 1998) fail to respond  to 
LPS. Eklind and co-workers found an upregulation of the mRNA expression of CD14 in the 
immature brain following LPS stimulation which has been described before (Eklind et al, 2001; 
Lacroix et al, 1998). The extent of involvement of each cell type probably depends on the level 
of endotoxin exposure. It does seem clear that the host cellular response to endotoxin, rather 
than a direct toxic effect of endotoxin, plays the major role in causing tissue damage (Baron et 
al, 1996). 
 
1.7. Intrauterine infection and brain damage 
It is a recurring motif of modern medicine that more chronic diseases than was previously 
suspected, has probably infection or inflammation as an important part of its pathogenesis. 
Striking examples are multiple sclerosis, atherosclerosis, stroke (Ross; 1999; Becker, 1998) and 
in children tics and obsessive compulsive disorder (Shulman, 1999; Perlmutter et al, 1999). 
Several studies since 1955 have suggested that prenatal exposure to infection or associated 
factors can adversely influence brain development. Outcomes that may be associated with these 
risk factors according to early findings are CP (Eastman and DeLeon, 1955; Nelson and 
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Ellenberg, 1985), diminished intelligence (Broman et al, 1975), and morphological brain lesions 
in human infants and in experimental animals (Gilles et al, 1976; Leviton and Gilles, 1984). 
 
Recent studies have investigated the role of intrauterine infection (IUI) in causing cerebral palsy 
and some demonstrated a relationship (Murphy et al, 1995; O’Shea et al, 1998). 
Clinical chorioamnionitis is an infection of the uterus and its contents during pregnancy. Its 
diagnosis is based on the presence of fever (T > 38°C) plus two or more of the following 
conditions: maternal tachycardia, fetal tachycardia, uterine tenderness, foul smelling of the 
amniotic fluid, or maternal leukocytosis (Gibbs, 1989). The incidence varies between 10% and 
20% (Newton, 1993). 
Neonates who were born from mothers with an IUI are more prone to brain damage than their 
healthy peers (Yoon et al, 1997; Yoon et al, 2000). Antenatal exposure to intra-amniotic 
inflammation and evidence of a systemic fetal inflammatory response (funisitis, defined by 
neutrophil infiltration into the umbilical vessel walls or Wharton jelly) are strong and 
independent risk factors for the subsequent development of CP at the age of three years (Yoon et 
al,2000). Maternal endotoxaemia induced with LPS resulted in an increased expression of IL-1β 
and TNF-α mRNA in the fetal rat brain (Cai et al, 2000). A meta-analysis by Wu showed that 
chorioamnionitis is a risk factor for both CP and cystic PVL, for both term as well as preterm 
infants (Wu, 2002). 
 
Although very low birth weight neonates are more prone for CP, the outcome depends on the 
reason for preterm delivery. Neonates born to preeclamptic mothers have a lower risk than 
neonates born early for other reasons (Murphy et al, 1995; Kitchen et al, 1987; Nelson and 
Grether, 1995). 
At least half of the incidence of CP occur in infants born weighing more than 2500 gram, but 
only one study has examined markers of infection as risk factors for CP in such infants (Grether 
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and Nelson, 1997). In this study, maternal fever in labour (>38O C) or clinical or histological 
evidence of chorioamnionitis or more than one of these were observed in 2.9% of control 
infants, 14.4% of children with moderate or severe spastic CP and 21.7% of children with severe 
CP. The cerebral palsy in this study was not explained by prenatal factors such as cerebral 
malformations of Toxoplasmosis, Rubella, Cytomegaly virus or Herpes (TORCH) infections. 
The estimated proportion of CP that might be attributed to IUI not including TORCH infections 
was 12%, which is at least comparable with the potentially birth-asphyxiating conditions for 
which the attributable risk was estimated to be 6% (Nelson and Grether, 1998). A number of 
potential confounders did not alter the association of IUI and CP, most children with CP born of 
pregnancies complicated by IUI did not have sepsis or other recognized neonatal infections. In 
most cases there was no prolonged rupture of the membranes raising the question of chronic or 
reactivated infection with organisms of relatively low virulence which has been postulated as a 
common cause of preterm birth (Goldenberg and Rouse, 1998), rather than fulminating acute 
ascending infection at the time of delivery. 
Maternal infection was also linked with low Apgar scores (Grether and Nelson, 1997; Badawi et 
al, 1998; Perlman, 1999; Alexander and McIntyre, 1999; Bahn et al, 1998) and was also 
associated with hypotension, the need for intubation, neonatal seizures, meconium aspiration 
syndrome and a clinical diagnosis of hypoxic-ischemic or neonatal encephalopathy (Grether and 
Nelson, 1997; Badawi et al, 1998; Keogh et al, 1999). 
IUI may interact with other factors in causing brain damage: children born to women with not 
only an infection, but also potentially asphyxiating obstetric complications, were at much higher 
risk than those with any one of these risk factors or neither (Nelson and Grether, 1998). This 
observation is based on small numbers but mechanisms that could explain this are known. IL-1 
beta injection aggravates ischemic damage in the striatum in the neonatal rat when subjected to 
middle cerebral artery occlusion (Stroemer and Rothwell, 1998). 
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Furthermore, exposure to fetoplacental inflammation is associated with perinatal brain damage 
especially in the very preterm fetuses, i.e. those born before 30 weeks of gestation, and/or those 
born with a very low birth weight (<1500 gr) (Damman and Leviton, 1997; Goldenberg and 
Rouse, 1998; Mazor et al, 1998). 
The combination of premature birth and chorioamnionitis increases the risk of peri-and 
intraventricular haemorrhage up to 80 % (Berger et al, 1997). 
Yoon and co-workers observed an increased expression of TNF-α, IL-1β, and IL-6 being much 
higher in brains with periventricular lesions than in those without PVL (Yoon et al, 1997). The 
mothers of newborns with brain white matter lesions had higher concentrations of these 
cytokines in their amniotic fluid than did mothers delivered of newborns without brain damage 
(Yoon et al, 1997; Yoon et al, 2000) although this difference disappeared after adjustment for 
birthweight and gestational age. Nelson and co-workers did not find an association between 
cytokine concentration and CP risk in infants of less than 32 weeks gestational age born to non-
preeclamptic mothers. Cytokines are produced as a response to infection but they play many 
roles at many points in brain development (Mehler and Kessler, 1998) and can be either 
neurotoxic or neuroprotective depending upon the timing and other factors (Morganti-Kossman 
et al, 1997; Carlson et al, 1999). It seems the fetal environment itself influences the 
susceptibility to detrimental perinatal effects. IUI cause an increase in cytokines and surfactant 
proteins. This effect was more profound than that induced by glucocorticoids (Jobe et al, 2000). 
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2. The effects of endotoxins on cardiovascular control 
2.1. Adult cardiovascular control 
In 1914, Schottmüller wrote, “Septicaemia is a state of microbial invasion from a portal of entry 
into the blood stream which causes sign of illness.” This definition remained unchanged since 
the terms sepsis and septicaemia were ill-defined and referred to several clinical conditions, 
present in a patient with bacteraemia (Schotmüller, 1914). However, less than fifty percent of 
patients with signs and symptoms of sepsis have positive results on blood culture, and not all 
patients with bacteraemia have signs of sepsis. Thus, sepsis and septicaemia are two very 
different definitions. In the last few decades, discovery of endogenous mediators of the host 
response have led to the recognition that the clinical syndrome of sepsis is the result of 
excessive activation of host defence mechanisms rather than the direct effect of micro- 
organisms. 
Serious bacterial infections, either with or without bacteraemia, are associated with important 
changes in the function of every organ system in the body. These changes are mediated by 
elements of the host immune system against infection. Shock is deemed present when volume 
replacement fails to treat hypotension and associated clinical evidence indicates inadequate 
perfusion of major organ systems, leading to multi organ failure. 
The American College of Chest Physicians / Society of Critical Care Medicine consensus 
conference created definitions of sepsis (after Bone et al, 1992). 
The clinical features of sepsis include 2 or more of the following conditions as a result of a 
documented infection: 
1) Rectal temperature greater than 38°C or less than 36°C 
2) Tachycardia (>90 bpm) 
3) Tachypnea (>20 breaths per min) 
With sepsis, at least 1 of the following manifestations of inadequate organ function/perfusion 
also must be included: 
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1) alteration in mental state 
2) hypoxemia (PaO2 <72 mm Hg with pulmonary disease not as the direct cause of hypoxemia), 
3) elevated plasma lactate level  and 
4) oliguria (urine output <30 mL or 0.5 mL/kg for at least 1 h) 
 
Thus, septic shock is defined as a condition in a subset of people with severe sepsis who develop 
hypotension despite adequate fluid resuscitation, along with the presence of perfusion 
abnormalities that may include lactic acidosis, oliguria, or an acute alteration in mental status 
(Holzheimer and Mannick, 2001). Patients receiving inotropic or vasopressor agents may not be 
hypotensive by the time that they manifest hypoperfusion abnormalities or organ dysfunction. 
Multiple organ dysfunction syndrome is the presence of altered organ function in a patient who 
is acutely ill and in whom homeostasis cannot be maintained without intervention. 
 
The manifestations of septicaemia depend on the age of the patient, the illness being more lethal 
at extremes of age. Signs are non specific but there are signs in the skin suggestive of the 
diagnosis such as purpuric lesions associated with meningococcaemia and pustular lesions in 
staphylococcal septicaemia. Usually there is a rapid deterioration in the patient’s conditions and 
also mental state. Often patients have fever with tachycardia and bounding pulse but as the 
illness progresses there can be hypothermia with a rapid pulse and peripheral vasoconstriction. 
The diagnosis can be made by clinical assessment but blood and urine cultures, wound swabs 
and aspirate from an infected site should always be obtained so antibiotic treatment can start 
without undue delay (Souhami and Moxham, 1990). The largest problem in the treatment of 
endotoxic shock is multi organ failure. Over the past years the incidence of septic shock in 
humans still increased, with a mortality of 30%-50%. 
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2.2. Fetal cardiovascular control 
Regarding the effects of LPS on fetal cardiovascular control it seems likely that the main 
problems in adult circulation such as profound hypotension caused by peripheral vasodilatation 
will also occur in the fetal situation. The first study regarding LPS in the pregnant ewe was 
performed in 1972, when LPS was administered to the ewe. It showed a rapid decrease in mean 
arterial pressure and uteroplacental blood flow, which is followed by a decrease in 
uteroplacental oxygen delivery to about 30% of control value. However, the same authors found 
no change in cardiac output and umbilical blood flow in the acutely prepared fetal sheep even 
when given a large dose endotoxin (Bech-Jansen et al, 1972). Few data have been published on 
the cardiovascular effects of LPS since this publication. 
In respect to the defence mechanism of the fetus when encountering hypoxia, the presence of 
endotoxin might lead to a disturbance in this defence, leading to hypoperfusion of vital organs 
such as the brain and perfusion of non-vital organs such as the lungs, skin, muscles and other 
peripheral organs in analogy with the adult situation during endotoxaemia. A fall in oxygen 
delivery to the brain and/or cerebral hypoperfusion might then lead to brain damage. 
Furthermore, it is stipulated that LPS can also have a direct neurotoxic effect on the brain thus 
leading to brain damage. Intrathecal LPS in piglets causes an inflammatory reaction with an 
increased blood-brain barrier permeability and cerebral oedema (Gardenfors et al, 2002). 
One might suggest that due to this increased permeability, LPS can gain access to the brain and 
thus cause damage. 
 
3. The effects of endotoxins on the brain 
As stated before, the monocyte receptor CD14 is an important mediator of the inflammatory 
response. When stimulated by LPS through this receptor, monocytes are activated and produce a 
large variety of inflammatory cytokines such as IL-1 and TNF α that can activate arterial 
endothelium. When monocytes are activated they also release platelet-derived growth factor that 
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leads to proliferation of smooth muscle cells. Monocytes also lead to an increased expression of 
tissue factor in the clotting pathway and thus can cause an increased coaguloability. 
This increased coaguloability was recently established when a polymorphism in the promotor of 
the CD14 gene, C (-260) T, was detected as a risk factor for coronary heart disease in two 
separate studies (Unkelbach et al, 1999; Hubacek et al, 1999). A different group of investigators 
studied the associated risk of the TT genotype and found that the TT-genotype is not associated 
with an increased risk of cerebral ischemia in general but is associated with a risk of 
atherosclerotic or microangiopathic stroke (Lichy et al, 2002). 
The influence of endotoxin on global cerebral blood flow, metabolism, net flux of cytokines and 
catecholamines, was investigated in eight healthy young volunteers. Although TNF-alpha 
peaked at 90 minutes, coinciding with a peak in subjective symptoms, there was no direct 
reduction in cerebral oxidative metabolism (Moller et al, 2002). 
A hallmark of endotoxemia and sepsis is the heterogeneous pattern of vasoconstriction and 
vasodilation in different organs, culminating in a fall in total peripheral vascular resistance 
concomitant with regional maldistribution of blood flow. These changes in the distribution of 
cardiac output are most likely caused by vasoactive substances, i.e. such as NO, PGI2, 
angiotensin converting enzyme (ACE) activity, endothelin and adrenomedullin, released from 
the endothelium under experimental septic conditions. In this context, the role of two very 
important vasoregulators, NO and endothelin, in the endotoxin mediated alterations of fetal 
cardiovascular control is discussed. 
 
3.1. Nitric Oxide (NO) 
NO is a free radical and is synthesized from the amino acide L-arginine and oxygen through a 
reaction which is catalysed by NO synthase (NOS) (Nathan, 1992; Bolanos et al, 1998). NO 
relaxes vascular smooth muscle through intracellular processes some dependent (Moncada, 
1992) and some independent of cGMP (Bolanos et al, 1998). Several isoforms have been 
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purified and cloned. These include the calcium-dependent isoforms (isolated from nerve and 
endothelial cells), nNOS and eNOS, and the inducible calcium-independent isoform (iNOS) 
(Bredt et al, 1990; Marletta et al, 1988). All three isoforms of NOS can be expressed in large 
blood vessels (Beasley, 1990, Bredt et al, 1990; Nozaki et al, 1993, Wood et al, 1990). 
Biological effects of cytokines that could influence the progression of injury in the brain include 
stimulation of the synthesis of other cytokines and neuronal injury mediators such as NO 
synthase (Saliba and Henrot, 2001). Overproduction of the vasodilator nitric oxide contributes to 
hypotension and vascular hyporeactivity to vasoconstrictor agents. 
LPS stimulates astrocytes and microglia to produce various cytokines such as TNF-α, IL-1β and 
IL-6. Recent clinical studies have demonstrated that expression of  TNF-α, IL-1β, and IL-6 is 
much higher in brains with periventricular lesions (PVL) than in those without PVL (Yoon et al, 
1997). 
Hypoxia/ischemia also induces an inflammatory response in the immature rodent central 
nervous system, characterized by the very early expression of IL-1β and TNF-α (Szaflarski et 
al, 1995). The latter induces NO production in astrocytes (Cerami, 1992). 
Regardless of the involvement of NO on normal physiological brain development and function, 
an increasing body of evidence suggests that excessive biosynthesis of NO is involved in brain 
damage due to perinatal asphyxia (Dorrepaal et al, 1997). 
NO is known to be a potent mediator in the regulation of resting tone in cerebral, renal, 
mesenteric and hindquarter vascular beds and hence in blood pressure homeostasis in adults 
(Gardiner et al, 1990; Garnier et al, 2002). There is also some suggestion that NO contributes to 
cardiovascular control during hypoxia in adults and fetal sheep (Gardiner et al, 1990; Green et 
al, 1996; Harris et al, 2001; Iadecola et al, 1994). NO might mediate the fetal circulatory 
centralization that occurs during partial cord occlusion (Santos et al, 1997). As posed before, the 
ability of the fetus to mount an appropriate cardiovascular response to episodes of reduced 
oxygen supply is a crucial mechanism that protects the fetal brain from neuronal injury by 
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increasing cerebral perfusion during hypoxia. There is experimental evidence that NO is an 
important vasodilator in the cerebral circulation and that developmental changes in NOS may 
contribute to developmental changes in hypoxic cerebral vasodilation (Harris et al, 2001). Green 
and co-workers (Green et al, 1996) demonstrated the central role of NO in maintaining fetal 
cardiovascular function during both normoxia and hypoxia. In term fetal sheep intravenous 
application of the NO-synthase inhibitor L-NAME resulted in bradycardia and lowered carotid 
blood flow. This was accompanied by transient hypertension and an increase of both the carotid 
and femoral vascular resistance. During intra-uterine exposure to hypoxia, the magnitude of the 
subsequent chemoreflex bradycardia was reduced after L-NAME treatment and the well known 
rebound tachycardia during recovery was absent with NOS inhibition (Green et al, 1996). 
Moreover, NOS inhibition blunted the rise in carotid blood flow and fall in carotid vascular 
resistance during hypoxia. Since there were no significant differences in mean arterial pressure 
in vehicle- and L-NAME infused groups during hypoxia, it is thought that NO mediates the 
vasodilation of the carotid bed during hypoxia in the fetus. 
 
3.2. Endothelin 
In addition to the relaxing factors prostacyclin and NO, the vascular endothelium synthesizes the 
21-amino acid peptide, endothelin-1 (ET-1). ET-1 is released in response to several stimuli, 
including hypoxia (Elton et al, 1992; Li et al, 1994), endotoxemia (Morel et al, 1989; Nakamura 
et al, 1991), increased pressure (Hishikawa et al, 1995) and shear stress (Kuchan and Frangos, 
1993). In response to these stimuli, ET-1 causes both acute responses, such as vasodilation and 
vasoconstriction, as well as chronic changes, such as smooth muscle proliferation. Interestingly, 
the vascular responses to ET-1 vary with developmental age in fetal and neonatal sheep and 
these effects are vascular bed specific, i.e. ET-1 induced vasoconstriction increases with 
gestational age in femoral, middle cerebral, and renal arteries but not adrenal arteries (Docherty 
et al, 2001). These hemodynamic effects are mediated through two receptor subtypes: ETA 
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receptors and ETB receptors. ETA receptors and a very small subpopulation of ETB receptors are 
located on vascular smooth muscle cells and are responsible for the vasoconstricting effects of 
ET-1. A second very large subpopulation of ETB receptors are located on vascular endothelial 
cells and are responsible for the vasodilating effects of ET-1, that are mediated by NO-
production (Lusher et al, 1990). 
The possible involvement of the endothelin system in human septic shock is further supported 
by a clear correlation between endothelin plasma levels and morbidity and mortality in septic 
patients (Pittet et al, 1991). Increased plasma ET-1 levels are seen in various species during 
endotoxemia (Kaszaki et al, 1997; Pernow et al, 1989). Infusion of ET-1 to humans causes 
cardiovascular changes resembling in part those seen during sepsis, i.e. decreased cardiac output 
and vasoconstriction in the pulmonary, splanchnic and renal circulation (Weitzberg et al, 1991; 
Weitzberg et al, 1993). In fetal sheep ET-1 is able to constrict fetoplacental microcirculation and 
decrease fetal oxygen consumption (Adamson et al, 1996). Bacterial endotoxin or sepsis was 
shown to increase ET-1 concentrations in fetal umbilical arterial plasma more than fivefold in 
both pigs and humans reaching levels close to threshold vasoconstriction (Lundberg et al, 1991). 
Other pro-inflammatory agents such as IL-1, TNF-α, and TGF-β, also increase the production of 
ET-1 from endothelial cells. 
Endothelin-induced pulmonary hypertension is a reproducible phenomenon seen in several 
animal models (Volk and Cox, 2000). The pathophysiology includes a characteristic biphasic 
increase in mean pulmonary artery pressure and pulmonary vascular resistance and is thought to 
involve different mediators, including cytokines, which lead to increased expression of adhesion 
molecules, leukocyte activation and endothelial damage resulting in endothelial edema, vascular 
obliteration and vasoconstriction (Bigatello and Zapol, 1996). Although ET-1 produces systemic 
vasoconstriction, its effects on the pulmonary circulation vary with age and vascular tone (Black 
et al, 1988; Wong et al, 1993; Wong et al, 1994). In the lung of the fetal lamb the ETB receptor 
is highly expressed. ET-1 activates the ETB receptor, which stimulates endothelial NO-synthase 
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(eNOS) activity and NO production, mediating vascular smooth muscle relaxation and 
pulmonary vasodilation (Filep, 1993). In fact, pulmonary vasodilation has been described after 
exposure to NO, a substance, which is produced in large amounts after LPS application. 
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From clinical studies it is known that fetuses whose mothers have an intrauterine infection, are 
more susceptible to perinatal brain damage. The relation between intrauterine infection and fetal 
brain damage is however incompletely understood. Two pathways appear to be likely. First, 
brain damage might result from a direct cytotoxic effect of lipopolysaccharides (LPS) on 
cerebral tissue or second, brain injury might be caused by alterations of the fetal cardiovascular 
system leading to cerebral hypoperfusion and hypoxic-ischemic brain injury. 
We used fetal endotoxemia with LPS as a paradigm for fetal infection. 
In chapter 3 we studied the effects of LPS on the fetal circulation to answer the following 
questions: 
1. What happens with the distribution of fetal organ blood flow, when a fetus is subjected 
to LPS, during a period of normoxia? 
2. What are the effects of LPS on the fetal circulation, and the distribution of organ blood 
flow when this endotoxemic fetus is rendered asphyctic for a short period? 
3. Does the fetal circulation recover after a short period of asphyxia when the state of 
endotoxemia continues? 
Endotoxin also stimulates the synthesis of inflammatory cytokines including IL -1β and TNF-
in amnion cells even in intact fetal membranes. Since TNF-	

to further examine the role of NO in the process of fetal organ blood flow distribution. 
Therefore, we first studied the contribution of NO per se in fetal organ blood flow distribution 
during normoxia and hypoxia and addressed the following questions in chapter 4:  
1. Does NO regulate cardiovascular control in the fetal sheep during normoxia and 
hypoxia? 
2. Does NO alter the fetal response mechanism of redistribution to acute hypoxia? 
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Secondly, in chapter 5, we maintained the same experimental set-up and pretreated the fetuses 
with the NOS inhibitor L-NAME, shortly before administration of LPS. Therefore, in chapter 5, 
we studied the role of NO in fetal blood flow distribution and addressed the following questions: 
1. Is the redistribution of fetal organ blood flow, during endotoxemia, NO dependent? 
2. Will the increase in peripheral blood flow be attenuated by pretreating the animals with 
L-NAME? 
 
In the course of analyzing the data on the lungs we observed remarkable changes in the cardiac 
output distribution to the lung after LPS. Changes in cardiac output distribution to the fetal lung 
after LPS application were not studied before. 
The following questions were addressed in chapter 6: 
1. Is the mechanism of increased percentage cardiac output to the fetal lung after LPS 
administration mediated by NO? 
2. Is the mechanism of increased percentage cardiac output to the fetal lung after LPS 
administration mediated by endothelin? 
 
After studying the distribution of fetal organ blood flow during normoxia and hypoxia in the 
endotoxemic fetal sheep and the role of NO in this process, an important issue was left 
unanswered. In the immediate recovery period, oxygen delivery to the fetal brain was nearly 
arrested. It is therefore quite conceivable that such disturbances of the cardiovascular system 
might cause fetal brain injury. 
On the other hand, endotoxins may also damage the brain directly. Animal studies provide 
evidence that endotoxin induces increased cytokine expression in adult rat brains.  
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In chapter 7 we wanted to answer the following questions: 
1. Does LPS without cerebral hypoxia-ischemia lead to brain injury in neonatal rats?  
2. Does LPS aggravate hypoxic-ischemic cerebral injury in neonatal rats? 
In order to avoid effects of LPS on the cardiovascular system, we chose a direct route by 
application of LPS into the intrathecal space in the brain. 
 
In chapter 8, we studied the long-term effects of LPS on umbilical blood flow and brain 
histology. 
The following questions had our interest: 
1. What is the time course of the fall in umbilical blood flow after LPS administration? 
2. Is there a relationship between fetal endotoxemia and histological brain injury? 
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Introduction 
Hypoxic-ischemic cerebral damage is an important contributor to perinatal mortality and 
morbidity, including long-term neurologic sequalae in term and preterm fetuses. Furthermore, 
there is increasing evidence that perinatal brain damage is caused not only by hypoxic-ischemic 
insults, but also by ascending intrauterine infection before or during birth (1). It is well known 
that gram-negative anaerobic bacteria are involved in colonization and infection of the 
genitourinary tract in pregnant women and could be associated with preterm labor and birth. 
Because pregnant women with fever and bacteriuria give birth to a higher incidence of infants 
with neurologic defects at 1 year of age than do mothers free of urinary tract infection (2), it 
appears that human maternal endotoxemia is associated with fetal central nervous system 
damage. Furthermore, there is evidence from epidemiologic studies that exposure to placental 
infection before or during birth is associated with cerebral white matter damage especially in 
very preterm fetuses (ie, those born before 32 weeks' gestation) and those born with very low 
birth weight (<1500 g) (1). In addition, the incidence of periventricular or intraventricular 
hemorrhage is significantly higher in premature babies exposed to intrauterine infection (3, 4).  
However, the relation between intrauterine infection and fetal brain damage is incompletely 
understood. Two pathways seem to be likely. First, brain injury might result from a direct 
neurotoxic effect of lipopolysaccharides (LPS) released from gram-negative bacteria during 
chorioamnionitis. Second, cerebral damage might be caused by endotoxemic alterations of the 
fetal cardiovascular system resulting in placental and cerebral hypoperfusion. In addition, 
endotoxemia can also affect fetal circulatory centralization during acute asphyxia, a vital 
mechanism that enables the fetus to maintain cerebral blood flow during asphyxia and thus to 
protect its brain from hypoxic-ischemic injury. The purpose of the present study was to examine 
whether endotoxemia induced by intravenous infusion of LPS would affect the fetal 
cardiovascular system during normoxia and asphyxia.  
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Methods 
Animal preparation 
Thirteen fetal sheep were chronically instrumented at a mean gestational age of 107 ± 1 days 
(term = 147 days). All ewes had surgery with use of sterile techniques while they were under 
general anesthesia (thiopental sodium 1 g/70 kg intravenously for induction and 0.5–1.0% 
halothane in a 1:1 nitrous oxide and oxygen mixture for maintenance). The ewe received 1 g 
ampicillin (Pentrexyl; Bristol-Myers, Woerden, The Netherlands) subcutaneously and 10 g 
buprenorphin (Temgesic; Schering, The Netherlands) per kilogram of body weight twice a day 
for three consecutive postoperative days. The ewe's abdominal wall was opened in the midline, 
and a snare was placed around the descending aorta below the renal artery, which was then used 
to arrest uterine and ovarian blood flow during the experiment, as described previously (5). 
Polyvinyl catheters (1.25 mm outer and 0.75 mm inner diameter) were inserted into a tibial fetal 
vein and artery of each hindleg and advanced into the caudal vena cava and abdominal aorta, 
respectively. Furthermore, catheters were placed into both brachial arteries. An additional 
catheter was placed into the amniotic cavity. All catheters were filled with heparin (100 IU/mL; 
Heparin-Natrium, Braun, Melsungen, Germany) and exteriorized through the ewe's flank and 
protected by a pouch sewn to the skin. Ewes were housed in individual cages with free access to 
food and water.  
Experimental protocol 
The experiments were performed 3 days after the surgical procedure, ie, at 110 ± 1 days. After 
control measurements of the physiologic variables were made, seven of 13 fetuses were treated 
randomly by an intravenous infusion (at -60 minutes) of LPS derived from Escherichia coli 
(O127:B8, Sigma-Aldrich, Deisenhoten, Germany) at a dose of 53 ± 3 g/kg fetal body weight 
for 10 minutes, while the remaining fetuses received saline solution. Although the most common 
infection in newborns is gram-positive group B streptococcus, E coli also has been reported to 
be an important placental pathogen involved in chorioamnionitis at preterm birth. 
       Chapter 3 
 
 
64 
The dosage of LPS used in the present study was taken from similar studies on term fetal sheep 
previously performed in our laboratory (6). Furthermore, we did a pilot experiment on a preterm 
sheep fetus in which we applied LPS at a dosage of 50 
after injection we could not detect any significant changes in fetal heart rate (control 192; 1 hour 
207; 2 hours 175 bpm) or mean arterial blood pressure (control 55.8; 1 hour 51.9; 2 hours 48.7 
mmHg). Up to this time point the LPS dose was therefore unlikely to have been excessive. We 
used endotoxin instead of live organisms because of its easy handling, simple quantification for 
controlled experiments, and the convenient standardization of endotoxin, whereas live 
organisms are difficult to standardize and prepare (7).  
To determine the effects of endotoxemia on the time course of circulatory centralization before, 
during, and after asphyxia, blood flow to the fetal organs and the distribution of combined 
ventricular output were measured using a modified microsphere technique (4). The isotope-
labeled microspheres (141Ce, 114In, 113Sn, 103Ru, 95Nb, and 46Sc, 16-m diameter, New England 
Nuclear, Boston, MA), suspended in 10% dextran containing 0.01% Tween 80, were sonicated 
and checked for size, shape, and aggregation. Depending on the specific activity, 0.7–1.8 million 
microspheres per batch were injected into the inferior vena cava at baseline (-60 minutes), 
shortly before the onset of maternal aortic occlusion (-1 minute), at the peak of asphyxia (+2 
minutes), and after the release of the snare (+4, +30, and +60 minutes, recovery period) (8, 9). 
Reference blood samples were withdrawn from both a carotid and a femoral artery at a rate of 
1.75 mL/min. Sampling was continuous for 390 seconds from -1 to +5.5 minutes. Separate 
samples were taken for 90 seconds at baseline (-60 minutes) and during recovery (+30 minutes 
and +60 minutes). The volume of blood withdrawn was about 38.5 mL and was simultaneously 
replaced by maternal blood maintained at 39C in a water bath. Asphyxia was induced by arrest 
of uterine blood flow by a single occlusion of the descending maternal aorta for 2 minutes.  
The experimental protocols were approved by the Animal Medical Ethics Committee of 
Maastricht University and met the guidelines of the responsible governmental agency.  
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Measurements 
Fetal heart rate and mean arterial blood pressure were recorded continuously during the 
experiment on a personal computer, using a customized hemodynamic data acquisition system. 
Before each blood flow measurement, and also at -30 minutes (control period), blood samples 
were taken from the fetal descending aorta and analyzed for blood gases, acid-base balance 
(AVL 993; AVL Medical Instruments AG, Schaffhausen, Switzerland), hemoglobin 
concentration, and arterial oxygen saturation of hemoglobin ([SO2]; OSM 2 Hemoximeter, 
Radiometer, Copenhagen, Denmark). After the experiment, a lethal dose of sodium 
pentobarbitone (Euthasate; Apharmo, Duiven, The Netherlands) was given to the ewe, and the 
fetuses were perfused with 200 mL of formalin (10%, w/v, saline). This procedure made the 
dissection of the fetuses much easier. No effect of formalin on organ wet weight was observed. 
Fetal organs were weighed and placed in vials, which were filled to the same height to reduce 
variations in geometry. The intestines were separated from the mesentery, opened, and cleared 
of contents. Paired organs (lungs, kidneys, and adrenals) were counted separately, as were the 
right and left sides of the cerebrum. Significant preferential streaming of microspheres could not 
be detected. Specimens of skin and muscle were taken from the hips and shoulders. Cotyledons 
and upper and lower body were homogenized by a meat chopper and the samples filled into 
vials.  
The applied solid-state semiconductor gamma counter (thallium activated, sodium iodine 
crystal) had a high energy resolution of about 2 keV and was connected to a multichannel 
(1024) pulse height analyzer (LKB 1282; Compugamma, Wallac, Turku, Finland). The results 
were normalized with respect to time and sample weight.  
Calculations 
Fetal combined ventricular output and blood flow to the various organs were calculated from 
counts of the injected nuclide recovered in fetal organs or placenta, from counts in the 
appropriate reference sample, and from the withdrawal rate of the reference sample (8, 9). The 
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percentage of combined ventricular output distributed to a given organ was calculated from the 
absolute blood flow to that organ and the combined ventricular output. The vascular resistance 
was calculated by dividing arterial blood pressure (corrected for amniotic fluid pressure) by 
blood flow and was expressed in mmHg/mL per minute per 100 g of tissue. Blood flow below 1 
mL/minute per 100 g was treated as 1. Umbilical vascular resistance (mmHg/mL per minute per 
kilogram of fetal weight) was calculated by dividing the perfusion pressure of the umbilical 
circulation (arterial blood pressure minus the estimated umbilical venous blood pressure before 
[11 mmHg] and during [17 mmHg] reduction in uterine blood flow) by umbilical blood flow 
(10). However, one has to take into account that during severe vasoconstriction of the umbilical 
arteries umbilical venous pressure could be underestimated. Oxygen delivery to the various 
organs ([DO2]; mL O2/minute per 100 g) was calculated according to the following formula: 
organ blood flow (mL/minute per 100 g) × SO2 × hemoglobin (g/mL) × 1.34 (mL O2/g 
hemoglobin).  
Statistics 
Results are given as mean ± standard error of the mean. The data were analyzed for intragroup 
and intergroup differences by two-way multivariate analysis of variance for repeated measures. 
Games-Howell test was used as a post-hoc testing procedure. Statistical analysis was performed 
using Super Anova Statistical Package (Abacus Inc., Berkeley, CA).  
 
Results 
Control group 
During the control period, combined ventricular output, fetal heart rate, mean arterial blood 
pressure, blood gases, pH, and plasma concentrations of glucose and lactate were in the normal 
range for chronically prepared immature fetal sheep (11). During the control period there were 
no significant changes in fetal heart rate and mean arterial blood pressure, blood gases, acid-
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base balance, and organ blood flow. The small but insignificant decrease in cardiac output might 
be attributable to slight fetal stress from flushing vascular catheters.  
Arrest of uterine blood flow for 2 minutes significantly decreased SO2, pO2, pH, and BE, and 
increased partial pressure of carbon dioxide (pCO2) and plasma concentrations of lactate (Table 
1). At the end of occlusion, fetal heart rate decreased by 40% but blood pressure did not change 
(Figure 1). At this time point, combined ventricular output decreased by 72%, whereas the 
portion distributed to the placenta did not change and blood flows to central organs, ie, heart, 
brain, and adrenals increased by 474%, 248%, and 464%, respectively (Table 2, Table 3 and 
Table 4). There was uneven distribution of combined ventricular output to the various regions of 
the brain during asphyxia. The portion distributed to the cerebrum and brainstem progressively 
increased after 2 minutes of asphyxia, whereas that to the cerebellum, choroid plexus, and 
hippocampus did not change (data not shown). During asphyxia the distribution of combined 
ventricular output and regional blood flow to most of the peripheral organs of the upper and 
lower body segments, ie, the intestines, liver, kidney, skin, scalp, and carcass, decreased to very 
low values and recovered gradually thereafter (Table 2, Table 3 and Table 4).  
Figure 1. Changes in fetal heart rate and mean arterial blood pressure in control (n = 6) and 
lipopolysaccharide (LPS)-treated (n = 7) immature fetal sheep before, during, and after arrest 
of uterine blood flow for 2 minutes.  
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Fetal heart rate tended to decrease, and mean arterial blood pressure tended to increase 
immediately after LPS infusion with a reversed  response later on, but those changes were not 
significant. Compared with control fetuses, LPS-treated fetuses developed sustained 
hypotension during the immediate recovery period 
(P < 0.01). Unlike the control fetuses, five of seven LPS-treated fetuses died within 30 minutes 
after arrest of uterine blood flow. Values are given as mean ± standard error of the mean. The 
data were analyzed within and between groups using a two-way analysis of variance 
followed by Games-Howell post-hoc test (*P < 0.05, **P < 0.01). 
In the immediate recovery period, ie, at +4 minutes, fetal heart rate decreased significantly but 
mean arterial blood pressure did not change (Figure 1). At this time point blood flow to the 
heart, adrenals, and all parts of the brain significantly increased whereas blood flow to the 
choroid plexus decreased (Table 4). Blood flow to the body was still poor while placental flow 
returned to baseline values (Table 2 and Table 4). At +30 and +60 minutes those values were not 
different from baseline.  
 
 
 
 
 
 
 
 
 
Figure 2. Combined ventricular output directed to the placenta and carcass in control (n = 6) 
and lipopolysaccharide (LPS)-treated (n = 7) immature fetal sheep before, during, and after 
arrest of uterine blood flow for 2 minutes.  
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Unlike in control fetuses, in LPS-treated fetuses there was a significant decrease in the 
percentage of combined ventricular output directed to the placenta, whereas that directed to the 
carcass significantly increased. During arrest of uterine blood flow the portion distributed to the 
carcass remained elevated in fetuses of the study group (P <0 .001). Values are given as mean ± 
standard error of the mean. The data were analyzed within and between groups using a two-way 
analysis of variance followed by Games-Howell post-hoc test (*P < 0.05, **P <0 .01).  
Study group 
Before application of LPS (control -60 minutes) there were no significant differences in 
physiologic variables, blood gases, and blood flows between control and study groups (Table 1, 
Table 2, Table 3 and Table 4). However, after LPS infusion was started, SO2 and pH 
significantly decreased, whereas plasma concentrations of lactate increased indicating mixed 
acidemia. Fetal heart rate tended to decrease, and mean arterial blood pressure tended to 
increase immediately after LPS infusion with a reversed response later on, but these changes 
were not significant (Figure 1).  
After application of LPS fetal cardiovascular control was severely affected. During the control 
period there was an inverse response in the distribution of combined ventricular output directed 
to the placenta and that directed to the fetal body. The percentage of cardiovascular output 
directed to the placenta decreased from 48% to 16% (P < 0.001), whereas that to the carcass 
increased from 32% (control -60 minutes) to 47% (control -1 minute; P < .01; Figure 2). Blood 
flow to the adrenals doubled during this period, and the portions of combined ventricular output 
directed to the heart (P <0.05) and peripheral organs, including the intestines (P < 0.05), liver (P 
<0 .05), and carcass (P <0 .05), were significantly higher in LPS-treated fetuses compared with 
controls (Table 3 and Table 4). Regarding blood flow to the parts of the brain, there were no 
significant changes between groups despite a significant decrease in O2 saturation in LPS-
treated fetuses during the control period, which resulted in significantly decreased cerebral 
oxygen delivery in LPS-treated fetuses (P <0 .05; Figure 3).  
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Figure 3. Oxygen delivery to the cerebrum (mL O2/minute × 100 g) in control (n = 6) and 
lipopolysaccharide (LPS)-treated (n = 7) immature fetal sheep before, during, and after arrest 
of uterine blood flow for 2 minutes.  
 
During the immediate recovery period there was still a severe cut back in delivery of oxygen in 
fetuses of the study group. Values are given as mean ± standard error of the mean. The data 
were analyzed within and between groups using a two-way analysis of variance followed by 
Games-Howell post-hoc test (*P < 0.05, **P < 0.01).  
 
Arrest of uterine blood flow for 2 minutes caused severe acidosis and metabolic changes in LPS-
treated fetuses (Table 1). Thus, the decrease in pH and the increase in plasma concentrations of 
lactate were more pronounced in the study group than those in the control group. However, there 
were only minor changes in fetal heart rate and mean arterial blood pressure (Figure 1). There 
was a progressive decrease in the portion of combined ventricular output distributed to the 
placenta at the peak of asphyxia (+2 minutes), whereas the percentage distributed to the carcass 
remained elevated (P < 0.001; Figure 2). Furthermore, adrenal blood flow was still high.  
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During the immediate recovery, ie, 2 minutes after arrest of uterine blood flow had been 
released, arterial oxygen saturation and PO2 were still poor and severe mixed acidemia persisted 
(pH below 7.0). Combined ventricular output remained low, and placental blood flow did not 
recover. Compared with control fetuses, blood flow to the parts of the brain were 50% lower, 
and cerebral oxygen delivery remained at very low values (P < .01; Figure 3). In addition, 
sustained hypotension developed in LPS-treated fetuses (P < .01; Figure 1), and unlike the 
control fetuses, five of seven LPS-treated fetuses died within 30 minutes after arrest of uterine 
blood flow. 
 
 
 
 
 
 
 
Ch
ap
te
r 3
 
  72
 
Ta
bl
e 
1.
  A
ci
d-
ba
se
 b
al
an
ce
 a
nd
 b
lo
od
 g
as
es
 in
 c
on
tro
l a
nd
 e
nd
ot
ox
in
 (L
PS
) t
rea
ted
 im
ma
tur
e f
eta
l  
 
 
V
al
ue
s 
ar
e 
gi
v
en
 a
s 
m
ea
n
s 
±
 
SD
.
 
a<
0.
05
, b
<0
.0
1,
 
c<
0.
00
1 
sig
n
ifi
ca
n
t b
et
w
ee
n
 
gr
o
u
ps
; d
<0
.0
5,
 
e<
0.
01
, f
<
0.
00
1 
sig
n
ifi
ca
n
t v
er
su
s 
co
n
tr
o
l w
ith
in
 g
ro
u
ps
 
  
 
 
 
 
En
do
to
xe
m
ia
 
an
d 
as
ph
yx
ia
 
in
 fe
ta
l s
he
ep
 
 
 
 
 
 
 
 
73
 
Ta
bl
e 
2.
 C
ha
ng
es
 o
f b
loo
d f
low
s, 
dis
tri
bu
tio
n o
f c
om
bin
ed
 ve
ntr
icu
lar
 ou
tpu
t a
nd
 va
scu
lar
 re
sis
tan
ce
 in
 co
ntr
ol 
an
d e
nd
oto
xin
 (L
PS
) t
rea
ted
 
im
m
a
tu
re
 fe
tal
 sh
eep
 
 
V
al
ue
s 
ar
e 
gi
v
en
 a
s 
m
ea
n
s 
±
 
SD
.
 
a<
0.
05
, b
<0
.0
1,
 
c<
0.
00
1 
sig
n
ifi
ca
n
t b
et
w
ee
n
 
gr
o
u
ps
; d
<0
.0
5,
 
e<
0.
01
, f
<
0.
00
1 
sig
n
ifi
ca
n
t v
er
su
s 
co
n
tr
o
l w
ith
in
 g
ro
u
ps
 
 
 
 
 
 
 
 
Ch
ap
te
r 3
 
  74
 
Ta
bl
e 
3.
 O
rg
an
 b
lo
od
 flo
ws
 in
 co
ntr
ol 
an
d e
nd
oto
xin
 (L
PS
) tr
ea
ted
 im
ma
tur
e f
eta
l s
he
ep
  
.
 
 
V
al
ue
s 
ar
e 
gi
v
en
 a
s 
m
ea
n
s 
±
 
SD
.
 
C=
 c
o
n
tr
o
l f
et
us
es
 E
=
 
en
do
to
xi
n 
tre
at
ed
 
fe
tu
se
s.
 
*
 P
< 
0.
00
1 
vs
 c
o
n
tr
o
l w
ith
in
 g
ro
u
p 
§ P
< 0
.05
 b
et
w
ee
n
 
gr
o
u
ps
  
| | P
<0
.0
5 
vs
 co
n
tr
o
l w
ith
in
 g
ro
u
p 
‡ P
<0
.01
 v
s c
o
n
tr
o
l w
ith
in
 g
ro
u
p 
† P
<0
.0
01
 b
et
w
ee
n
 
gr
o
u
ps
 ¶ 
P<
 0.
01
 b
et
w
ee
n
 
gr
o
u
ps
 
  
 
 
 
 
En
do
to
xe
m
ia
 
an
d 
as
ph
yx
ia
 
in
 fe
ta
l s
he
ep
 
 
 
 
 
 
 
 
75
 
Ta
bl
e 
4.
 P
er
ce
nt
ag
e 
Ca
rd
ia
c 
O
ut
pu
t i
n 
co
nt
ro
l a
nd
 e
nd
ox
in
 (L
PS
) t
rea
ted
 im
ma
tur
e f
eta
l s
he
ep
 
 
V
al
ue
s 
ar
e 
gi
v
en
 a
s 
m
ea
n
s 
±
 
SD
.
 
a<
0.
05
, b
<0
.0
1,
 
c<
0.
00
1 
sig
n
ifi
ca
n
t b
et
w
ee
n
 
gr
o
u
ps
; d
<0
.0
5,
 
e<
0.
01
, f
<
0.
00
1 
sig
n
ifi
ca
n
t v
er
su
s 
co
n
tr
o
l w
ith
in
 g
ro
u
ps
       Chapter 3 
 
 
76 
Discussion  
There is evidence from recent epidemiologic and clinical studies that exposure to intrauterine 
infection and chorioamnionitis is associated with white matter brain damage especially in very 
low birth weight infants (1,12). Lipopolysaccharides derived from the cell walls of gram-
negative bacteria seem to be the link between intrauterine infection and brain damage. 
Lipopolysaccharides stimulate astrocytes and microglia to produce large amounts of various 
	
				-
-1, and IL-6. Tumor 
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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		 !
combines with superoxide anion to peroxynitrate, a very reactive agent that destroys cell 
membranes and leads to cell death. In a recent in vitro study LPS caused a significant increase in 
TNF-		""	!terestingly, NO production 
was not modulated after oxygen-glucose deprivation in that experimental model (14). In 
addition, after oxygen-glucose deprivation, LPS did not affect the prolonged inhibition of 
protein synthesis, which is known to be a sensitive marker of neuronal cell death. The question 
therefore remains open whether fetal brain damage is brought about by a direct toxic effect of 
LPS on neuronal tissue or is caused by reduced cerebral oxygen delivery resulting from 
cardiovascular deterioration during endotoxemia.  
We therefore studied cardiovascular responses to LPS in preterm fetal sheep before, during, and 
after intrauterine asphyxia of 2 minutes duration. Infusion of LPS severely affected the fetal 
cardiovascular system. Within 30 minutes after asphyxia five of seven LPS-treated fetuses died 
of sustained circulatory decentralization. The most pronounced changes in organ blood flow 
were observed in the placenta and the fetal carcass. After injection of LPS the percentage of 
cardiovascular output distributed to the placenta decreased from 48% to 16%, whereas that to 
the carcass increased from 32% to 47%. These changes were accompanied by both hypoxemia 
and combined respiratory and metabolic acidosis.  
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Placenta 
Because the umbilical and placental vessels lack autonomic innervation (15), the regulation of 
umbilical and placental blood flow must depend on circulating or locally released vasoactive 
substances (16,17). In the fetal sheep the microcirculation of the placenta is remarkably inert to 
many vasoconstrictors, including norepinephrine and angiotensin II, whereas the umbilical 
artery and vein are more vasoactive (18,19). When endotoxin is administered to the pregnant 
ewe, there is a precipitous decrease in mean arterial blood pressure and uteroplacental blood 
flow, which is followed by a decrease in uteroplacental oxygen transfer to about one third of the 
control value (20). Interestingly, the same authors found no significant changes in cardiac output 
and umbilical blood flow in the acutely prepared fetal sheep even when they administered very 
large doses of endotoxin to the fetus (21). In the present study we found a highly significant 
decrease in placental blood flow and an increase in placental vascular resistance within 60 
minutes after LPS treatment. Because we did not measure umbilical venous blood pressure in 
the present study, it remains unknown whether the observed increase in placental vascular 
resistance was caused by vasoconstriction of the large umbilical arteries or the microcirculation. 
The increase in placental vascular resistance might be the result of endothelin-mediated 
vasoconstriction. Endothelin (ET-1) is a potent endothelium-derived vasoconstrictive peptide 
that is able to constrict fetoplacental microcirculation and decrease fetal oxygen consumption in 
sheep (22). Bacterial endotoxin or sepsis was shown to increase ET-1 concentrations in fetal 
umbilical arterial plasma more than fivefold in both pigs and humans, reaching levels close to 
threshold vasoconstriction (23). Therefore, the significant increase in placental vascular 
resistance in our model resulting in prolonged placental hypoperfusion and hypoxia seems to be 
mediated by LPS-induced production of ET-1 in the umbilical circulation.  
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Carcass 
The severe reduction in placental blood flow during the control period in the study group was 
accompanied by an inverse response in the fetal carcass. At that time moderate hypoxemia (SO2 
29.6 ± 20.7%) and acidosis (pH 7.16 ± 0.11) were present. Blood flow to the carcass decreased 
during severe maternal hypoxemia or reduction in uterine blood flow (10,24). It increased, 
however, during graded reduction in umbilical blood flow (25). Interestingly, oxygen 
consumption of the carcass decreased twice as much during uterine blood flow reduction (10) 
than during umbilical blood flow reduction (25), although in both studies total fetal oxygen 
delivery was reduced by a similar amount (50%). In the present study oxygen delivery to the 
carcass was not significantly different between control and study groups. However, arterial liver 
blood flow significantly increased during endotoxemia, which reflects the hyperdynamic early 
stage of sepsis, with subsequent local and systemic liberation of proinflammatory mediators. 
Fetuses treated with LPS did not have lower blood flow to the carcass despite moderate 
hypoxemia and acidosis during the control period, which reflects a lack of control of vascular 
resistance resulting in circulatory decentralization during and after asphyxia.  
 
Brain 
During the control period significant differences in blood flow to the brain were not observed in 
LPS-treated fetuses, although oxygen saturation decreased by 50%. This finding is surprising, 
because an inverse relationship between cerebral blood flow and arterial O2 content has been 
described in term and preterm fetal sheep (11, 26, 27). One possible explanation for this 
phenomenon might be that the physiologic mechanisms mediating the response of cerebral 
blood flow to hypoxia are altered by LPS. After 2 minutes of asphyxia, blood flow to the brain 
remained unchanged and did not differ between groups. During the immediate recovery period 
cerebral blood flow increased significantly in control fetuses, probably because of lower oxygen 
and higher carbon dioxide partial pressures. In addition, the increase in mean arterial blood 
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pressure also might have led to cerebral hyperperfusion, because autoregulation of cerebral 
blood flow is usually lost during hypoxemia (10). In contrast, LPS-treated fetuses had severe 
hypotension that was accompanied by a 50% reduction in brain blood flow compared with 
control fetuses. At mean arterial blood pressures of below 25–30 mmHg there is increased loss 
of cerebral autoregulation and hence reduced cerebral blood flow, which particularly affects the 
parasagittal region of the cerebrum and the white matter. Immature fetuses seem to be at risk by 
their limited ability to increase the cerebral circulation through vasodilation (27). This inability 
caused a prolonged and severe decrease in cerebral oxygen delivery below 3 mL O2/100 g tissue 
per minute. In a previous study in preterm fetal sheep, oxygen delivery below that threshold 
caused neuronal cell death (28).  
By analyzing the raw data on radionuclide counting in the lungs, we made some interesting 
observations. During and after asphyxia the percentage of injected microspheres trapped in the 
lungs of LPS-treated fetuses increased significantly compared with other organs (-60 minutes 
4.5 ± 0.8%; -1 minute 9.5 ± 3.5% [P < 0.05 versus -60 minutes] +2 minutes 24.9 ± 6.8% [P < 
0.01 versus -60 minutes]). Although we were not able to measure pulmonary blood flow exactly 
because we did not draw a reference sample from the pulmonary artery, the most obvious reason 
for this phenomenon would seem to be vasodilation of the pulmonary vascular bed. In fact, 
pulmonary vasodilation has been described after exposure to NO, a substance that is produced in 
large amounts after LPS application. These observations warrant further experiments to study 
the effects of LPS on pulmonary vascular control.  
It could be said that in the present study the LPS dose was excessive and that the failure of the 
LPS group to recover from asphyxia resulted from excessive application of endotoxin rather 
than from a combined effect of LPS and asphyxia. However, we believe that this is not very 
likely. Shortly before asphyxia (-1 minute) the cardiovascular system of the LPS-treated group 
was altered but not severely compromised, as shown in Table 1. Additional effects of asphyxia 
were observed at +2 minutes and +4 minutes. Thus, up to that time point the LPS dose was not 
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excessive. Furthermore, as mentioned in the Methods section, we studied fetal heart rate and 
mean arterial blood pressure in a pilot experiment after injection of LPS over 2 hours. Within 
this time interval we did not observe any significant changes in fetal heart rate (control 192; 1 
hour 207; 2 hours 175 bpm) or mean arterial blood pressure (control 55.8; 1 hour 51.9; 2 hours 
48.7 mmHg). We therefore think that the high rate of fetal demise in the present study was 
brought about by the combined effect of asphyxia and LPS and would not have been observed 
by the injection of LPS alone. However, that will have to be investigated in further studies. 
Experiments using smaller amounts of LPS to study longer recovery periods after asphyxia and 
endotoxemia are in progress.  
It is difficult to speculate whether the dose of LPS used in the present study would cause similar 
effects under clinical conditions. As we know from the literature, LPS has been used in a wide 
range of doses under various experimental conditions. One reason might be that the endotoxic 
effect of LPS varies widely with the bacterial strain from which it has been isolated as well as 
with the animal species into which it is injected. Experimental findings can therefore hardly be 
applied to the human situation. However, because severe endotoxemic shock has been described 
in preterm human neonates after ascending intrauterine infection, LPS-induced alterations of 
fetal cardiovascular control are likely to occur under clinical conditions as well.  
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Introduction: 
Fetal asphyxia is an important contributor to perinatal mortality and morbidity. The incidence of 
asphyxia has been reported to be between 0.29% and 0.9% depending on the inclusion criteria 
and the population studied (1). The ability of the fetus to mount an appropriate cardiovascular 
response to episodes of reduced oxygen supply is of great importance for its survival and 
development. When a fetus is exposed to asphyxia, several responses have been observed. First, 
there is a rapid fall in heart rate and a rise in peripheral vascular resistance. This is 
predominantly mediated by carotid chemoreflexes (2). After these changes, a maintained 
peripheral vasoconstriction and vasodilatation of cerebral, myocardial and adrenal beds occur. 
This mechanism, redistribution, results in blood flow being directed from peripheral tissues 
towards vital, centrally localized organs like the brain, heart and adrenals (3, 4, 5). The 
vasoconstriction is attributed to a rise in plasma catecholamines. In addition, hypoxia has a 
direct effect at a local tissue level, where the vascular endothelium may act as a hypoxic sensor 
and effector system. This has also been proven in fetal sheep where in late-gestation fetal lambs 
(132-140 days) fetal pulmonary vasoconstriction after acute constriction of the ductus arteriosus 
was mediated by NO-ET-1 interactions (6). This includes the release of a variety of vasoactive 
substances such as nitric oxide (NO), endothelin-1 and prostacyclin.  
NO is a free radical and is synthesized from the amino acide L-arginine and oxygen through a 
reaction which is catalysed by nitric oxide synthase (NOS) (7,8). NO relaxes vascular smooth 
muscle through intracellular processes some dependent (1) and some independent of cGMP (8). 
Several isoforms have been purified and cloned. These include the calcium-dependent isoforms 
(isolated from nerve and endothelial cells), nNOS and eNOS, and the inducible calcium-
independent isoform (iNOS) (9, 10). All three isoforms of NOS can be expressed in large blood 
vessels (11, 9, 12, 13). After the infusion of NOS-inhibitors fetal heart rate falls, whereas arterial 
blood pressure progressively rises (14). In addition, cardiac output is severely reduced (15) and 
an increase in carotid, femoral, and placental vascular resistance can be observed (14, 15, 16).  
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However, after prolonged inhibition of NOS, this system is replaced by alternative mechanisms 
regulating fetal cardiovascular control (10). During hypoxia, arterial blood pressure does not rise 
and rebound tachycardia is absent, if NOS is inhibited by L-NAME. Furthermore, the increase 
in carotid blood flow and fall in vascular resistance is blunted (14). Thus, NO seems to alter 
fetal cardiovascular control during basal and hypoxic conditions.  
Nevertheless, the impact of NO on fetal cardiovascular control is only partially understood and 
as yet no studies have been performed on the effects of NO on fetal blood flow distribution after 
acute hypoxia. In particular, there is a significant lack of data on NO-mediated blood flow 
regulation in 0.75 gestation fetuses. Hence, the role of NO in redistributing cardiac output 
towards the central organs, i.e. brain, heart, adrenals, during asphyxia in immature fetuses 
remains unexplored. We therefore studied the distribution of cardiac output in 0.75 gestation 
sheep during normoxia and acute hypoxia. NOS was inhibited using nitro-L-arginine methyl 
ester (L-NAME). 
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Methods: 
Animal preparation 
Thirteen fetal sheep were chronically instrumented at a mean gestational age of 107 ± 1 days 
(term is 147 days). All ewes underwent surgery with use of sterile techniques while they were 
under general anesthesia (thiopental sodium 1 gm/70 kg intravenously for induction, 0.5-1.0% 
halothane in a 1:1 nitrous oxide and oxygen mixture for maintenance). The ewes received 1 gm 
ampicilline (Pentrexyl®; Bristol-Myers, Woerden, The Netherlands) s.c. and 10 µg 
buprenorphin (Temgesic®; Schering, The Netherlands) per kg body weight twice a day for three 
consecutive postoperative days. A midline abdominal incision was performed. A snare was 
placed around the maternal distal aorta below the renal artery to induce fetal hypoxia (24). The 
fetal limbs were identified and exteriorised through an incision in the uterus. Polyvinyl catheters 
(Maxxim Medical BV, Den Bosch, The Netherlands) with 0.75 mm inner diameter and 1.25 mm 
outer diameter were inserted via a tibial fetal vein and artery of each hindleg and advanced into 
the caudal vena cava and abdominal aorta, respectively. Catheters were also placed into both 
brachial arteries. The fetal skin was closed with cyanoacrylate glue (Cyanolit, Japan). An 
intrauterine pressure catheter was inserted, and the uterus was sutured after replacing the 
amniotic fluid with a 0.9 %saline solution at 390C. Catheters were filled with heparin (500 
IU/ml; Heparin-Natrium®, Braun, Melsungen, Germany) and exteriorised through a small 
incision in the flank of the ewe. Catheters were protected by a pouch sewn to the skin of the 
ewe. A recovery period of 72 hours followed the operation before experiments were started. 
Ewes were housed in individual cages and had free access to food and water. 
Guidelines for care and use of animals, as approved by the local Animal Medical Ethics 
Committee at Maastricht University, were followed.  
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Experimental protocol 
The experiments were performed 3 days after the surgical procedure at 110 ± 1 days. This 
recovery period is generally accepted as an adequate recovery period from surgical stress in the 
model at hand. Seven fetuses were treated with a 30 mg bolus i.v. L-NAME (at –70 min) 
followed by a continuous L-NAME i.v. infusion of 6 mg/min until the end of the experiments 
(+30 min) (Sigma Aldrich, Zwijndrecht, The Netherlands), while the remaining six fetuses 
received vehicle solution (NaCl 0.9%). The applied dosage of L-NAME was within the 
therapeutic range as described in the literature (16). To determine the effects of L-NAME on 
circulatory centralization before, during and after hypoxia, blood flow to fetal organs and the 
distribution of combined ventricular output were measured by injecting five batches of 
differently labeled isotope microspheres (141 Ce, 114 In, 113 Sn, 103 Ru and 46 Sc, 16 µm diameter, 
New England Nuclear, Boston, MA, USA) into the inferior vena cava (17, 18). Depending on 
the specific activity, 0.7-1.8 million microspheres were injected over a period of 20 seconds, 
before infusion of L-NAME (at –75 min), before the onset of maternal aorta occlusion (-1 min), 
at the bottom of hypoxia (+2 min), and after the release of the snare (+4 min and +30 min) with t 
0 being the start of the full occlusion of the maternal aorta. Reference blood samples were 
withdrawn from both a carotid and a femoral artery at a rate of 1.75 ml/min. Sampling was 
continuous for 390 s from –1 to +5.5 min. Separate samples were taken for 90 s at control (-75 
min) and during recovery (+30 min). The volume of blood withdrawn was simultaneously 
replaced by maternal blood maintained at 390C in a waterbath. The experimental protocols were 
approved by the Animal Medical Ethics Committee of Maastricht University and met the 
guidelines of the responsible governmental agencies.
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Measurements 
Fetal heart rate and mean blood pressure were continuously recorded during the experiment on a 
personal computer, using a customized hemodynamic data acquisition system. 
Before each blood flow measurement, and additionally at –30 min, blood samples were taken 
from the fetal descending aorta and analysed for blood gases, acid base balance (AVL 993, 
Radiometer, Copenhagen, Denmark), hemoglobin concentration and arterial oxygen saturation 
of hemoglobin (OSM 2 Hemoximeter, Radiometer, Copenhagen, Denmark). The hemoximeter 
was calibrated to fetal sheep hemoglobin. HCO3- concentration was calculated by the blood gas 
analyzer according to the following formula: HCO3- =0.0307 x PCO2 x 10(pH-6.105). At the 
same time points, glucose and lactate were measured (YSI, 2300 Statplus Analyzer/2, Yellow 
Springs Instruments, Ohio, United States). 
After the experiment animals were humanely killed using a lethal intravenous dose of sodium 
pentobarbitone (Euthesate®; Apharmo, Duiven, The Netherlands) which was administered to the 
ewe. The fetuses were perfused in utero with 200 ml formalin (10%, w/v, saline). Fetal organs 
were weighed and placed in vials, which were filled to the same height to reduce variations in 
geometry. The intestines were separated from the mesentery, opened and cleared from contents. 
Paired organs (lungs, kidneys, and adrenals) were counted separately, as were the right and left 
sides of the cerebrum. Significant preferential streaming of microspheres could not be detected. 
Specimens of skin and muscle were taken from the hips and shoulders. Cotyledons, upper and 
lower carcass were homogenized with a meat chopper and the samples placed in vials. 
The applied solid-state semi-conductor gamma counter (thallium activated, sodium iodine 
crystal) had a high energy resolution of about 2 keV and was connected to a multichannel 
(1024) pulse height analyzer (LKB 1282, Compugamma, Wallac, Turku, Finland). The results 
were normalized with respect to time and sample weight. 
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Calculations 
Fetal combined ventricular output (CVO) and blood flow to the various organs were calculated 
from counts of the injected nuclide recovered in fetal organs or placenta, from counts in the 
appropriate reference samples, and from the withdrawal rate of the reference samples (17,18). 
Blood flows below 1 ml/min/100 gram were treated as 1. 
The percentage of combined ventricular output distributed to a given organ was calculated from 
the absolute blood flow to that organ and the combined ventricular output. Oxygen delivery to 
the various organs ([DO2]; ml O2/min/100g) was calculated according to the following formula: 
organ blood flow (ml/min/100g) x SO2 x hemoglobin (g/ml) x 1.34 (ml O2/g Hb). 
Statistics 
Results are given as means ± SEM. The data were analysed for intra- and intergroup differences 
by two-way multivariate analysis of variance for repeated measures. Games-Howell-test was 
used as post-hoc testing procedure. Statistical analysis was performed by Super Anova 
Statistical Package (Abacus, Inc. Ca. USA). 
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Results: 
Blood gases, MAP and FHR  
At the beginning of the experiments (- 75 min), blood gases (Table 1), MAP and FHR (Fig 1 
and 2) were within the normal range for chronically prepared fetal sheep (19, 5). Acute hypoxia 
caused a severe fall in oxygen saturation, pH and BE as well as a rise in PCO2 and plasma 
lactate concentration. Except for a significant decrease in pH and BE at the end of the recovery 
period (+30 min) and a transient rise in hemoglobin, differences between the two treatments 
could not be detected in these variables (Table 1). 
 
Table 1. Acid-base balance and blood gases in control (n=6) and L-NAME treated (n=7) 
premature sheep, given as means ± SE 
  normoxia occlusion recovery 
Time  -75 -30 -1 2 4 30 
SO2 (%) Control 49.9±4.3 43.9±6.2 44.5±3.8 2.5±0.8 # 34.6±6.7 37.0±5.5 
 L-Name 40.1±6.6 35.0±7.6 35.6±9.1 2.0±1.2 # 30.5±3.4 26.1±7.9 
PCO2 (mmHg) Control 47.7±1.6 48.8±1.8 51.3±1.0 69.0±3.0 58.7±1.8 47.8±4.3 
 L-Name 50.6±1.7 48.4±4.1 52.0±2.5 72.6±3.2 # 61.9±2.8 51.0±12.0 
PO2 (mmHg) Control 26.5±3.1 24.0±2.2 25.6±2.8 4.7±1.7# 26.9±2.2 25.3±1.7 
 L-Name 25.9±1.8 24.3±1.9 25.4±1.7 14.4±3.7*,# 24.6±2.1 22.7±1.9 
pH Control 7.35±0.01 7.34±0.01 7.33±0.01 7.15±0.01 # 7.21±0.02 # 7.27±0.02 
 L-Name 7.33±0.02 7.29±0.01 7.27±0.01 7.12±0.01 # 7.15±0.01 # 7.14±0.04*,# 
BE (mmol/L) Control 1.3±1.0 0.9±0.7 1.4±0.4 -4.3±0.3 # -4.5±1.4 # -3.7±1.1 # 
 L-Name 0.3±0.5 -3.4±1.6 -2.6±0.7 -6.3±1.1 # -7.8±0.6 # -9.0±1.2 *,# 
Glucose Control 0.58±0.1 0.61±0.1 0.60±0.1 0.16±0.1 0.51±0.1 1.00±0.2 
 L-Name 0.68±0.1 0.61±0.1 0.62±0.1 0.14±0.0 # 0.49±0.1 1.30±0.2 # 
 Lactate Control 1.4±0.2 1.4±0.3 1.4±0.3 3.0±0.5 # 3.5±0.4 # 3.0±0.7 # 
 L-Name 1.3±0.2 1.4±0.3 1.4±0.3 2.7±0.4 # 3.4±0.3 # 3.9±0.4 # 
Hb (g/dl) Control 9.2±0.3 9.3±0.7 9.3±0.6 10.7±0.4 10.3±0.5 9.4±0.9 
 L-Name 9.3±0.5 10.8±0.5 # 10.5±0.8 11.8±0.6 # 11.1±0.4 # 10.4±0.2 
Values are given as means ± standard error.    
* P<0.05, significant between groups at the same timepoint.   
# P<0.05, significant versus control at timepoint t –75 within group. 
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After injection of L-NAME, fetal MAP increased significantly by 16 % (p<0.05) while FHR fell 
significantly by 17 % (p<0.05 ) in contrast to the control group where FHR and MAP did not 
change during normoxia. During acute hypoxia (+2 min) MAP rose significantly (p<0.05) and 
FHR was maintained in the L-NAME group in contrast to controls where MAP initially 
decreased and then returned to control values while FHR fell significantly (p<0.05). In the 
immediate recovery period, MAP was still higher and FHR lower after L-NAME infusion 
compared to control values (p<0.05) (Figures 1 and 2). Thus, there was a significant higher 
MAP and lower FHR in the L-NAME group compared to the control group during normoxia. 
During the hypoxia period FHR was not different between the two groups, although MAP was 
significantly higher in the L-NAME group (p<0.05). During the recovery period MAP was still 
significantly higher and FHR was significantly lower (p<0.05) in the L-NAME group (p<0.05). 
 
Table 2. Blood flows in control (n=6) and L-NAME treated (n=7) premature sheep.  
  
  normoxia occlusion recovery 
  -75 -1 2 4 30 
blood flow (ml/min/100 gram) 
CVO Control 591.5±30.3 400.9±16.9 # 206.1±42.3 # 460.1±73.6 521.6±61.8 
 L-Name 602.1±63.4 218.9±18.7 *,# 78.4±12.3 *,# 109.2±9.7 211.3±34.5 *,# 
placenta Control 269.6±30.2 189.6±19.9 # 92.2±34.2 # 251.0±45.7 253.2±33.7 
 L-Name 267.7±36.2 92.2±10.3 *,# 32.6±8.7 # 44.6±7.6 *,# 92.9±15.7 *,# 
fetal body Control 321.9±38.4 211.3±32.5 # 113.9±14.6 # 209.1±35.7 268.4±46.7 
 L-Name 334.4±33.2 126.7±13.4 # 45.8±6.7 # 64.6±5.6 *,# 118.4±20.9 *,# 
percentage cardiac output 
placenta Control 45.6±4.0 47.3±3.6 44.7±7.4 54.6±4.6 48.5±4.5 
 L-Name 44.5±2.8 42.1±3.4 41.6±6.6 40.8±4.6 * 44.0±3.6 
fetal body Control 54.4±4.1 52.7±3.6 55.3±7.4 45.4±4.6 51.5±4.5 
 L-Name 55.5±2.8 57.9±3.4 58.4±6.6 59.2±4.6 * 56.0±3.6 
CVO Combined Ventricular Output 
Values are given as means ± standard error.  
* P<0.05, significant between groups at the same timepoint.     
# P<0.05, significant versus control at timepoint t –75 within group. 
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Table 3. Organ blood flows in control (n=6) and L-NAME treated (n=7) premature sheep 
blood flow (ml/min/100 gr) 
  control occlusion recovery 
  -75 -1 2 4 30 
heart Control 418.2±75.0 293.8±70.1 632.1±16.8 # 672.2±72.4 # 530.2±53.2 
 L-Name 438.0±45.0 245.6±22.7 # 528.2±33.3 268.3±23.4 * 316.2±25.0 * 
brain Control 167.3±50.5 93.7±21.1 145.9±30.1 237.6±37.4 152.4±31.9 
 L-Name 223.1±26.9 101.6±19.4 # 123.6±21.3 # 158.4±23.6 # 154.3±14.5 # 
cerebrum Control 118.6±25.8 61.8±3.6 # 97.6±15.8 178.1±31.1 # 110.2±21.6 
 L-Name 132.5±18.3 60.0±11.8 # 54.7±12.5 # 85.4±15.4 *,# 83.8±11.7 # 
brainstem Control 260.6±58.7 157.8±36.7 288.3±41.0 386.5±30.3 # 244.0±51.7 
 L-Name 311.4±37.0 147.1±27.6 # 211.0±30.5 212.6±37.6 * 193.3±38.9 # 
nucl caudatus Control 152.5±40.0 81.1±12.2 # 109.0±16.9 166.5±18.3 139.9±28.7 
 L-Name 163.5±19.4 72.8±14.5 # 77.2±18.0 # 86.2±14.7 *,# 112.6±16.6 
cerebellum Control 228.1±52.6 118.3±18.6 # 169.9±28.0  279.5±39.0 213.0±47.0 
 L-Name 220.0±27.1 92.6±18.3 # 102.2±23.1 # 142.5±24.0 134.5±21.2 # 
hippocampus Control 143.1±31.3 78.1±8.8 # 141.4±16.8 220.2±33.0 # 154.0±32.4 
 L-Name 189.0±22.9 91.3±18.5 # 119.0±24.3 # 133.3±25.7 * 122.6±18.5 # 
(hypo)thalamus Control 195.8±44.7 100.8±10.8 # 192.5±28.4 343.8±65.6 # 233.3±50.6 
 L-Name 237.8±27.9 112.9±21.0 #   145.9±24.1 # 173.1±30.0 * 180.8±14.3 
pons Control 322.7±76.0 160.1±17.8 # 380.3±52.7 527.0±66.9 # 344.9±78.9 
 L-Name 388.2±48.0 178.7±33.4 # 296.8±41.3 277.4±52.5 * 249.9±41.9 # 
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Table 3 continued 
 
 
  normoxia occlusion recovery 
  -75 -1 2 4 30 
adrenal Control 477.6±100.8 347.5±84.5 605.6±145.9 1016.6±255.3 597.3±142.8 
 L-Name 441.3±96.0 192.0±28.0 198.4±54.2 215.9±29.5 * 451.2±52.2 
kidney Control 162.5±20.4 141.3±17.9 21.1±9.2 # 101.5±30.0 # 195.7±28.9 
 L-Name 215.3±23.2 115.7±9.7 # 18.7±7.1 # 50.3±5.9 # 146.7±21.8 
gastro-intestinal Control 71.1±22.5 61.1±11.1 6.1±2.0 # 56.7±17.1 71.5±18.7 
 L-Name 60.1±5.6 21.3±1.9 *,# 6.5±1.0 # 10.0±8.0 *,# 19.9±3.4 
liver Control 4.4±0.6 3.4±0.5 1.7±0.4 2.5±0.4 3.3±0.7 
 L-Name 5.5±0.7 2.5±0.3 1.4±0.6 0.5±0.2 2.3±1.0 
muscle Control 29.5±6.6 14.5±1.9 # 5.5±4.0 # 10.0±4.2 # 18.5±2.6 *,# 
 L-Name 32.7±6.1 11.6±1.6 # 1.1±0.4 # 1.5±0.3 # 7.3±2.2 # 
spleen Control 332.3±62.0 218.1±58.0 11.1±5.0 # 74.3±14.2 # 240.9±65.8 
 L-Name 385.3±62.0 230.7±38.8 # 2.9±0.8 # 18.0±4.3 # 147.5±48.8 
carcass Control 37.2±5.9 17.0±3.5 # 6.2±2.5 # 10.9±1.0 # 23.9±3.9 # 
 L-Name 38.5±3.8 13.9±1.5 # 1.9±0.6 # 4.9±0.6 # 12.0±2.5 *,# 
 
Values are given as means ± standard error.  
# P<0.05, significant versus control at timepoint t –75 within group. 
P<0.05, significant between groups at the same timepoint. 
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Figure 1: Mean Arterial Pressure  
Figure 2: Fetal Heart Rate 
Changes in mean arterial pressure and fetal heart rate in control (n=6) and L-NAME treated 
(n=7) 0.75 gestation sheep before, during and after acute hypoxia. 
*  P<0.05 between the groups at the various timepoints 
Changes within groups are not depicted. 
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Blood flow 
Cardiac Output 
A decrease in cardiac output by 32% occurred in the control group during the control period, 
which was as a consequence reflected in organ blood flows (table 2 and 3). In the control group, 
hypoxia caused a severe fall in cardiac output followed by a full recovery thereafter. In the L-
NAME group, L-NAME injection reduced cardiac output by 64 % during normoxia. In contrast 
to controls cardiac output remained low in fetuses of the L-NAME group throughout the entire 
recovery period (Table 2). 
Placenta 
As with cardiac output, placental blood flow declined by 66 % after L-NAME injection (-1 min) 
and dropped to 12 % of the control value at the nadir of hypoxia (+ 2 min) (Table 2). In the L-
NAME group, blood flow increased only partially after occlusion and was significantly lower 
during the recovery period (+4 min and +30 min). As compared to untreated fetuses, the 
resistance in the placental circulation at the maximum of hypoxia (+2 min) was significantly 
higher while the percentage of cardiac output distributed to the placenta during the immediate 
recovery period (+4 min) was lower (Table 2). 
Fetal body 
Blood flow to the fetal body decreased in both groups and although this decrease was more 
pronounced in the L-NAME group this was not significantly different from the decrease in the 
control group (+2 min), but the rise in blood flow thereafter was much lower in the L-NAME 
group (+4 min and +30 min) (Table 2). Shortly after hypoxia the percentage of cardiac output 
distributed to the fetal body was higher after L-NAME infusion (Table 2). 
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Blood flow to various organs 
Heart 
In both groups, cardiac blood flow rose during aorta occlusion. However, shortly thereafter, 
blood flow to the heart fell again in the L-NAME treated fetuses and remained low until the end 
of the experiments (+ 30 min) (Table 3).  
 
Brain 
Blood flow to the brain decreased by 55 % after L-NAME administration. Shortly after hypoxia 
(+4 min), the rise in cerebral blood flow was more pronounced in the control group (Table 3). 
As with blood flow to the brain oxygen delivery fell to very low levels during aortic occlusion 
and did not recover completely (Figure 3). In deeper parts of the brain the changes in blood flow 
resembled those seen in the cerebrum, with almost only a minor increase in blood flow after 
occlusion in the L-NAME group in comparison to controls (Table 3). 
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Figure 3. Oxygen delivery to the brain 
 
Oxygen delivery to the brain (ml O2/minute × 100 g) in control (n=6) and L-NAME treated 
(n=7) immature fetal sheep before, during and after acute hypoxia.  
**  P<0.001 between the groups at timepoint t +4.
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Table 4. % Cardiac output in control (n=6) and L-NAME (n=7) treated premature fetal sheep. 
  normoxia occlusion recovery 
  -75 -1 2 4 30 
heart Control 4.3±0.6 7.2±3.2 23.7±5.0 # 10.6±1.5 # 6.5±0.4 
 L-Name 2.9±0.4 4.4±0.4 28.0±2.8 # 9.8±1.1 # 6.5±1.1 
brain Control 3.8±0.6 3.7±0.3 14.7±3.3 # 10.1±2.6 # 4.9±0.9 
 L-Name 2.7±0.3 3.7±0.6 12.2±2.3 # 12.8±3.4 # 5.8±2.0 
cerebrum Control 2.1±0.5 2.2±0.3 6.6±1.9 # 5.9±1.8 # 2.5±0.7 
 L-Name 0.6±0.1 0.6±0.1 1.8±0.5 * 2.0±0.6 * 1.2±0.4 
brainstem Control 1.6±0.6 1.0±0.1 5.2±1.0 # 2.9±0.5 1.2±0.4 
 L-Name 1.4±0.2 1.7±0.3 7.5±1.4 # 7.1±1.7 *,# 3.5±1.2 
adrenal Control 0.2±0.0 0.2±0.1 0.8±0.2 # 0.5±0.2 0.2±0.1 
 L-Name 0.1±0.0 0.2±0.0 0.5±0.1 0.4±0.1 0.5±0.1 
carcass Control 37.5±3.3 31.8±4.3 16.7±2.4 # 16.9±3.1 # 29.9±3.4 
 L-Name 46.2±2.1 45.6±2.8 * 17.0±4.3 # 32.7±4.0 *,# 39.5±2.3 
 
Values are given as means ± standard error.  
# P<0.05, significant versus control at timepoint t –75 within group 
P<0.05, significant between groups at the same timepoint. 
 
Adrenal 
Blood flow to the adrenals decreased by 57 % immediately after L-NAME injection and 
remained low compared to the control group where there was an increase in blood flow during 
and after aorta occlusion (+2 and +4 min) (Table 3).  
Carcass 
During hypoxia, changes in blood flow to the carcass were very similar in the two groups. In the 
L-NAME group the increase in percentage cardiac output during the recovery period was less 
than that measured in the control group. 
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Comments 
NO is known to be a potent mediator in the regulation of resting tone in cerebral, renal, 
mesenteric and hindquarter vascular beds and hence in blood pressure homeostasis in adults 
(19,20). There is also some suggestion that NO contributes to cardiovascular control during 
hypoxia in adults and 0.75 gestation sheep (19, 14, 20). NO might mediate the fetal circulatory 
centralization that occurs during partial cord occlusion (21). There is also evidence that NO 
regulates the rise in fetal cerebral blood flow and fall in carotid vascular resistance seen during 
hypoxia (14). Nevertheless, the impact of NO on fetal cardiovascular control is only partially 
understood and especially in 0.75 gestation fetuses, there is significant lack of data on NO-
mediated blood flow regulation. There are no data concerning the impact of NO on the regional 
blood flow distribution using radioactive microspheres. Also, blood flow changes in a chronic 
sheep model using acute hypoxia, are not yet studied. We therefore examined the distribution of 
cardiac output in 0.75 gestation sheep during normoxia and acute hypoxia studying a large 
amount of organs. NOS was inhibited using nitro-L-arginine methyl ester (L-NAME). 
 
The amount of hypoxia was quite severe since oxygen content fell almost to zero at the bottom 
of hypoxia but also recovered quickly during recovery period. Since none of the control animals 
became acidemic the hypoxic period was not too extreme. Intravenous application of L-NAME 
to 0.75 gestation fetal sheep resulted in bradycardia, hypertension and a significant fall in 
combined cardiac output. Blood flow to the fetal body and placenta decreased by more than 60 
%. During acute hypoxia, L-NAME did not change the redistribution of cardiac output towards 
the central organs. However, the control of fetal heart rate and blood pressure was altered in the 
L-NAME group. After hypoxia L-NAME delayed the recovery of cardiac output and blunted the 
increase in blood flow to the brain and heart. NO, therefore, seems to play a role in fetal 
cardiovascular control during normoxia and acute hypoxia. An alternative explanation for part 
of the observed changes might be a direct action of NO on the heart itself. 
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The rise in MAP after L-NAME injection was most likely caused by systemic and umbilico-
placental vasoconstriction due to inhibition of NOS. The simultaneous fall in fetal heart rate that 
seems to result from baroreflex activation associated with an increased vagotonus exerting a 
direct effect on the sino-atrial node (22). In addition, inhibition of NOS was also accompanied 
by a transient rise in hemoglobin concentration. Since no significant release of erythrocytes 
occurs from storage sites such as the spleen in chronically instrumented fetal sheep (23), the 
most plausible explanation for this finding is a reduction in plasma volume associated with a 
fluid shift from intravascular to extravascular compartments. One factor that presumably 
contributed to such a fluid shift is the high permeability of fetal capillaries, which predisposes to 
transudation of fluid across the capillary membrane with increases in hydrostatic pressure (24). 
In line with this proposal, increases in hemoglobin concentration accompanied by falls in fetal 
blood volume have been reported after elevation of fetal blood pressure following infusion of 
vasoconstrictor compounds such as norepinephrine, epinephrine and angiotensin II (25, 26).  
 
The observed changes in MAP, FHR, and hemoglobin concentration that were found to 
accompany inhibition of NOS are particularly relevant, since increases in MAP (27, 28), 
reductions in FHR (29), hemoconcentration (30), and fall in circulating blood volume (31) all 
reduce fetal cardiac output. It is therefore likely that these alterations contribute to the fall in 
combined ventricular output evident with inhibition of NOS (15). The fall in fetal cardiac output 
in 0.75 gestation sheep after blockade of NOS seems to be much more pronounced than in term 
fetal sheep.  
During acute hypoxia redistribution of cardiac output towards the central organs was not 
influenced by L-NAME suggesting that chemoreflex mechanisms remained intact. The 
observation that MAP rose significantly in the L-NAME group suggests that the activity of 
vasoconstrictive mechanisms during acute hypoxia in 0.75 gestation sheep is counteracted by 
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NO under normal circumstances. This is also true for the immediate recovery period. 
Furthermore, L-NAME seems to inhibit baroreflex activation during acute hypoxia, since the 
rise in MAP was not accompanied by a fall in FHR in the L-NAME group. This observation 
concurs with a previous report showing that the sensitivity of the baroreflex is reduced by NOS 
inhibition (28) in the rat.  
 
During the immediate recovery period, the increase in blood flow to the heart and brain was 
blunted in the L-NAME group suggesting that in the vascular bed of these organs hypoxia-
induced hyperperfusion is mediated via activation of NOS. This observation ties in with 
previous studies showing that NOS inhibition attenuated the delayed rise in brain blood volume 
after cerebral ischemia (31). Van Bel and co-workers (32) described that NO mediates resting 
tone in the fetal cerebral vascular bed and is required for hypoxia-induced vasodilation. Recent 
work by Blood et al show that adenosine can account for virtually all of cerebral blood flow 
increases during acute hypoxia in near-term fetal sheep (33). 
Faraci and colleagues (34) reported how NO influences the resting tone of vessels but that the 
effect was greater in larger vessels. In the present study regional differences in vascular control 
within the brain could not be detected after L-NAME application. The hypoxia-induced 
activation of NOS seems therefore to be quite uniform throughout the cerebral circulation.  
 
L-NAME attenuated the postasphyxic rebound tachycardia observed in the control group. The 
absence of rebound tachycardia has been described earlier (14). This effect might be attributed 
to a possible reduction in catecholamine release from adrenals during acute hypoxia in 
connection with the abolished increase in adrenal blood flow after L-NAME. In addition, 
application of L-NAME could have inhibited NO mediated heart rate responses to adrenaline 
(19).  
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The recovery of cardiac output after hypoxia was considerably delayed in the L-NAME group. 
Placental hypoperfusion was followed by progressive fetal deterioration resulting in hypoxemia 
and acidemia.    
The decrease in cardiac output in the control group before hypoxia is significant, and this 
decrease in cardiac output during control measurements is then reflected in nearly all other 
organ blood flow measurements. A number of shortcomings, which are difficult to control for in 
such a complicated model, may be responsible for this effect. Firstly, fetal stress may occur 
from handling during repeated flushing of vascular catheters, sampling and blood withdrawal 
and infusion. Secondly, the three-day post surgical period may have been too short for the 
fetuses to recover and be stable. Thirdly, the impact of extensive fetal instrumentation with 
arterial and venous catheters in fore and hindlimbs, a prerequisite for complete fetal organ blood 
flow measurements, may have caused perturbation of the physiological status, as damage in 
downstream tissues will occur and release of cytokines and vasoactive substances ensues (35), 
especially as catheterisation in smaller peripheral vessels is limited with younger gestational age 
and smaller fetuses. Furthermore, one cannot rule out chance happenings as may occur with the 
microsphere technique. This potential bias appears to be unavoidable in this model as we have 
observed this untoward effect also in earlier studies with the same experimental setup (36). The 
results are therefore to be interpreted  in view of  these premises. 
Despite these limitations the current study documents the essential role of  NO in the fetal 
circulation both during normoxia and acute hypoxia in the preterm sheep. 
In conclusion, inhibition of NOS causes fetal bradycardia and transient hypertension. This is 
accompanied by a severe fall in combined cardiac output without any considerable redistribution 
of blood flow. During acute hypoxia application of L-NAME does not alter fetal circulatory 
centralisation, but it prevents baroreflex-induced bradycardia. Activation of NOS seems to 
mediate the hypoxia-induced rise in blood flow to the heart and brain. The recovery of cardiac 
output after acute hypoxia is considerably delayed by application of L-NAME and associated 
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with progressive fetal deterioration. These results indicate that NO plays a role in maintaining 
organ and placental perfusion and regulating vascular tone during both normoxia and hypoxia in 
preterm sheep. 
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Introduction 
Newborn encephalopathy was previously thought to be caused by birth asphyxia in the majority 
of cases, but studies of antenatal and intrapartum factors involved in the development of cerebral 
palsy have identified other etiologies such as intra uterine growth retardation, metabolic 
diseases, clotting disorders and infection. The causes of newborn encephalopathy are thus 
heterogenous and many relate to the antepartum period (1). Birth asphyxia is often preceded by 
antenatal infections and therefore often linked to the occurrence of brain damage (2). Combined 
exposure to perinatal infection and birth asphyxia dramatically increases the risk of spastic 
cerebral palsy (3). On the long term, other studies have shown that antenatal exposure to intra-
amniotic inflammation and evidence of a systemic fetal inflammatory response such as funisitis 
are strong and independent risk factors for the subsequent development of cerebral palsy at the 
age of 3 years (4). 
The exact mechanism by which asphyxia and infection are linked in the development of brain 
damage is not yet understood. In this process, several products like LPS (lipopolysaccharides, 
pyrogens that are derived from cell walls of gram-negative bacteria during infection) may play a 
role. LPS stimulates astrocytes and microglia to produce various cytokines such as TNF-α, IL-
1β and IL-6. Recent clinical studies have demonstrated that expression of TNF-α, IL-1β, and 
IL-6 is much higher in brains with periventricular lesions (PVL) than in those without PVL (5). 
The mothers of newborns with brain white matter lesions had higher concentrations of these 
cytokines in their amniotic fluid than did mothers delivered of newborns without white matter 
lesions (6). 
Hypoxia/ischemia also induces an inflammatory response in the immature rodent central 
nervous system, characterized by the very early expression of IL-1β and TNF-α (7). The latter 
induces nitric oxide (NO) production in astrocytes (8). 
NO, a vascular and neuronal messenger and a cytotoxic and cytostatic agent, is synthesized from 
L-arginine by the enzyme nitric oxide synthase (NOS) (9). In a study on the effects of LPS on 
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the fetal circulation during normoxia and hypoxia, we found that endotoxemia resulted in 
prolonged placental hypoperfusion and reduction in oxygen delivery to the brain, which may 
contribute to perinatal brain damage in preterm fetal sheep. Furthermore, LPS blunted 
circulatory centralisation, resulting in decreased blood flow to the placenta and brain, while that 
to the carcass, heart, lungs and adrenals increased (10). 
Our hypothesis was that LPS-induced peripheral vasodilation and the circulatory 
decentralisation during acute hypoxia might be NO-mediated. 
Therefore, we studied the effects of LPS after blocking the NOS system using nitro-L-arginine 
methyl ester (L-NAME) in 0.75 gestation fetal sheep. 
 
Methods 
Animal preparation 
Fifteen preterm sheep were chronically instrumented at a mean gestational age of 107 ± 1 days 
(term is 147 days). All ewes underwent surgery with use of sterile techniques while they were 
under general anesthesia (thiopental sodium 1 gm/70 kg intravenously for induction, 0.5-1.0% 
halothane in a 1:1 nitrous oxide and oxygen mixture for maintenance). The ewes received 1 gm 
ampicilline (Pentrexyl®; Bristol-Myers, Woerden, The Netherlands) s.c. and 10 µg 
buprenorphin (Temgesic®; Schering, The Netherlands) per kg body weight twice a day for three 
consecutive postoperative days. A midline abdominal incision was performed. A snare was 
placed around the maternal distal aorta below the renal artery to arrest uterine and ovarian blood 
flow and to induce fetal asphyxia. The fetal limbs were identified and through an incision in the 
uterus exteriorised. Polyvinyl catheters (Maxxim Medical BV, Den Bosch, The Netherlands) 
with 0.75 mm inner diameter and 1.25 mm outer diameter were inserted via a tibial fetal vein 
and artery of each hindleg and advanced into the caudal vena cava and abdominal aorta, 
respectively. Catheters were also placed into both brachial arteries. The fetal skin was closed 
with cyanoacrylate glue (Cyanolit, Japan). An intrauterine pressure catheter was placed, and the 
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uterus was sutured after replacing the amniotic fluid with a saline solution at 390 C. Catheters 
were filled with heparin (100 IU/ml; Heparin-Natrium®, Braun, Melsungen, Germany) and 
exteriorised through a small incision in the flank of the ewe. Catheters were protected by a 
pouch sewn to the skin of the ewe. A recovery period of 72 hours followed the operation before 
experiments were started. Ewes were housed in individual cages and had free access to food and 
water. 
Guidelines for care and use of animals met the guidelines of the responsible governmental 
agencies and were approved by the Animal Medical Ethics Committee of Maastricht University. 
 
Experimental protocol 
The experiments were performed 3 days after the surgical procedure at 110 ± 1 days. After 
control measurements of blood flow and physiological variables, eight random selected fetuses 
were injected with a 30 mg intravenous bolus L-NAME (t –75) (Sigma Aldrich, Zwijndrecht, 
The Netherlands) followed by a continuous L-NAME infusion of 6 mg/min. Adequate blockade 
of NOS was proven by injection of 2 µg acethylcholine (ACH) intravenously. Before NOS 
inhibition, ACH induced a decrease in MAP of ± 15 mm Hg which was completely abolished 
with NOS inhibition. All fifteen fetuses received LPS (51 ± 7 µg/kg) (t = -60) (E.Coli; 0127:B8, 
Sigma Aldrich, Zwijndrecht, The Netherlands) in the same dose as in our previous study namely 
50 µg/kg estimated fetal weight (13). To determine the effects of L-NAME and endotoxemia on 
the time course of circulatory centralization before, during and after hypoxia, blood flow to fetal 
organs and the distribution of combined ventricular output were measured by injecting five 
batches of differently labeled isotope microspheres (141Ce, 114In, 113Sn, 103Ru and 46Sc, 16 µm 
diameter, New England Nuclear, Boston, MA, USA) suspended in 10% dextran containing 
0.01% Tween 80, sonicated and checked for size, shape and aggregation. Depending on the 
specific activity 0.7-1.8 million microspheres per batch were injected over a period of 20 
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seconds before infusion of L-NAME (control, at -75), before the onset of maternal aortic 
occlusion (-1), at the bottom of asphyxia (+2), and after the release of the snare (recovery, at +4 
and +30) into the inferior vena cava (12; 13) with t 0 being the start of the occlusion. In fetal 
lambs, 6 different injections of 0.5-2.0 x 106 microspheres of 15 m diameter, can be made 
without significant acute or choronic hemodynamic changes (14). Reference blood samples 
were withdrawn from both a carotid and a femoral artery at a rate of 1.75 ml/min. Sampling was 
continuous for 390 s from –1 to +5.5 minutes. Separate samples were taken for 90 sec at control 
(-75 min) and during recovery (+30 min). The volume of blood withdrawn was replaced by 
maternal blood maintained at 39o C in a waterbath. 
The experimental protocol was approved by the Animal Medical Ethics Committee of 
Maastricht University and met the guidelines of the responsible governmental agency. 
 
Measurements 
Fetal heart rate (FHR) and mean blood pressure (MAP) were continuously recorded during the 
experiment on a personal computer, using a customized hemodynamic data acquisition system. 
Before each blood flow measurement, and additionally at –30 min, blood samples were taken 
from the fetal descending aorta and analysed for blood gases, acid base balance (AVL 993, 
Radiometer, Copenhagen, Denmark), hemoglobin concentration and arterial oxygen saturation 
of hemoglobin (OSM 2 Hemoximeter, Radiometer, Copenhagen, Denmark). At the same time 
points, glucose and lactate were measured (YSI, 2300 Statplus Analyzer/2, Yellow Springs 
Instruments, Ohio, United States). 
After the experiment a lethal dose of sodium pentobarbitone (Euthesate®; Apharmo, Duiven, 
The Netherlands) was given to the ewe and the fetuses were perfused with 200 ml formalin 
(10% in saline). Fetal organs were weighed and placed in vials, which were filled to the same 
height to reduce variations in geometry. The intestines were separated from the mesentery, 
opened and cleared from contents. Paired organs (lungs, kidneys, and adrenals) were counted 
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separately, as were the right and left sides of the cerebrum. Significant preferential streaming of 
microspheres could not be detected. Specimens of skin and muscle were taken from the hips and 
shoulders. Cotyledons, upper and lower carcass were homogenized by a meat chopper and the 
samples filled into vials. 
The applied solid-state semi-conductor gamma counter (thallium activated, sodium iodine 
crystal) had a high energy resolution of about 2 keV and was connected to a mulitchannel 
(1024) pulse height analyzer (LKB 1282, Compugamma, Wallac, Turku, Finland). The results 
were normalized with respect to time and sample weight. 
 
Calculations 
Fetal combined ventricular output (CVO) and blood flow to the various organs were calculated 
from counts of the injected nuclide recovered in fetal organs or placenta, from counts in the 
appropriate reference samples, and from the withdrawal rate of the reference samples (11;12). 
The percentage of combined ventricular output distributed to a given organ was calculated from 
the absolute blood flow to that organ and the combined ventricular output. Oxygen delivery to 
the various organs ([DO2];ml O2/min/100g) was calculated according to the following formula: 
organ blood flow (ml/min/100g) x SO2 x hemoglobin (g/ml) x 1.34 (ml O2/g Hb). 
 
Statistics 
Results are given as means ± SEM. The data were analysed for intra- and intergroup differences 
by two-way multivariate analysis of variance for repeated measures. Games-Howell-test was 
used as post-hoc testing procedure. Statistical analysis was performed by Super Anova 
Statistical Package (Abacus, Inc. Ca. USA). 
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Results 
Control measurements of cardiac output, organ blood flow distribution, blood gases, pH, 
glucose and lactate were in the normal range for chronically prepared immature fetal sheep 
(10;15) with the same experimental set-up and showed no significant differences between the 
LPS group and the LPS + L-NAME group (tables 1-4).  
LPS Group 
Normoxia 
During normoxia, LPS injection severely affected fetal cardiovascular control leading to a 
significant decrease in oxygen saturation, arterial pH, base excess and an increase in partial 
bicarbonate pressure and lactate levels (Table 1). MAP tended to decrease after LPS injection 
although this was not significant while FHR increased between t-30 and t-1 (p<0.001) (Figures 
1 and 2). Administration of LPS caused a significant fall in cardiac output (-35%). The 
percentage of cardiac output directed to the placenta decreased with 70 % after LPS (p<0.001) 
and in contrast the percentage cardiac output to the fetal body increased with 62 % after LPS 
(p<0.01 at t-1). After LPS administration, blood flow to the heart increased with 69% (p<0.05 at 
t-1) and to the adrenals with 107% (p<0.001 at t-1). The percentage cardiac output to the liver 
was 6 times higher (p<0.001 at t-1) and to the carcass increased with 44 % (p<0.01 at t-1). In 
various regions of the brain, such as the cerebrum, cerebellum and colliculi, blood flow did not 
change significantly after LPS (Table 3,4). Although blood flow to the brain was unchanged 
there was a significantly decreased oxygen delivery to the cerebrum after LPS (p<0.001). 
Acute hypoxia 
Arrest of uterine blood flow for 2 minutes resulted in severe acidosis and metabolic changes 
(Table 1). Also a significant decrease in FHR (-38%) and MAP (-30%) to significant lower 
levels at the end of occlusion was observed. (Figures 1 and 2).  
Arrest of uterine blood flow also lead to a further decrease in cardiac output (-70%, p<0.001). 
Placental blood flow also decreased further (p<0.001) during occlusion. In contrast, the 
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percentage cardiac output to the fetal body increased with 76 % compared to control value 
(p<0.001). The percentage of cardiac output to the heart was 5 times higher at the bottom of 
asphyxia compared to control values (p<0.001). The portion of cardiac output to the adrenals 
was 4.5 times higher at the bottom of the occlusion compared to control value (p<0.001 at t2). 
Also the percentage cardiac output to the liver increased further to 6.8 times control value 
during occlusion (p<0.001). Percentage blood flow to the carcass increased after LPS (p<0.01 at 
t2). In the cerebrum, cerebellum and colliculi, flow did not change during occlusion. (Table 3,4) 
Oxygen delivery to the cerebrum decreased further to nearly zero at the bottom of occlusion 
(p<0.001).  
 
Post occlusion phase 
During the immediate recovery phase (t4) there was no improvement in the metabolic status of 
the LPS treated animals and mixed acidosis persisted. Cardiac output did not recover and 
placental blood flow remained low. Cerebral oxygen delivery remained low during the recovery 
phase (p<0.001). The prolonged hypotension in combination with bradycardia led to the death 
of five of seven LPS animals after timepoint t 4 unlike in the L-NAME + LPS group in which 
six of eight animals survived up to the end of the experiment when animals were sacrificed at t 
30. 
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Figure 1.  
Mean Arterial Pressure in LPS (n=7) and L-NAME + LPS (n=8) treated fetuses before, during 
and after hypoxia.  
* p<0.05  ** p<0.001 significance between the groups 
# p<0.05 ## p<0.001 significance versus control within the LPS group 
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Figure 2.  
Fetal heart rate in LPS (n=7) and L-NAME + LPS (n=8) treated fetuses before, during and 
after hypoxia.  
# p<0.05 ## p<0.001 significance versus control within the LPS group  
* p<0.05  ** p<0.001 significance between the groups 
Figure 2. Fetal Heart Rate 
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L-NAME + LPS group 
Normoxia 
Control values of blood gases were not different from the LPS group. 
During normoxia, L-NAME injection resulted in a lower arterial pH (p<0.01 at t –1) and BE 
(p<0.001 at t-1) in the L-NAME + LPS group than in the LPS group. Glucose concentration was 
higher in the L-NAME + LPS group (p<0.05 at t-1). Partial bicarbonate pressure, oxygen 
saturation and lactate concentrations were not statistically different between the two groups 
(Table 1). MAP tended to increase after L-NAME whereas after LPS the hypotensive effect 
overruled and MAP was not different anymore between the two groups. Fetal heart rate in the L-
NAME + LPS group tended to decrease in the normoxic period unlike the LPS group where 
FHR increased (p<0.001 between the groups). (Figures 1 and 2). During normoxia, cardiac 
output decreased after L-NAME administration and was 39% of the value in the LPS group 
(p<0.01 at t -1). Placental blood flow decreased to about the same level in both groups. Fetal 
body flow decreased after L-NAME and was significantly lower in this group (p<0.001 at t-1). 
The percentage cardiac output distributed to the heart was twice as high in the L-NAME + LPS 
group during normoxia (p<0.01 at t -1). Adrenal blood flow showed a lesser increase in the L-
NAME + LPS group during normoxia compared to the LPS group (p<0.05 at t-1). In contrast to 
the LPS group there was no change in percentage cardiac output to the liver in the L-NAME + 
LPS group which was lower than the flow in the LPS group (p<0.001 at t-1). Cerebral blood 
flow was not different between the two groups although the percentage cardiac output to the 
brain was lower in the L-NAME + LPS group, especially in the recovery phase (p<0.01). 
Cerebral oxygen delivery showed the same pattern in both groups decreasing with about 50% 
during normoxia (Tables 3, 4). 
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Acute hypoxia  
Oxygen saturation declined to the same extent in both groups during hypoxia. Partial oxygen 
pressure and glucose concentration were higher in the L-NAME  + LPS group (p<0.05). Arterial 
pH and BE were lower in the L-NAME + LPS group (p<0.05). MAP showed an increase in the 
L-NAME + LPS group at the end of occlusion whereas in the LPS group MAP decreased further 
(p<0.01 at  t2) while FHR was not different between the groups (Figures 1 and 2). In both 
groups cardiac output decreased during occlusion (p<0.001) and thus showed no difference 
between the two groups. Although absolute flow in the placenta was not different between the 
two groups, the percentage cardiac output to the placenta was three times higher in the L-NAME 
group during hypoxia (p<0.05). Fetal body flow decreased with 83% after L-NAME and was 
significantly lower in this group (34% of flow in the LPS group, p<0.05 at t2). The increase in 
percentage cardiac output to the fetal body was less in the L-NAME + LPS group than in the 
LPS group and this difference became significant at the end of the occlusion (p<0.05 at t2). 
Cardiac blood flow was not different between the two groups in the hypoxia period. During 
occlusion blood flow to the adrenals increased in the LPS group but decreased in the L-NAME 
+ LPS group (p<0.05 between the groups). The percentage cardiac output to the liver was also 
lower in the L-NAME + LPS group (p<0.001). The percentage cardiac output to the cerebrum 
was 3.4 times lower in the L-NAME group during hypoxia (p<0.01 at t2). Cerebral oxygen 
delivery decreased to the same extent in both groups to levels almost zero at the bottom of 
asphyxia (Tables 3,4). 
Post occlusion phase 
Oxygen saturation was reduced to significant lower levels in both groups (p<0.001) and was not 
different between both groups. Arterial pH and BE were not significantly different between the 
two groups. Partial oxygen pressure and glucose concentration remained higher in the L-NAME  
+ LPS group (p<0.05). During the recovery phase MAP showed an increase in the L-NAME + 
LPS group in the recovery period whereas in the LPS group MAP decreased (p<0.01 at t4). FHR 
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increased in the L-NAME + LPS group and exceeded values of those in the LPS group (p<0.05 
at t4). (Table 1, Figure 1 and 2).  
Cardiac output remained significantly lower throughout the experiment in the L-NAME + LPS 
group compared to the LPS group (p<0.05 at t4). The percentage cardiac output to the placenta 
was higher during recovery after L-NAME + LPS (p<0.05 at t4). Fetal body blood flow 
remained significantly lower in this group during the immediate recovery period (p<0.001 at t4) 
and also the increase in percentage cardiac output to the fetal body was lower in the L-NAME + 
LPS group during recovery (p<0.05 at t4). Adrenal blood flow and percentage cardiac output to 
the liver remained lower in the L-NAME + LPS group (p<0.05 at t4) as well as blood flow to 
the carcass (p<0.01 at t4). The lower percentage cardiac output to the cerebrum persisted in the 
L-NAME + LPS group during recovery (p<0.01 at t4. The expected post-hypoxia rise in 
cerebral blood flow was absent in both groups (Tables 3,4). 
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Comments: 
LPS-induced endotoxemia severely impairs fetal cardiovascular control during normoxia and 
acute asphyxia resulting in circulatory decentralisation with a decrease in placental blood flow 
and an increase in flow to the fetal body, adrenals, carcass and heart. This decentralisation leads 
to a severe decrease in oxygen delivery to the brain (10). 
NO is produced in large quantities after LPS administration and hence might be involved in the 
pathway that connects endotoxemia to circulatory failure (8). Several studies have investigated 
the effect of NO on circulation, but the role of NO in the process of circulatory decentralisation 
caused by endotoxins was not established. We therefore studied the effects of NOS inhibition on 
fetal circulation and blood flow distribution during endotoxemia. 
Circulation 
After application of LPS fetal cardiovascular control was severely affected with the 
development of tachycardia and hypotension which became more severe during and after 
occlusion. These changes were of the same order and magnitude as we have described before 
(10).  
In the L-NAME + LPS group, NOS inhibition induced a rise in fetal blood pressure and a 
decrease in fetal heart rate immediately after L-NAME but as soon as the effect of LPS on the 
circulation was established (t-30) fetal heart rate increased again and blood pressure started to 
fall during the control period. The fetal hypertension and bradycardia immediately after L-
NAME has been described in fetal sheep studies (16). The initial transient rise in MAP in the L-
NAME + LPS group, although not significant, is most likely caused by systemic and umbilico-
placental vasoconstriction due to NOS inhibition (17).  
In the LPS group hypotension was more pronounced during occlusion and after occlusion 5 out 
of 7 fetuses died while in the L-NAME group 6 out of the 8 fetuses survived.  
These findings might indicate that the LPS induced fetal heart changes are mediated by NO. 
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The steep decrease in cardiac output in the L-NAME + LPS group did not recover after hypoxia. 
Cardiac output in the L-NAME + LPS group was approximately 40 % of cardiac output in the 
LPS group at the bottom of asphyxia, which can be ascribed to an increase in MAP leading to an 
increase in afterload and a decrease in FHR which reduce fetal cardiac output (18). These 
alterations contribute to the fall in combined ventricular output evident with inhibition of NOS 
(19). 
Fetal body 
LPS induced peripheral vasodilation with an increase in blood flow to the fetal body that was 
partly blocked by pretreating the animals with L-NAME. In the L-NAME + LPS group blood 
flow to the fetal body was lower than in the LPS group. Studies of adults have shown evidence 
of a role for NO in the regulation of resting tone in renal, mesenteric, hindquarter, carotid and 
cerebral vascular beds and thus in blood pressure homeostasis (20;21). Our results suggest that 
the vascular bed of the preterm fetal body is also mediated via NO and that the vascular beds 
remain NO dependent during hypoxia and even under endotoxemic conditions. 
Placenta 
Absolute placental blood flow was not different in both groups, since flow was diminished to 
almost zero at the bottom of asphyxia and did not recover. The normal umbilico-placental 
circulation of sheep receives 40% of the fetal combined ventricular output at term (22). In our 
study this percentage was about 45% during normoxia which decreased during occlusion with a 
slight recovery in the L-NAME treated fetuses. Absolute placental flow also decreased in both 
groups and there was no significant difference between the two groups. The regulation of 
umbilical and placental blood flow must depend on circulating or locally released vasoactive 
substances (23;24) since these vessels lack autonomic innervation (25). In the fetal sheep, the 
microcirculation of the placenta is remarkably inert to many vasoconstrictors whereas the 
umbilical artery and vein are more vasoactive (26;27). NOS inhibition seems to merely partially 
influence the changes in placental blood flow in endotoxin treated fetal sheep. Therefore this 
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decrease could also result from endothelin (ET) mediated vasoconstriction of the umbilical 
arteries. ET-1 is a strong endothelium-derived vasoconstrictor peptide, which constricts 
fetoplacental microcirculation and decreases fetal oxygen consumption in sheep. The 
vasoconstrictive effects of ET-1 are brought about by ETA receptors and a small subpopulation 
of ETB. ETA receptors predominate on vascular smooth muscle, are highly specific for ET-1 and 
are the primary effectors of its vasoconstrictor activity. ETB receptors are located primarily on 
endothelial cells and respond to all three isoforms of endothelin. Activation of the ETB1 
receptor, located on vascular endothelium, causes the release of vasoactive substances such as 
NO leading to vasodilation (28;29). Activation of the ETB2 receptor located on vascular smooth 
muscle leads to vasoconstriction. The placental blood flow changes might be attributed to a 
combination of ETB2 and ETB1 effects. 
Brain 
Cerebral blood flow and percentage cardiac output to the brain decreased in the L-NAME + LPS 
group. At mean arterial pressures below 25-30 mmHg there is increased loss of autoregulation 
and thus reduced cerebral blood flow. In the L-NAME + LPS group, MAP was higher than 25-
30 mmHg, therefore we assume cerebral autoregulation still to be present in the L-NAME 
group. Thus reduced cerebral blood flow seems to be caused by increased resistance in the brain.  
In both groups there was an absent post-hypoxia rise in the cerebrum as seen in control animals 
undergoing hypoxia (11). In the LPS group this is probably due to hypotension after occlusion 
whereas in the L-NAME + LPS group the lack of NO is involved. NO mediates resting tone in 
the fetal cerebral vascular bed and is required for hypoxia-induced cerebral vasodilation (30). At 
0.6 and 0.9 gestation the post-hypoxia rise in cerebral blood flow was not diminished after L-
NAME compared to the control group (33). Also, NOS inhibition attenuated the delayed rise in 
cerebral blood volume and increased the extent of cerebral injury (16;32). In our study, 
endotoxemia resulted in a constant cerebral blood flow but a severe fall in oxygen saturation 
coincided. Previous studies have shown a positive correlation between cerebral blood flow and 
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oxygen saturation (33). The normally occurring response of cerebral blood flow to hypoxia 
might be altered by endotoxemia. In the L-NAME + LPS group there was a reduction of 
cerebral flow by half although saturation was the same in both groups. This may be caused by a 
normalizing effect of NOS inhibition on the altered response during endotoxemia thus leading to 
a higher vascular resistance in the cerebrum. In the literature there is evidence that severe 
hypoxia in the newborn lamb induces impairment of the autoregulatory ability of the cerebral 
vascular bed and that even low-dose NOS inhibition started upon reperfusion, restored 
autoregulation suggesting a role for NO induced vasodilation in the impairment of 
autoregulation of the cerebral blood flow after birth asphyxia (34).  
 
We conclude from our data that NOS inhibition causes a collapse in combined ventricular 
output and a general vasoconstriction in practically all organs.  
The changes in blood flow distribution in endotoxin treated fetal sheep seem in part to be 
mediated by NO. Certain changes in organ blood flow seem less affected by NOS inhibition 
such as the placenta where other mediators might be more important. 
Furthermore, we conclude from these results that NOS inhibition partially overrules the LPS-
induced peripheral vasodilation and that NOS inhibition leads to a reduction in the 
decentralisation caused by LPS. 
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Introduction 
Despite widespread adoption of preventive strategies, Respiratory Distress Syndrome (RDS) is 
still a major health concern in low birth weight infants leading to chronic lung disease or 
bronchopulmonary dysplasia (BPD) (5;11). Apart from other factors such as preeclampsia, intra 
uterine growth retardation and cervical incompetence, infection is the most important causative 
factor in preterm delivery. 
BPD has been attributed to the effects of oxidant toxicity and barometric or volumetric trauma 
resulting from mechanical ventilation necessary for treatment. Recent evidence, however, 
suggests that pulmonary inflammation plays a role in predisposing preterm infants to the 
development of BPD (5;6;11;12;18). Pulmonary inflammation might be caused by 
chorioamnionitis and intrauterine infection. Chorioamnionitis enhances the risk of BPD but 
decreases the risk of RDS (7;23). These findings led to the hypothesis that intrauterine infection 
causes lung inflammation with subsequent acceleration of lung maturation, but also fosters the 
development of lung damage, manifested as BPD. 
Endotoxins, (Lipopolysaccharides, LPS) are frequently used in animal models as a paradigm for 
fetal infections. Endotoxin, injected intra-amniotically 6 days before delivery, increased lung 
compliance by 59%, increased lung gas volume 2.3 fold, raised concentrations of surfactant 
lipids, increased surfactant A and B protein levels and increased messenger ribonucleic acid 
expressions for surfactant proteins while betamethasone exposure resulted in less consistent 
effects (12). The mechanisms behind these changes however are not yet clear although an 
acceleration of maturation leading to increased production of surfactant protein due to 
inflammation is often mentioned (9). However recent work by Moss and co-workers on lung 
maturation following intra-amniotic endotoxin administration showed that pulmonary 
inflammation was only present if there was a communication between the respiratory tract and 
the amniotic sac which was then associated with lung function improvement and increased 
surfactant production by a direct effect on the developing respiratory system (16). 
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In an experimental model of endotoxaemic shock in preterm sheep induced by LPS, we 
observed pulmonary hyperperfusion during normoxia and asphyxia (4). We hypothesized that 
these changes in lung perfusion are mediated by endothelin and nitric oxide. In the present study 
the effects of LPS on pulmonary perfusion were analyzed after pre-treatment with the selective 
endothelin-A antagonist BQ123 and the nitric oxide synthase inhibitor nitro-L-arginine methyl 
ester (L-NAME) during normoxia and acute asphyxia. 
 
Material and methods 
Animal preparation 
All 25 preterm sheep were chronically instrumented at a mean gestational age of 107 ± 1 days 
(term is 147 days). All ewes underwent surgery with use of sterile techniques while under 
general anesthesia (thiopental sodium 1 gm/70 kg intravenously for induction, 0.5-1.0% 
halothane in a 1:1 nitrous oxide and oxygen mixture for maintenance). Ewes received 1 gm 
ampicilline (Pentrexyl®; Bristol-Myers, Woerden, The Netherlands) s.c. and 10 µg 
buprenorphin (Temgesic®; Schering, The Netherlands) per kg body weight twice a day for three 
consecutive postoperative days. A midline abdominal incision was performed. A snare was 
placed around the maternal descending distal aorta below the renal artery to arrest uterine and 
ovarian blood flow and to induce fetal asphyxia. The fetal limbs were identified and exteriorised 
through an incision in the uterus. Polyvinyl catheters (Maxxim Medical BV, Den Bosch, The 
Netherlands) with 0.75 mm inner diameter and 1.25 mm outer diameter were inserted via a tibial 
fetal vein and artery of each hindleg and advanced into the caudal vena cava and abdominal 
aorta, respectively. Catheters were also placed into both brachial arteries. Fetal skin was closed 
with cyanoacrylate glue (Cyanolit, Japan). An intrauterine pressure catheter was placed, and the 
uterus was sutured after replacing the amniotic fluid with a saline solution at 390 C. Catheters 
were filled with heparin (100 IU/ml; Heparin-Natrium®, Braun, Melsungen, Germany) and 
exteriorised through a small incision in the flank of the ewe. Catheters were protected by a 
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pouch sewn to the skin of the ewe. A recovery period of 72 hours followed the operation before 
experiments were started. Ewes were housed in individual cages and had free access to food and 
water. 
Guidelines for care and use of animals met the guidelines of the responsible governmental 
agencies and were approved by the Animal Medical Ethics Committee of Maastricht University. 
 
Experimental protocol 
The experiments were performed 3 days after the surgical procedure at 110 ± 1 days. Fetuses 
were randomized into 4 different groups:  
Group 1. Control group (n=6),  
Group 2. LPS group (n=7) with LPS injection at t-60 (52 ± 6 µg/kg) (LPS from E.Coli; 
0127:B8, Sigma Aldrich, Zwijndrecht, The Netherlands),  
Group 3. L-NAME + LPS group (n=8) with L-NAME pre-treatment at t -75 with a 30 mg 
intravenous bolus followed by a continuous L-NAME infusion of 6 mg/min and LPS 
administration at t-60 as described above (L-NAME from Sigma Aldrich, Zwijndrecht, The 
Netherlands),  
Group 4. BQ123 + LPS group (n=4) with BQ 123 pre-treatment at t-75 minutes with a 50 µg 
bolus iv, followed by 3.3 µg/min for 2 h and LPS injection at t-60 as described above (BQ 123 
from Sigma Aldrich, Zwijndrecht, The Netherlands).  
Adequate blockade of eNOS was proven by intravenous injection of 2 µg acethylcholine (ACH). 
Before eNOS inhibition, ACH induced a decrease in MAP of ± 15 mm Hg which was 
completely abolished with NOS inhibition. 
To determine the effects on the time course of circulatory centralization before, during and after 
asphyxia, blood flow to fetal organs and the distribution of combined ventricular output were 
measured by injecting six batches of differently labeled isotope microspheres (141Ce, 114In, 113Sn, 
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103Ru, 95Nb, and 46Sc, 16 µm diameter, New England Nuclear, Boston, MA, USA) suspended in 
10% dextran containing 0.01% Tween 80, sonicated and checked for size, shape and 
aggregation. Depending on the specific activity 0.7-1.8 million microspheres per batch were 
injected over a period of 20 seconds before infusion of either vehicle or L-NAME or BQ123 
(control, at -75), before the injection of vehicle or LPS (t-60), shortly before maternal occlusion 
(-1), at the bottom of asphyxia (+2), and after the release of the snare (recovery, at +4 and +30) 
into the inferior vena cava (19) with t 0 being the start of the occlusion. Reference blood 
samples were withdrawn from both a carotid and a femoral artery at a rate of 1.75 ml/min. 
Sampling was continuous for 390 s from –1 to +5.5 minutes. Separate samples were taken for 90 
sec at control (-75 min) and during recovery (+30 min). The volume of blood withdrawn was 
replaced by maternal blood maintained at 39o C in a waterbath. 
The experimental protocol was approved by the Animal Medical Ethics Committee of 
Maastricht University and met the guidelines of the responsible governmental agency. 
 
Measurements 
Fetal heart rate (FHR) and mean blood pressure (MAP) were continuously recorded during the 
experiment on a personal computer, using a customized hemodynamic data acquisition system. 
Before each blood flow measurement, and additionally at –30 min, blood samples were taken 
from the fetal descending aorta and analysed for blood gases, acid base balance (AVL 993, 
Radiometer, Copenhagen, Denmark), hemoglobin concentration and arterial oxygen saturation 
of hemoglobin (OSM 2 Hemoximeter, Radiometer, Copenhagen, Denmark). After the 
experiment a lethal dose of sodium pentobarbitone (Euthesate®; Apharmo, Duiven, The 
Netherlands) was given to the ewe and the fetuses were perfused with 200 ml formalin (10% in 
saline). The lungs were weighed and placed in vials, which were filled to the same height to 
reduce variations in geometry. Both lungs were counted separately. Significant preferential 
streaming of microspheres could not be detected. The applied solid-state semi-conductor gamma 
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counter (thallium activated, sodium iodine crystal) had a high energy resolution of about 2 keV 
and was connected to a multichannel (1024) pulse height analyzer (LKB 1282, Compugamma, 
Wallac, Turku, Finland). The results were normalized with respect to time and sample weight. 
 
Calculations 
Fetal combined ventricular output (CVO) and blood flow to the various organs were calculated 
from counts of the injected nuclide recovered in fetal organs, from counts in the appropriate 
reference samples, and from the withdrawal rate of the reference samples (19). The percentage 
of combined ventricular output distributed to a given organ was calculated from the absolute 
blood flow to that organ and the combined ventricular output.  Measurement of absolute blood 
flow to the lungs requires a catheter in the pulmonary artery, which was not inserted. Relative 
changes in lung blood flow are therefore expressed as percentage change in the number of 
radioactive microspheres trapped in the capillary beds of the lungs. 
 
Statistics 
Results are given as means ± SEM. The data were analysed for intra- and intergroup differences 
by two-way multivariate analysis of variance for repeated measures. Differences between 
control group and LPS group and between L-NAME + LPS group versus LPS group and BQ 
123 + LPS group versus LPS group are compared since we were interested in the role of NO and 
endothelin in the LPS induced changes in lung perfusion. Games-Howell-test was used as post-
hoc testing procedure. Statistical analysis was performed by Super Anova Statistical Package 
(Abacus, Inc. Ca. USA). 
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Results 
Control measurements for MAP, FHR, blood gases and blood flows were all in the normal range 
for fetal sheep in this experimental set-up (4).  
Results from the control group, LPS group and L-NAME + LPS group are from previously 
completed experiments, all with the same experimental set-up. 
 
Control group 
In the control group no significant changes in MAP, FHR or acid-base balance in the normoxic 
period were observed. At the end of occlusion, MAP was lower although this change was not 
significant and FHR decreased by 40% (Figure 1 and 2). Cardiac output was 610 ± 85 
ml/min/kg fetus during the normoxic period which was in the same range as the other groups 
(Figure 3). Cardiac output decreased with 72% (from 610 to 170 ml/min) at the end of 
occlusion. During the recovery phase cardiac output returned to baseline values. Although pH 
did not change significantly during the experiment, the other parameters decreased significantly 
as shown in Table 1. 
The percentage microspheres to the lungs did not change during the course of the experiment in 
the control group (Figure 4).  
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Table 1. Blood gases in control (n=6), LPS (n=7) , L-NAME + LPS (n=8), BQ123 + LPS (n=4) 
group. 
pH  -75 -30 -1  2  4  30  
 Control 7.36±0.02 7.34±0.01 7.34±0.01  7.17±0.01 § 7.30±0.02 § 7.31±0.02 § 
 LPS 7.37±0.01 7.32±0.02 7.14±0.05 §† 7.01±0.04 §† 6.94±0.04 §†   
 L-NAME+ LPS 7.32±0.01 7.25±0.01 6.98±0.08 §¢ 6.90±0.07 §¢ 6.89±0.08 §¢ 6.82±0.03  
 BQ + LPS 7.30±0.0 7.24±0.0 7.06±0.0 §# 6.92±0.0 § 6.87±0.1 § 6.96±0.10 § 
SO2  -75 -30 -1  2  4  30  
 Control 49.9±4.3 43.9±6.2 44.5±3.8  2.5±0.8 § 34.6±6.7  37.0±5.5  
 LPS 52.4±3.6 44.5±3.2 23.4±5.7 §† 1.9±0.4 § 3.9±1.8 §†  
 
 L-NAME + LPS 53.4±3.9 45.1±5.5 17.6±8.8 § 1.0±0.4 § 16.4±6.5 § 10.6±4.3 
 
 BQ + LPS 35.1±8.6 38.3±7.8 20.5±7.2 # 2.9±1.7 § 6.4±2.9 §# 18.3±6.8 # 
PO2  -75 -30 -1  2  4  30  
 Control 26.5±3.1 24.0±2.2 25.6±2.8  4.7±1.7 § 26.9±2.2  25.3±1.7  
 LPS 25.8±2.0 23.9±2.0 20.3±0.8  4.9±2.8 § 11.5±2.5 §†  
 
 L-NAME + LPS 24.8±1.6 24.7±2.4 23.0±3.0  13.3±1.0 §¢ 21.2±4.5 §¢ 29.6±4.8  
 BQ + LPS 19.3±1.8 25.6±2.7 20.9±1.2 
 
5.6±1.7 § 14.8±2.2 
 
17.0±5.8 
 
PCO2  -75 -30 -1  2  4  30  
 Control 47.7±1.6 48.8±1.8 51.3±1.0  69.0±3.0  58.7±1.8  47.8±4.3  
 LPS 48.2±0.9 51.1±1.7 64.1±6.1 § 85.6±4.1 § 98.4±6.3 §†  
 
 L-NAME + LPS 52.8±4.04 53.2±2.8 83.0±12.8 § 92.9±13.0 § 95.8±15.8 § 114.7±10.4 
 
 BQ + LPS 50.7±1.1 50.9±1.8 72.1±7.3 
 
95.6±9.4 
 
103.2±6.1 
 
64.1±24.9 
 
BE  -75 -30 -1  2  4  30  
 Control 1.3±1.0 0.9±0.7 1.4±0.4  -4.3±0.3 § -4.5±1.4 § -3.7±1.1 § 
 LPS 2.2±0.4 0.4±0.6 -4.9±2.4 §† -10.1±2.4 §† -13.1±1.2 §†  
 
 L-NAME + LPS 0.1±1.6 -3.4±0.8 -12.2±2.4 ¢§ -14.9±2.4 ¢§ -16.0±2.7 § -18.0±1.7  
 BQ + LPS 1.4±0.5 -3.7±0.8 -8.6±2.2 
 
-12.1±2.9 
 
-14.7±2.6 
 
-14.6±3.3 
 
 
§ p<0.05 between control period in the same group 
† p< 0.05 between control group and LPS group  
¢ p<0.05 between LPS and L-NAME + LPS 
# p<0.05 between LPS and BQ123 + LPS group 
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LPS group 
Compared with the control group the following differences were observed in the LPS group. In 
the LPS group, mean arterial blood pressure tended to increase and FHR tended to decrease 
immediately after LPS with a reversed response later on but these changes were not significant. 
MAP decreased significantly during occlusion and remained low during the recovery phase in 
the LPS group (p<0.01) while FHR was in the same range in both groups (Figures 1 and 2). 
Base excess, SO2 and pH significantly decreased. Acidosis occurred in the LPS group before 
occlusion deepened during occlusion and did not recover afterwards. PO2 was lower and PCO2 
higher in the LPS group during the recovery phase (Table 1). Cardiac output during normoxia 
decreased to significantly lower levels in the LPS group (p<0.05) and did not return to control 
levels during the recovery period as occurred in the control group. (Figure 3). The percentage 
microspheres to the lungs significantly increased after LPS and increased even further during the 
occlusion period. During the recovery period the percentage microspheres to the lungs slowly 
decreased (Figure 4). At the end of the experiment sustained hypotension lead to the death of 
five of seven fetuses in the LPS group whereas all fetuses in the control group recovered 
completely. 
L-NAME + LPS group 
Compared to the LPS group the following changes occurred. MAP increased after L-NAME but 
45 minutes after LPS injection, there was a decrease in MAP in both groups. MAP showed an 
increase in the L-NAME + LPS group at the end of occlusion whereas in the LPS group MAP 
decreased further (p<0.01 at  t2 and t4) (Figure 1). Fetal heart rate in the L-NAME + LPS 
decreased in the normoxic period unlike the LPS group where FHR  did not attenuate (p<0.001 
from LPS group). During occlusion FHR was not different between the groups but  at the end of 
the occlusion FHR increased in the L-NAME + LPS group and exceeded values of those in the 
LPS group (p<0.05) (Figure 2). L-NAME injection resulted in a lower arterial pH (p<0.05) in 
the L-NAME + LPS group than in the LPS group during the experiment (p<0.05) (Table 1). 
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Cardiac output was lower in the L-NAME + LPS group compared to the LPS group before the 
start of the occlusion and during the immediate recovery period (Figure 3). Six out of eight 
fetuses survived the experiment up to the end of the experiment. 
The increase in percentage microspheres to the lungs caused by LPS was completely absent 
after pre-treatment with L-NAME (Figure 4).  
BQ 123 + LPS group 
The course of FHR and MAP showed the same pattern in the BQ123 + LPS group as well as in 
the LPS group (Figures 1 and 2). Blood gases in both BQ123 group and LPS group were in the 
same range during the entire course of the experiment (Table 1). 
Cardiac output was not different between BQ123 + LPS and LPS group (Figure 3). The increase 
in percentage microspheres directed to the lungs after LPS injection was partially blocked by 
pre-treatment with BQ123 before LPS (p<0.05 at t2) (Figure 4). In this group all fetuses 
survived until the end of the experiment.  
 
Figure 1a.First arrow indicating injection of vehicle, second arrow indicating injection of LPS  
* indicating p<0.05 between control group and LPS group at this timepoint  
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Figure 41b. First arrow indicating injection of L-NAME, second arrow indicating injection of 
LPS  
 
* indicating p<0.05 between L-NAME + LPS group and LPS group at this timepoint 
 
Figure 1c. First arrow indicating injection of BQ 123, second arrow indicating injection of LPS 
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Figure 1b. Mean Arterial Pressure in LPS and L-NAME +
LPS group
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Figure 2a and 2b. First arrow indicating injection of L-NAME, second arrow indicating 
injection of LPS  
* indicating p<0.05 between L-NAME + LPS group and LPS group at this timepoint
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Figure 2c. First arrow indicating injection of BQ123, second arrow indicating injection of LPS  
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Figure 3.  
First arrow (t-75) indicating the pre-treatment with either vehicle, L-NAME or BQ123. 
Second arrow (t-60) indicating the injection of either vehicle or LPS. 
* p<0.001 between Control group and LPS group 
# p<0.001 between L-NAME + LPS group and LPS group 
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Figure 4.  
First arrow (t-75) indicating the pre-treatment with either vehicle, L-NAME or BQ123. 
Second arrow (t-60) indicating the injection of either vehicle or LPS. 
* p<0.05 between Control group and LPS group 
# p<0.05 between L-NAME + LPS group and LPS group 
$ p<0.05 between BQ123+ LPS group and LPS group 
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Discussion 
After LPS application, the percentage cardiac output to the fetal lung, was markedly enhanced 
and even further increased when a short period of asphyxia was superimposed. This increase 
might be explained by the following hypothesis. Endotoxemia causes an increase in cytokines 
which can lead to an increased production of endothelin and NO. The hyperperfusion during 
superimposed asphyxia might be caused by the higher circulating cytokine levels after hypoxia-
ischema leading to even higher NO production (22). NO relaxes vascular smooth muscle and 
leads to vasodilatation, thus increasing blood flow. After pre-treatment with L-NAME, a non-
selective NO synthase inhibitor, a complete abolishment of the increased cardiac output to the 
lung, during normoxia as well as during acute asphyxia occurred. Whizemann and co-workers 
concluded that intravenous injection of rats with LPS caused a time-dependent increase in 
inducible nitric oxide synthase (iNOS) mRNA expression in the lung, which reached a 
maximum after 24 h (24). From our results we conclude that the pulmonary hyperperfusion 
following LPS injection seems to be, at least in part, NO mediated. 
On the other hand, endothelin (ET) also appears to play a significant role in the mechanism of 
pulmonary perfusion following LPS (15). In this study we observed a partial inhibition of 
endotoxin mediated pulmonary hyperperfusion after BQ123 was administered. MAP and FHR 
did not change after BQ123 pretreatment. Endothelin 1 is a potent vasoconstrictor which is 
induced by endothelial cells (27). Endothelin has two forms of receptors. ETA receptors are the 
primary effectors of its vasocontrictor activity. ETB receptors have two subtypes, ETB1 
activation causes the release of vasoactive substances such as nitric oxide leading to 
vasodilation. Activation of the ETB2 receptor located on vascular smooth muscle leads to 
vasoconstriction (2;21). Although the ETA receptor predominates, ETB receptors have been 
shown in pulmonary resistance arteries. 
Wong and co-workers investigated the role of ET-1 and its receptors in the regulation of fetal 
pulmonary vascular tone using BQ 123 and 4 Ala ET-1 (an ETB receptor agonist). In six fetal 
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sheep, BQ 123 increased pulmonary blood flow and decreased pulmonary vascular resistance 
but 4 Ala ET-1 lead to a higher increase in pulmonary blood flow and decreased pulmonary 
vascular resistance. This study demonstrates that ETA receptor activation has a role in 
maintaining basal fetal pulmonary vascular tone, but specific ETB receptor activation produces 
a more distinctive pulmonary vasodilation (25).  
Recently, a clinical study showed that postoperative elevation of pulmonary vascular resistance 
in children after surgical intervention for congenital heart disease is responsive to endothelin A 
blockade with BQ123 (20).  
In order to find a concise answer to why merely the lungs show such explicit changes in our 
study, several mechanisms are possible. Bound BQ123 dissociates easier than bound endothelin. 
BQ123 inhibited 0.1 nM ET-1 binding by more than 80% after 15 min of incubation, and the 
inhibition decreased to less than 20% after 24 hours of incubation. This suggests that the ability 
of antagonists to inhibit ET-1 binding to the receptor is critically dependent on the incubation 
time (26). For this reason we decided to give a BQ123 perfusion during the entire experiment. 
The dose BQ123 used in this study is in accordance with previous established doses in the 
literature (10).  
Since BQ123 only partially, and L-NAME completely abolishes pulmonary hyperperfusion, it 
seems that, besides the NO production following endothelin, a different route of NO production 
exists. 
In the preterm infant, the lungs are susceptible to injury leading to RDS and BPD. BPD 
develops in 20% of neonates who require mechanical ventilation and in 15% to 47% of those 
with birthweights lower than 1500 gram (1;3). Infants with BPD are at risk for death, cerebral 
palsy, recurrent respiratory infection, cardiovascular disease and delayed growth. Although 
immaturity, barotraumas and oxygen toxicity are important contributors, Rojas and co-workers 
observed a role for infection in the etiology of BPD (18). There is clinical evidence that 
histologic chorioamnionitis can enhance maturation of fetal lungs but this inflamed pulmonary 
150        Chapter 6 
 
tissue may be vulnerable to injury, thus predisposing the infant to BPD and long-term disease 
(23;28). Several studies showed improvement in lung compliance, lung volumes and an increase 
in surfactant levels after a single injection into the amniotic fluid of E.Coli endotoxin across a 
wide range of doses (13;14). Endotoxin infusion into the trachea, stomach and amniotic cavity 
each resulted in inflammatory responses in lung fluid and improved postnatal lung function. 
These effects occurred with minimal features of systemic inflammation although intraperitoneal 
infusion resulted in severe fetal acidosis or death (17). 
 
In this study we show that LPS induces pulmonary hyperperfusion during normoxia and acute 
asphyxia, that can be partly counteracted by BQ 123, a selective endothelin A antagonist, and it 
can be completely abolished by pretreating the animals with L-NAME, a NO synthase inhibitor. 
 
We conclude that endotoxin-induced pulmonary hyperperfusion is partly mediated by 
endothelin and nitric oxide. 
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Introduction. 
Hypoxic-ischemic cerebral damage is an important contributor to perinatal mortality and 
morbidity, including long-term neurologic sequelae in term and preterm fetuses (1,2). 
However, as shown in recent studies, perinatal brain injury may be associated not only with 
hypoxic-ischemic insults but also with an ascending intrauterine inflammation before or during 
birth (3). It is widely known that gram-negative anaerobic bacteria are involved in colonization 
and infection of the genitourinary tract in pregnant women, which could affect labor and 
preterm birth. Because pregnant women with fever and bacteriuria give birth to infants with a 
higher incidence of neurologic defects at 1 year of age than do mothers free of urinary tract 
infection (4), it seems that human maternal endotoxemia is associated with fetal central nervous 
system damage. Furthermore, there is a growing body of evidence from epidemiologic studies 
that exposure to placental inflammation before or during birth is accompanied by cerebral 
white matter damage, especially in the very preterm fetuses, i.e. those born before 32 wk of 
gestation (3). In addition, the incidence of peri/intraventricular hemorrhage is significantly 
increased in premature infants who are exposed to intrauterine inflammation (5,6). 
 
An increasing number of experimental studies showing various effects of endotoxins on 
cerebral tissue are being published. Thus, administration of endotoxin has been reported to 
induce an increased cytokine expression in adult rat brains (7-9). In particular, a rise in the 
release of TNF-α has been thought to be associated with neuronal cell damage (10). In 
addition, an increased expression of IL-1β and TNF-α mRNA has been observed in the brain 
of fetal rats after intraperitoneal application of LPS to the dam. This was followed by minimal 
cerebral injury (11). Similar observations have been described in immature rabbits after uterine 
infection with bacteria (12) and in newborn kittens after intraperitoneal injection of LPS (13). 
Only recently, it was reported that intraperitoneal injection of LPS in neonatal rats aggravates 
hypoxic-ischemic damage in the immature brain (14). To elucidate the effects of endotoxins on 
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fetal cardiovascular control we applied i.v. LPS to preterm fetal lambs (15). During a short 
period of superimposed asphyxia, these fetuses were not able to maintain circulatory 
centralisation, i.e. to increase blood flow to the central organs at the expense of the peripheral 
perfusion. In the immediate recovery period, oxygen delivery to the fetal brain was nearly 
arrested. It is quite conceivable that under such conditions, fetal brain injury is brought about 
by hypoxic-ischemic insults. 
 
Under clinical conditions, intrauterine inflammation is often accompanied by fetal asphyxia. 
The combination of exposure to inflammation and aspyhxia during birth has been linked to a 
dramatic increase in the risk of spastic cerebral palsy (16), suggesting that there may be an 
interaction between the pathophysiological mechanisms induced by inflammation and perinatal 
hypoxia. Up to now, few data have been presented on the effect of an early administration of 
endotoxins before a hypoxic-ischemic insult in the immature brain. In the present study, we 
therefore investigated whether intracisternal (i.c.) application of LPS enhances the 
susceptibility to subsequent hypoxic-ischemic brain damage in neonatal rats. 
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Material and Methods. 
Animals 
Experiments were performed on 7-day-old neonatal Wistar rats (n = 61) of both sexes. Until the 
day of the surgery, the pups stayed under controlled conditions in cages with their dams. A 
constant temperature of 20°C, a 12 hour day / night rhythm, food and drink at libitum were 
maintained. Mean body weight on the surgery day was 14.9 ± 0.7 g. 
 
Surgical procedure 
The pups were held and fixated by hand. After the skin was disinfected with 70 % alcohol, NaCl 
or LPS (5 µg / pup; Escherichia coli; O127:B8, Sigma Chemical Co. Aldrich) was manually 
injected into the cisterna magna as described previously (17). Briefly, a syringe connected to a 
32-gauge needle was used to inject 10 µl of fluid intracisternally. The landmarks for the 
injection were the opistion and the crista occipitalis externa on the superior side and the basion 
on the inferior side. The needle was inserted within the quadrangle bounded by these points 
about one third of the way between the opistion and the basion. To check that the LPS was 
indeed being injected into the cisterna magna, we performed a pilot study on fifty 7-day-old rat 
pups. In these animals, Chinese ink was co-injected with NaCl or LPS and the correct 
administration was verified macroscopically. After the first ten animals, this pilot study had a 
success rate of 96 %. 
 
One hour after i.c. application of LPS, the rat pups were anesthetized deeply by halothane 
inhalation. The left common carotid artery was exposed through a midline neck incision and 
ligated with 6-0 surgical silk. The duration of anesthesia and surgery never exceeded 15 min. 
After surgery, the pups were allowed to recover with their dams for another hour. The pups were 
placed in an incubator (Intensive Care Incubator 7510, Fa. Dräger, Lübeck, Germany) and were 
exposed to a hypoxic gas mixture (8 % oxygen / 92 % nitrogen). The ambient temperature was 
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strictly maintained at 360C. After 60 min of hypoxia, the incubator was opened to room air and 
the pups returned to their dams (18). In the present study, we did not measure body temperature 
in the rat pups, since this is extremely difficult to do in such small animals. However, in 
experiments on adult animals, fever has not been reported after intracerebroventricular 
administration of LPS (19, 20). The experimental protocols were approved by the appropriate 
institutional review committee and met the guidelines of the governmental agency responsible. 
 
Experimental groups 
The pups were randomized to four experimental groups. 
Sham control group (1): Animals of this group underwent the surgical procedure described 
above except for the ligation of the carotid artery (n=5). 
LPS group (2): These animals were subjected only to i.c. application of LPS (n=7). 
Hypoxic-ischemic study group (3): Animals received an i.c. injection of NaCl and were exposed 
to hypoxia for 60 min after ligation of the left carotid artery (n=17). 
Hypoxic-ischemic / LPS study group (4): Animals received an i.c. injection of  LPS and were 
exposed to hypoxia for 60 min after ligation of the left carotid artery (n=19). 
 
Histology 
Seven days after the insult, the rat pups were anesthetized with i.p. thiopental (12 mg / animal), 
a butterfly needle (21 gauge) was inserted into the left ventricle, and the right atrium was 
incised. Each animal was perfusion-fixed with 4 % formaldehyde. After perfusion, the brains 
were removed and stored in the same fixative for at least 3 days. Coronal blocks of the brains 
were processed in graded ethanols and rotihistol. After embedding in paraffin wax, 5 µm-thick 
coronal slices were sectioned every 500 µm and stained with cresyl-violet / fuchsin. 
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Hypoxic-ischemic brain injury was assessed directly after the brains were removed from the 
cranial cavity using a macroscopic 4-point scale (modified after (21)): 0 = no macroscopically 
detectable damage; 1 = discrete, delineated, superficial pigmentation of the ipsilateral 
hemisphere; 2 = moderate cystic infarction of the ipsilateral hemisphere (< 4 mm); 3 = severe 
cystic infarction of the ipsilateral hemisphere (> 4 mm). 
Hypoxic-ischemic neuronal cell damage within the cerebral cortex was also assessed 
microscopically. The cortex ipsilateral to the ligated carotid artery was evaluated at 6 coronal 
levels (longitudinal coordinates relative to Bregma: A 1.0 mm, A 2.0 mm, A 3.0 mm, A 4.0 mm, 
A 5.0 mm, A 6.0 mm). Coronal level A 2.0 mm showing the middle of the dorsal hippocampus 
was taken as the reference plane according to a stereotaxic atlas of 14-day-old rat brains (22). 
The longitudinal coordinates of the other coronal levels were determined by counting the 
number of the 5-µm-thick histologic slices in posterior and anterior direction. The ipsilateral 
cortex was analysed by visual field at a magnification of 250x. Neurons with ischemic cell 
damage were identified according to the criteria of Brown and Brierley (23). Neuronal cell 
damage in each microscopical visual field was quantified by the following score: 0-5 % damage 
(score 1), 5-50 % damage (score 2), 50-95 % damage (score 3), 95-99 % damage (score 4), and 
100 % damage (score 5) (24). The histologic score of each coronal level was calculated by 
averaging the scores of all visual fields analyzed in that level. In the same way, neuronal cell 
damage of four hippocampal structures (dentate gyrus, CA 4, CA 3, CA 1 and CA 2) was 
evaluated at the coronal plane A 2.0 mm and that of the striatum at the coronal planes A 3.0 mm 
and A 4.0 mm. The scoring system used in the present study has been previously established and 
evaluated by our group. The intraobserver and interobserver reliabilities were assessed by 
coefficients of variation and amounted to 3 and 10 %, respectively. This system has been used 
by our group and others successfully in a large number of studies (24-26). 
In addition, coronal sections were scanned at 2700 x 2700 dpi with a film scanner (SprintScan 
35 Plus, Polaroid Europe Ltd., Uxbridge, Middlesex, UK) and the digitized images were 
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analyzed using the public domain NIH Image program (Version 1.61, U.S. National Institute of 
Health, Bethesda, MD, USA). Neuronal injury to the cortex was defined as areas of decreased 
neuronal density, confirmed by simultaneous bright field microscopy, and the area of cortical 
brain damage was expressed as percentage of the total cortex in each section. The mean value 
per brain was calculated and used for statistical evaluation (27). All observers involved in the 
histologic evaluations were blind to the treatment procedures. 
 
Immunohistochemistry 
To clarify whether the injected LPS is really active in the immature brain, we studied the 
expression of TNF-α. For this purpose, another group of rat pups (n = 9) were treated with LPS 
as described above. At 4, 10 and 24 h after the application, these animals as well as NaCl treated 
control pups (n = 4) were killed and perfusion-fixed with 4 % formaldehyde. After incubation 
for 48 h in formaldehyde, the brains were transferred into 18 % sucrose. Twenty µm-thick 
coronal frozen sections of the brains were processed on a cryostat. For detection of TNF-α, anti-
rat TNF-α was used as primary antibody (Endogen, Woburn, MA, USA) at a working dilution 
of 1 : 1000. After incubation with primary antibody at room temperature for 2 h, the avidin-
biotin-horseradish peroxidase system (ABC kit from Vector Laboratories, Burlingame, CA, 
USA) was used for detection of immunopositive cells following the manufacturer’s instructions. 
Negative controls were performed by omitting the primary antibody and by preadsorbtion of the 
TNF-α antibody with the homologous antigen (PeproTech EC Ltd, London, UK). 
 
Statistics 
All data are given as means ± SD. Statistical differences between groups were evaluated by the 

2
 test, Mann-Whitney U test or unpaired t-test where appropriate. P < 0.05 was considered 
significant. 
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Results 
Neuronal cell damage could not be observed in sham control animals or in rat pups that were 
subjected solely to LPS injection into the cisterna magna. In the cerebral cortex of the animals 
allotted to macroscopic score 1 and 2, only selective neuronal necrosis could be detected without 
any evidence of infarction. In the neonates that underwent hypoxia-ischemia plus LPS injection, 
the macroscopically assessed brain injury was significantly higher than that observed in pups 
subjected to hypoxia-ischemia and administration of NaCl (Table 1).  
Table 1: Macroscopically evaluated hypoxic-ischemic brain injury in neonatal rats. 
Score NaCl/HI LPS/HI 
   0    8       4 
   1    6       8 
   2    3       0 
   3    0       7* 
__________________________________________________________________________ 
Rat pups were subjected to either i.c. application of NaCl (n = 17) or LPS (n = 19). One hour 
later, the animals underwent unilateral carotid artery occlusion followed by 60 min of hypoxia 
(HI). 0= no macroscopically detectable damage; 1 = discrete, delineated, superficial 
pigmentation of the ipsilateral hemisphere; 2 = moderate cystic infarction of the ipsilateral 
hemisphere (	


	
	

	


Statistically significant differences between control and study group were evaluated by X2 test  
(* p< 0.01).                                                                                                                    
 
Whereas 7 animals of the LPS group (group 4) developed severe cystic cerebral infarction, only 
mild to moderate damage could be observed in the rat pups of the NaCl group (group 3).  
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The extent of microscopically determined neuronal cell damage in these two groups is illustrated 
in Table 2 and Figure 1.  
Table 2: Microscopically evaluated hypoxic-ischemic brain injury in neonatal rats. 
 NaCl/HI LPS/HI 
Cortex 
Level 1 (A 1.0) 1.31 ± 0.21 1.95 ± 1.25  
Level 2 (A 2.0) 1.29 ± 0.23 2.13 ± 1.20 * 
Level 3 (A 3.0) 1.24 ± 0.15 1.88 ± 1.12  
Level 4 (A 4.0) 1.08 ± 0.11 1.60 ± 0.98 ** 
Level 5 (A 5.0) 1.03 ± 0.10 1.37 ± 0.90 ** 
Level 6 (A 6.0) 1.03 ± 0.13 1.39 ± 1.06 * 
total 1.18 ± 0.12 1.81 ± 1.05 * 
Hippocampus 
DG 1.59 ± 1.33 1.26 ± 0.73  
CA 1/2 1.59 ± 1.37 1.11 ± 0.32  
CA 3 1.82 ± 1.55 1.54 ± 1.01  
CA 4 1.65 ± 1.32 1.54 ± 1.20  
Striatum 
 1.27 ± 0.70 1.65 ± 1.16  
Rat pups were subjected to either i.c. application of NaCl (n = 17) or LPS (n = 19). One hour 
later, the animals underwent unilateral carotid artery occlusion followed by 60 min of hypoxia 
(HI). Score 1:0-5% damage; score 2: 5-50% damage; score 3:50-95% damage; score 4: 95-
99% damage; score 5: 100% damage. Values are given as means ± SD. Statistically significant 
differences between control and study group were evaluated by Mann-Whitney U test (*: p< 
0.05, **: p< 0.01, ***: p<0.001). 
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Figure 1. Photomicrographs showing coronal sections (A 2.0 mm) of NaCl- (A) and LPS-
treated (B) rat pups subjected to 60 min of hypoxia-ischemia. Sections were stained with cresyl-
violet/fuchsin. Whereas only selective neuronal necrosis (arrow heads) could be observed in the 
animals that received NaCl, the i.c. application of LPS sensitized the immature brain to a 
subsequent hypoxic-ischemic insult and resulted in cerebral infarction (arrow heads).  
 
Neuronal cell damage was most pronounced in the posterior levels of the cerebral cortex. Except 
at the levels A 1.0 and A 3.0 neuronal cell injury was significantly higher in the cortex of the 
animals subjected to hypoxia-ischemia and LPS injection. No differences between groups could 
be detected in the hippocampus and striatum. Cellular damage in the white matter could not be 
observed in any of the brains evaluated.  
The mean neuronal injury in the cerebral cortex of the animals of experimental group 4 analyzed 
by the above described CCD-based image analysis system was significantly higher than that in 
the rat pups of group 3 (8.9 ± 3.2 % versus 1.2 ± 0.2 %, p<0.001) (Figure 2). In group 4 animals, 
neuronal cell damage or white matter injury could not be detected in the contralateral 
hemisphere. We therefore did not randomize rat pups to sham surgery and LPS application. 
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Figure 2. 
 
 Groups 
 
Figure 2. Effect of LPS (5 µg/animal i.c.) on subsequent hypoxic-ischemic brain damage in 
neonatal rats. Neuronal injury to the cortex was defined as areas of decreased neuronal density, 
confirmed by simultaneous bright field microscopy, and the area of cortical brain damage was 
expressed as % of the total cortex in each section. Statistically significant differences between 
control and study group were evaluated by unpaired t test (p < 0.03). 
 
LPS NaCl
0
25
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75
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Ten hours after injection of LPS into the cisterna magna, a weak expression of TNF- could be 
observed in the leptomeninges (n=3). After 24 h, this expression was considerably stronger 
(n=3; Figure 3). Most of the cells that were positive for TNF-  staining seemed to be 
macrophages. No staining for TNF-α could be detected in the cerebral parenchyme at any time 
after LPS injection. Animals that received an injection with NaCl also gave no positive staining 
for TNF-α (n=4; Figure 3). 
 
Figure 3. Representative photomicrographs of immunostaining for TNF-α in neonatal rat 
brain-stem sections. Anti-rat TNF-α against TNF-α was used as primary antibody at a working 
dilution of 1 : 1000. After incubation with primary antibody at room temperature for 2 h, the 
avitin-biotin-horseradish peroxidase system was used for detection of immunopositive cells. Rat 
pups were subjected to either i.c.  application of NaCl (C) or LPS (A). The immunoreactive 
product could be detected only in the leptomeninges of the animals of the study group. Bar = 50 
µm.  B, The cytoplasmic TNF-a staining is indicated by arrows. Preadsorption of the TNF-α 
antibody with the homologous antigen is shown in D. Bar = 10 µm. v,  venous vessel.  
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Discussion. 
The central finding of the present study was that endotoxin enhances the susceptibility to 
subsequent hypoxic-ischemic brain damage in neonatal rats. In most studies on LPS and 
ischemic neuronal injury, preconditioning effects were described with reduced brain injury 
when LPS was applied several days before middle cerebral artery occlusion in adult rats (28). 
However, the time interval between the primary and secondary insults seem to be the most 
important variable determining whether an alleviation or an aggravation of the final outcome is 
observed. Thus, sensitization of the immature brain to injury has been demonstrated after 
repeated brief episodes of cerebral hypoxia-ischemia (26). A similar relationship may exist 
between LPS and hypoxia-ischemia. 
 
The mechanisms that mediate the sensitizing effects of LPS to hypoxic-ischemic insults are little 
understood. In a recent study on neonatal rats, altered expression of CD14 mRNA and toll-like 
receptor-4 mRNA (TLR) were detected in the brain after i.p. injection of LPS and a subsequent 
hypoxic-ischemic insult (14). After binding LPS, the membrane-bound and soluble forms of 
CD14 promote the activation of myeloid (monocyte / macrophage / polymorphonuclear 
leukocyte) and non-myeloid (endothelial / epithelial) cells, respectively (29). The elusive 
signaling unit of the LPS receptor includes members of the human TLR family. The cytoplasmic 
tail of TLR has a similar sequence homology to the IL-1 receptor I and TLR stimulation induces 
synthesis of pro-inflammatory cytokines, such as IL-1 and TNF-α (30; for review 31). IL-1 
mediates ischemic, excitotxic and traumatic brain injury, probably through multiple actions on 
glia, neurons and the vasculature. TNF-α has also been reported to contribute to neuronal injury 
(32). Altered expression of CD14 and TLR-4  may therefore be one of the underlying 
mechanism through which LPS sensitizes the immature brain to a subsequent hypoxic-ischemic 
insult (14). 
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It is interesting to note that in the present study, neuronal cell damage was only aggravated in 
the cortex, but not in deeper brain structures such as the striatum and the hippocampus. We 
speculate that the TNF-α released in the leptomeninges penetrated the underlying cerebral 
cortex and accelerated cyclooxygenase 2 and the inducible form of nitric oxide synthase in the 
microglia (33). Radicals produced through these pathways are widely known to injure the 
neuronal network. In addition, TNF-α has been reported to activate the Fas–receptor system and 
to cause subsequent apoptotic cell death (for review 31). Another mechanism by which TNF-α 
could injure the immature brain is its stimulatory effects on metalloproteinases. These enzymes 
are known to degrade virtually all components of the extracellular matrix. They also lyse the 
subendothelial basement membrane, which forms the blood-brain barrier around cerebral 
capillaries and mediates the extravasation of leukocytes (27, 34). However, additional 
experiments will have to be performed to clarify whether these mechanisms are involved in the 
LPS-induced sensitization of the immature brain to ischemia. 
 
Recently, Eklind et al (14) also described a sensitization of the immature rat brain to hypoxic-
ischemic insults by i.p. injection of LPS (0.3 mg / kg body wt). The aggravation of the hypoxic-
ischemic insult that they observed was more pronounced than that found in the present study. 
There could be various reasons for this: the LPS have been taken from different strains of 
bacteria and have been applied via differing routes in the two studies. Furthermore, the studies 
vary with regard to endpoints investigated. Whereas the rat pups were killed 3 d after the insult 
in the former report, in the present investigation animals were not perfusion-fixed until the 
seventh day after hypoxia. Eklind et al (14) also measured cerebral blood flow immediately after 
the insult using the antipyrine technique and did not detect any differences between their study 
and control groups. From these results, they concluded that the effects of LPS on the immature 
brain were not mediated by an alteration of cerebral vasculature. However, as shown in a recent 
study on fetal sheep, i.v. application of LPS at a much lower concentration (50 µg / kg body wt) 
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severely compromised fetal cardiovascular control and nearly arrested cerebral oxygen delivery 
shortly after superimposed hypoxia (15). LPS-induced effects on cerebral blood flow therefore 
cannot be excluded by a single measurement at the end of a hypoxic-ischemic insult. In the 
present study, LPS was injected directly into the cerebrospinal fluid. Severe disturbances of the 
cardiovascular system are unlikely under such conditions but cannot be excluded, because blood 
flow measurements were not performed. Some reports describe an increase in cerebral blood 
flow within the first hours after intracerebroventricular injection of LPS (19,20). Although such 
changes in cerebral perfusion are very unlikely to exacerbate hypoxic ischemic brain injury, 
LPS-induced alterations of cerebral blood flow that enhances the susceptibility of the immature 
brain to subsequent insults can not be excluded in the present study.  
 
Despite extensive histologic examination, we did not detect any white-matter injury in the brains 
investigated. This seems to contradict epidemiological data reporting an association between 
inflammation and white matter damage in immature fetuses (35,36). However, one should take 
into consideration that the endotoxins were applied intracisternally in the present study and that 
the expression of TNF-α could only be observed in the leptomeninges. It is therefore 
conceivable that the concentration of the administered LPS did not reach concentrations in the 
cerebral white matter high enough to activate the pathophysiological cascade leading to cellular 
damage. The same may be true for the striatum and the hippocampus. Since we did not perform 
immunohistochemistry to characterize the various cellular subtypes of the brain parenchyma, 
subtle injury to smaller groups of cells such as oligodendrocytes and their precursors cannot be 
fully excluded.  
 
Expression of TNF-α could not be observed in the present study until 10 h after the application 
of LPS, which is somewhat later than in previous studies performed in adult mice (37). As 
already mentioned, differences in the bacterial strain from which the LPS was derived as well as 
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differences in the maturity of the immunologic system of the studied animals may be 
responsible for this finding. 
 
From the results of the present study, we conclude that i.c. application of LPS enhances the 
susceptibility to subsequent hypoxic-ischemic brain damage in neonatal rats. The underlying 
mechanisms are not yet fully understood.  
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Introduction 
Hypoxic-ischemic brain damage was previously thought to be the leading cause of perinatal 
brain damage, but during the last years other aetiologies have been acknowledged as causes for 
such injury (1,2). Perinatal brain damage is often preceded by antenatal infections and antenatal 
infection is inherently associated with the development of cerebral palsy (3,4,5). Recently, a 
meta-analysis evaluated the potential association between chorioamnionitis and cerebral palsy, 
in both full term and preterm infants (6). The authors reported an association between clinical 
chorioamnionitis and both cerebral palsy (RR 1.9; 95% CI 1.-2.5) and cystic periventricular 
leukomalacia (RR 2.6; 95% CI 1.7-3.9). However, the pathogenesis of infection/inflammation- 
induced neuronal and oligodendroglial cell damage remains unclear. 
Yoon and co-workers have shown that antenatal exposure to intra-amniotic inflammation and 
evidence of a systemic fetal inflammatory response such as funisitis are strong and independent 
risk factors for the subsequent development of cerebral palsy at the age of 3 years (7). 
Furthermore, endotoxins may be involved in provoking preterm birth as they increase the 
expression of prostaglandins (8). There is evidence from epidemiologic studies that exposure to 
placental infection before or during birth is associated with cerebral white matter damage 
especially in very preterm fetuses (before 32 weeks gestation) and those with very low birth 
weight (<1500 g) (9). Endotoxin might cause an increased production of cytokines which may 
have a direct neurotoxic effect. Also, endotoxin might lead to perinatal brain damage by causing 
endotoxemic shock and hypoperfusion of the brain and placenta (10). A study we performed last 
year in neonatal rats showed that bacterial endotoxin sensitizes the brain to hypoxic-ischemic 
injury and induces cerebral infarction in response to short periods of hypoxia-ischemia that 
individually caused no injury (11). These results were also found after intraperitoneal injections 
of LPS (12). 
Results from an earlier study performed in our laboratory clearly show that systemic application 
of a large dose endotoxin in premature fetal sheep severely impairs fetal cardiovascular control 
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during normoxia and hypoxia. Thus, application of LPS resulted in placental hypoperfusion and 
alteration of circulatory centralization during hypoxia, leading to early fetal death in nearly all 
LPS treated animals (10). In the present study we examined the effects of a non-lethal dose LPS 
on the umbilicoplacental circulation. 
 
Material and Methods  
Animal preparation 
Twenty fetal sheep were chronically instrumented at a mean gestational age of 107 ± 1 days 
(term is 147 days). All ewes underwent surgery with use of sterile techniques while they were 
under general anesthesia (thiopental sodium (1 gm/70 kg) intravenously for induction, 0.5-1.0% 
halothane in a 1:1 nitrous oxide and oxygen mixture for maintenance). The ewes received 1 gm 
ampicilline (Pentrexyl®; Bristol-Myers, Woerden, The Netherlands) s.c. and 10 µg 
buprenorphin (Temgesic®; Schering, The Netherlands) per kg body weight twice a day for three 
consecutive postoperative days. A midline abdominal incision was performed. The fetal limbs 
were identified and exteriorised through an incision in the uterus. Polyvinyl catheters (Maxxim 
Medical BV, Den Bosch, The Netherlands) with 0.75 mm inner diameter and 1.25 mm outer 
diameter were inserted via a tibial fetal vein and artery of each hindleg and advanced into the 
caudal vena cava and abdominal aorta, respectively. A transonic flow probe (Transonics 
Systems Inc., Ithaca, NY, USA) was placed around the common umbilical artery through a 
retroperitoneal approach. In eight fetuses, anatomical variation with a too short common 
umbilical artery precluded placement around the common umbilical artery and therefore the 
flow probe had to be placed around one of the two single umbilical arteries. The fetal skin was 
closed with cyanoacrylate glue (Cyanolit, Japan). An intrauterine pressure catheter was placed, 
and the uterus was sutured after replacing the lost amniotic fluid with a 0.9 % saline solution at 
390C. Catheters were filled with heparin (500 IU/ml; Heparin-Natrium®, Braun, Melsungen, 
Germany) and exteriorised through a small incision in the flank of the ewe. Catheters were 
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protected by a pouch sewn to the skin of the ewe. A recovery period of 72 hours followed the 
operation before experiments were started. After the experiment the animals were anesthetized 
with thiopental (thiopental sodium 1 gm/70 kg intravenously for induction, 0.5-1.0% halothane 
in a 1:1 nitrous oxide and oxygen mixture for maintenance). The right atrium and both jugular 
veins were incised. After intracardiac injection with 10.000 IU heparin, each animal was 
perfusion-fixed through a needle placed in the left ventricle with 500 ml 10% formaldehyde 
until the fluid efflux from the jugular veins was clear.  
Ewes were housed in individual cages and had free access to food and water. 
Guidelines for care and use of animals, as approved by the local Animal Medical Ethics 
Committee at Maastricht University, were followed.  
 
Experimental protocol 
The experiments were performed 3 days after the surgical procedure at 110 ± 1 days. The study 
group was treated by either 100 (n=9) or 500 nanogram (n=5) LPS i.v. from one batch (derived 
from E. coli; O127:B8, Sigma-Aldrich) while the control group (n=6) received 2 mL 0,9% 
saline i.v. The total number of animals included in the experiment was 20. Six fetuses from the 
LPS group died during the experiment and were thus excluded from statistical analysis. 
Fetal heart rate (FHR), mean arterial pressure (MAP) and umbilical blood flow (Qumb) were 
monitored for three consecutive days. At timepoints –1 hour (control value), +1 hour, +6 hours, 
+12 hours, +18 hours, +24 hours, +48 hours and +72 hours with 0 corresponding to saline or 
LPS injection, blood gas analysis was performed. After 72 hours animals were perfusion fixed 
with formaldehyde as described above. 
The experimental protocols were approved by the Animal Medical Ethics Committee of 
Maastricht University and met the guidelines of the responsible governmental agencies. 
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Measurements 
Placental blood flow, fetal heart rate and mean blood pressure were continuously recorded 
during the experiment on a personal computer, using a customized hemodynamic data 
acquisition system (University of Maastricht, The Netherlands). 
Blood samples were taken at various timepoints from the fetal descending aorta and analysed for 
blood gases, acid base balance (AVL 993, Radiometer, Copenhagen, Denmark), hemoglobin 
concentration and arterial oxygen saturation of hemoglobin (OSM 2 Hemoximeter, Radiometer, 
Copenhagen, Denmark).  
Placental vascular resistance (mmHg/mL per minute per kilogram fetal weight) was calculated 
by dividing the perfusion pressure of the umbilical circulation by umbilical blood flow. 
Perfusion pressure was defined as mean arterial blood pressure minus caval vein pressure. 
 
Statistics 
The data were analysed for intra- and intergroup differences by two-way multivariate analysis of 
variance for repeated measures. Games-Howell-test was used as post-hoc testing procedure. 
Statistical analysis was performed by Super Anova Statistical Package (Abacus Inc., Ca., USA). 
Results are given as means ± SEM. 
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Results 
All measurements of MAP, FHR, blood gases and umbilical blood flow in the control period 
were in the normal range for chronically prepared fetal sheep of this gestational age (13). There 
were no significant differences between the control and LPS group at this time point (Table I). 
Mean Arterial Pressure (MAP) in the control group was 42±2.2 mmHg during normoxia, and 
did not change during the course of the experiment. MAP increased significantly in the LPS 
group 1 hour after LPS injection and returned to control levels 4-5 hours after LPS 
administration (from 39 ± 2.38 mmHg to 46±2.53 mmHg, +17.8%, p<0.001) (Figure 1). 
Fetal Heart Rate (FHR) increased five hours after LPS injection from 180±7 to 221±9 bpm 
(+22.4%), and was significantly higher than fetal heart rate in the control group which did not 
change significantly from control values (181±6 bpm, p<0.01). FHR normalized 15 hours after 
LPS injection (Figure 2).  
 
Table I. Blood gases in endotoxin treated (n=8) and control animals (n=6) 
  -1  1  3  6  12  24  48  72  
sO2  Control 46.2±4.4  50.9±2.0  51.6±4.0  52.7±2.6  45.5±4.5  51.2±3.3  51.2±8.9  54.8±10.7  
 LPS 50.9±6.9  51.3±5.0  38.8±6.0  32.2±4.2 a,d 40.9±5.1  49.5±3.2  51.7±4.6  35.5±6.6 a,d 
pH Control 7.31±0.01  7.33±0.01  7.33±0.02  7.33±0.01  7.32±0.02  7.32±0.01  7.34±0.02  7.31±0.01  
 LPS 7.36±0.01  7.33±0.02  7.31±0.02  7.31±0.01  7.36±0.02  7.34±0.01  7.32±0.02  7.27±0.05 e 
pO2 
(mmHg) Control 19.5±2.4  20.8±1.9  20.1±1.9  21.8±0.8  21.3±1.6  23.0±1.2  22.5±2.5  19.5±1.4  
 LPS 21.5±1.6  22.1±1.2  19.8±0.9  17.6±1.3  19.5±1.9  22.3±1.8  23.2±2.3  22.8±3.4  
pCO2 
(mmHg) Control 55.3±2.0  56.3±3.0  56.6±3.1  57.5±3.1  44.7±9.6  50.4±7.8  57.2±4.6  77.0±14.2  
 LPS 54.4±2.0  54.6±2.2  58.2±1.9  58.6±1.7  55.4±1.4  53.1±1.9  60.6±8.3  48.5±10.5  
Hb Control 6.1±0.2  6.1±0.2  6.8±0.3  5.7±0.1  5.9±0.3  5.9±0.4  5.8±0.9  5.3±0.5  
 LPS 6.5±0.4  6.8±0.4  7.0±0.4 a 6.6±0.4  6.3±0.4  6.2±0.3  6.0±0.2  6.0±0.3  
 
Values are given as means ± standard error, for statistical analyses a ANOVA and Games-
Howell post hoc test was used.    
a p<0.05, significant between groups d p<0.05, significant versus control within group 
b p<0.01, significant between groups e p<0.01, significant versus control within group 
c p<0.001, significant between groups f p<0.001, significant versus control within group 
 
 
                 
 
    Endotoxin and Umbilicoplacental Circulation    179
 
 
 
 
 
 
 
%
 ch
an
ge
 fr
o
m
 c
o
n
tr
ol
 v
al
ue
85
 
90
 
95
 
100
 
105
 
110
 
115
 
120
 
125
 
130
 
Control (n=6) 
LPS (n=8) 
 0          2             4             6                                    12       24  48 72 
    Time (hours) 
********
Figure 1. Mean arterial pressure in control and endotoxin treated 
* p<0.01 between the control and LPS group 
LPS 
 
 
180         Chapter 8 
 
 
 
 
Oxygen saturation was significantly lower in the LPS group at 6 hours (P < 0.05) and slowly 
recovered during the following 24 hours although not completely (p<0.05 at 72 hours). There 
was no significant difference in arterial blood pH between the two groups (Table I). There were 
no significant differences in the blood gas parameters detected between treated and untreated 
fetuses (Table I).  
Since in eight cases the flow probe was placed around one single umbilical artery, due to 
anatomical variations, we give the results as percentage change from control value. Absolute 
umbilical blood flow in the fetuses, with a flow probe around the common umbilical artery, was 
257 ± 31 ml/min/kg fetal weight. Statistical analysis revealed no significant intergroup 
differences in umbilical blood flow in response to 100 or 500 nanogram LPS treatment protocol 
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and these data were thus combined. In the control group, umbilical blood flow did not change 
significantly during the experiment. In contrast, in the LPS group (100 and 500 nanogram), 
umbilical blood flow decreased 1 hour after LPS to significant lower levels (-30% at timepoint 
+5, p<0.01) and remained low during 12 hours after LPS. Although placental blood flow 
recovered after LPS, attenuation of blood flow compared to the control group persisted for the 
remainder of the experiment (p<0.05) (Figure 3). 
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In line with the decrease in placental blood flow vascular resistance increased one hour after 
LPS and returned to control values 12 hours after LPS injection (p<0.01). In the control group 
vascular resistance did not change significantly during the experiment (Figure 4).  
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Figure 4. Placental vascular resistance in control and endotoxin treated animals. 
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Six out of the 14 LPS fetuses died within 2-12 hours because of impairment of umbilico-
placental perfusion and development of severe fetal acidosis. The non-survivors showed a more 
severe drop in umbilical blood flow which did not recover during the experiment. An example 
of the steep decrease in umbilical flow leading to fetal death within six hours after LPS is 
presented in Figure 5. 
 
 
 
 
 
Discussion 
Clinical and epidemiological studies have shown that exposure to intrauterine infection 
increases the risk of perinatal brain damage (3,4,5,6). In a previous study from our group we 
showed that a large dose of endotoxin during normoxia and hypoxia results in circulatory 
decentralization and hypoperfusion of the placenta leading to a decrease in cerebral oxygen 
delivery and subsequent fetal demise (10).  
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Figure 5. Three examples of the course of umbilical blood flow in endotoxin 
treated non survivors 
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In the present study we show that exposure to a non-lethal dose endotoxin causes a substantial 
and long-lasting decrease in placental blood flow resulting in hypoxemia without appreciable 
changes in pH in preterm sheep at 110 days gestation. 
 
After LPS injection there was an increase in MAP. In an earlier study in preterm sheep (10) we 
showed that adrenal blood flow increased with 100 % after endotoxin administration. This 
increase in flow leads to a surge of catecholamines, which have a vasoconstrictive effect on the 
circulation (14).  This surge of catecholamines might thus, apart from the release of other 
vasoconstrictors such as endothelin, explain the increase in MAP after endotoxin administration 
although it does not clarify the decrease in placental blood flow since the placental 
microcirculation is relatively inert to various vasoconstrictors including norepinephrine. A study 
by van Huisseling et al (15) showed that fetal arterial hypertension provoked by norepinephrine 
had no effect on placental vascular resistance, umbilical blood flow, and umbilical artery 
pulsatility index.  
Fetal heart rate was significantly increased after LPS and remained high during 12 hours after 
LPS, then slowly returned to control values (Figure 1). Other routes of administration cause 
different responses in FHR; when LPS is injected in the amniotic fluid of fetal sheep, there is no 
significant change in fetal heart rate (16), nor is there a reaction on FHR following the injection 
of a low-dose LPS in neonatal rats (12). 
Maternal administration of LPS induces maternal fever and an increase of fetal body 
temperature (17). The increase in FHR might thus be explained by a higher fetal body 
temperature, although we did not measure temperature.  
 
Several mechanisms are potentially involved in the fall in placental blood flow, which are 
discussed below. 
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Firstly, endotoxin is known to induce production of endothelin-1, which is a potent 
vasoconstrictive peptide that is able to constrict fetoplacental microcirculation and decrease fetal 
oxygen consumption in sheep (18) and is active in pigs and humans (19). ET-1 is released in 
response to several stimuli, including hypoxia (20,21), endotoxemia (22,23), increased pressure 
(24), and shear stress (25). In response to these stimuli, ET-1 causes both acute responses, such 
as vasodilation and vasoconstriction, as well as chronic changes, such as smooth muscle 
proliferation. ET-1 is the most active pressor substance yet discovered, with a potency some ten 
times that of angiotensin II (26). Endothelin-1 is mainly produced by vascular endothelium and 
is secreted constitutively thereby participating in the regulation of vascular tone (27). 
Endothelin-2 may be found in the intestine and endothelin-3 in the lung, central nervous system 
and intestine (28,29).  
Among the pathophysiological conditions known to activate the endothelin system, sepsis 
presents with the highest plasma levels of endothelin (30). The possible involvement of the 
endothelin system in human septic shock is further supported by a clear correlation between 
endothelin plasma levels and morbidity and mortality in septic patients (31). 
Bacterial endotoxin or sepsis was shown to increase ET-1 concentrations in fetal umbilical 
arterial plasma more than fivefold in both pigs and humans reaching levels close to threshold 
vasoconstriction (32). Other pro-inflammatory agents such as IL-1, TNF-α, and TGF-β, also 
increase the production of ET-1 from endothelial cells (33). 
 
Secondly, the fall in placental blood flow might be related to the formation of placental edema, 
caused by increases in vascular permeability during endotoxemia. The concurrent restriction of 
placental gas exchange contributes then to prolonged fetal hypoxemia. Cotyledons of fetuses 
that died after LPS appeared on gross examination edematous. Cock and co-workers also 
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observed changes in placental weight, placental edema and hemoconcentration at 4 hours after 
LPS administration (34).  
Thirdly, endotoxemia with high doses of LPS severely impairs fetal cardiovascular control both 
during normoxia and hypoxia. Under non-endotoxic circumstances the fetus protects itself 
against hypoxemia by redistribution of blood flow with increases in blood flow to central organs 
such as brain, heart and adrenals and reductions in blood flow to peripheral organs such as 
lungs, skin, muscle, gastro-intestinal tract, and fetal body. During endotoxemia however this 
protective mechanism is blunted by a lack of control of vascular resistance (10). Endotoxemia 
then leads to an increase in flow to the fetal body and adrenals at the expense of placental blood 
flow. This “steal” effect may add to the fall in umbilical blood flow.  
 
In summary, we found, that a non-lethal dose of endotoxin resulted in surviving fetuses (n=8) in 
transient tachycardia (+25%) and hypertension (+18%). There was also a long-lasting decrease 
in umbilical blood flow (-30%) with an increase in umbilico-placental resistance (+73%) and a 
sustained hypoxemia (-40%) without acidosis. We speculate, that the observed changes in 
placental blood flow might be attributed to an elevated production of endothelin-1, possibly in 
combination with increased capillary leakage and formation of placental edema. 
 
We conclude from these results that sublethal exposure to a single low dose endotoxin causes a 
substantial and longlasting decrease in umbilico-placental perfusion, resulting in sustained fetal 
hypoxemia without appreciable acidemia. Fetuses for which endotoxin was lethal within 12 
hours showed a more impaired umbilical perfusion upon endotoxin administration and 
subsequent development of severe hypoxia and acidosis with fetal demise. Further studies need 
to clarify the involvement of placental edema formation and release of vasoconstrictors in this 
process of impaired placental perfusion. Apart from the potential direct deleterious effect of 
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endotoxin on the brain by increases in e.g. cytokines, the concurrent fall in umbilical blood flow 
might contribute to the development of fetal brain damage associated with intrauterine infection. 
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Introduction 
As shown in Chapter 8, sublethal exposure to a single low dose endotoxin causes a substantial 
and longlasting decrease in umbilico-placental perfusion, resulting in sustained fetal hypoxemia 
without appreciable acidemia. In this appendix to the former study, some observations on brain 
histology are presented. 
 
Material and Methods 
Experimental protocol 
The brains were collected from the fetal sheep which were used in the study described in chapter 
8. At the end of the experiment, animals were perfusion-fixed with formaldehyde, the brains 
were removed and postfixed. Brains were divided in half, one part was used for frozen sections 
and the other half  was paraffin embedded. Ten coronal subserial sections of 10 µm were 
obtained from selected areas such as lateral from the cornu frontale, pars centralis, cornu 
temporale and cornu occipitale, and were then treated with Klüver-Barrera staining. Neuronal 
cell damage was assessed at a magnification of 250x. Neurons with ischemic cell damage were 
identified according to the criteria of Brown and Brierley (Brown and Brierley, 1972).  
As there was no neuronal cell damage in the cerebrum, evenly spaced subserial coronal sections 
of 10 µm were obtained from the periventricular region close to the interventricular foramen. 
With the use of Klüver-Barrera staining, the severity of the white matter lesions was assessed 
using scores such as normal, disarrangement of the nerve fibers, formation of marked vacuoles, 
and disappearance of myelinated fibers. 
 
Calculations  
Brain sections were analyzed by two independent observers, unaware of experimental group 
allocation. Periventricular white matter cell count was also assessed. 
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Results 
An increase in periventricular white cell count was observed in the LPS group (+110%, p<0.05) 
as depicted in figures 1, 2 and 3. Histopathological changes showed signs of programmed cell 
death in the periventricular white matter, with intense and uniform nuclear staining, chromatin 
condensation with karyorrhexis, and formation of apoptotic bodies (plasma membrane enclosing 
cytoplasm, which frequently obtained dense basophilic chromatin) (Figures 1,2 and 3). To 
obtain further evidence of programmed cell death, electron micrographs of selected areas were 
taken at a magnification of 16,000. Electron micrographs revealed characteristic chromatin 
condensation and segregation, extracellular apoptotic bodies, and cell fragments phagocytosed 
in macrophages in the periventricular white matter. The LPS animals showed an increased 
amount of apoptosis and mitosis in the periventricular region (Figure 4). Unlike in control 
animals, in all LPS treated animals, groups of inflammatory cell infiltrations were observed in 
both the periventricular white matter and thalamus, corresponding to groups of macrophages and 
polymorphonuclear cells (Figure 5). 
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Figure 1. Brain histology in the periventricular cell layer, around  the lateral ventricle in a 
control animal using Klüver-Barrera staining. Magnified 15 times and 100 times, respectively. 
1
2
1
2
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Figure 2. Brain histology in the periventricular cell layer, around  the lateral ventricle in an 
LPS animal using Klüver-Barrera staining. Magnified 15 times and 100 times, respectively.
1 
2 
1 
2 
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Figure 3. Periventricular white matter cell count 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Increased apoptosis and mitosis in the LPS animals. Electronmicroscopic picture 
taken in the periventricular region. Magnified 16,000 times. 
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Figure 5. Infiltration in the thalamus in an LPS animal, 20 times enlarged.  
 
Discussion 
The last few years there has been a change in the course of thinking about the cause of perinatal 
brain damage. Not only asphyxia but also endotoxemia increases the risk of brain damage in 
neonates. Therefore, we studied the hemodynamic effects of a low dose LPS, and investigated 
whether or not this endotoxemia could subsequently alter brain histology. 
We found an increase in periventricular white matter cell count, with intense and uniform 
nuclear staining and chromatin condensation with karyorrhexis. The increased periventricular 
white cell count appears to be activated microglia under electronmicroscopic investigation.  
The important question is, whether the observed histological changes in the fetal ovine brain are 
due to the mild hypoxia caused by endotoxemia-induced placental hypoperfusion, or because of 
an inflammatory response in the brain. 
 
Studies investigating hypoxic-ischemic brain injury have been inconsistent in producing specific 
neuropathological results. Differences in gestational age are likely to explain these apparent 
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discrepancies. Several studies reveal periventricular and subcortical white matter damage with 
involvement of the striatum and thalamus (Reddy et al, 1998; Mallard et al, unpublished). Areas 
of coagulation necrosis and accumulation of activated microglia were observed after 
hemorrhagic hypotension in fetal sheep (Matsuda, 1999).  Gunn and co-workers reported 
neocortical, hippocampal and striatal neuronal injury after occlusion of the common uterine 
artery, either alone, or in combination with superimposed maternal hypoxia at 119 to 128 days’ 
gestation (Gunn et al, 1992). White matter damage was not observed in this study. Sustained 
hypoxia caused periventricular white matter injury with cortical necrosis, but no selective 
neuronal injury in the near-term and midgestation ovine fetus (Penning et al, 1994). An episode 
of hypoxemia near mid-gestation in fetal sheep reduced neuronal numbers in the hippocampus 
and cerebellum (Rees et al, 1999).  
The effects of endotoxin on the perinatal brain have been investigated in several studies. 
In response to repeated dosages LPS in fetal sheep at 0.7 of gestation, less and less pronounced 
hemodynamic effects were observed, while white matter injury was present (Duncan et al, 
2002). Peebles and co-workers (unpublished) observed widespread injury in the periventricular 
and subcortical white matter, with regional infiltrates of inflammatory cells, after the injection of 
100 nanogram LPS in 93 day old fetal sheep.  
 
In our study, there is a distinct response, which shows groups of inflammatory cell infiltrations 
probably corresponding to clustered macrophages and activated microglia. A study by Young 
and co-workers also reported this finding on dogs (Young et al, 1983). In pregnant rabbits, 
injection of LPS in the cervix induced white matter injury with increased karyorrhexis and 
TUNEL positive cells in the fetuses (Yoon et al, 1997). 
 
Since the degree of hypoxia present in our study is moderate, it is not likely that it can lead to 
histological brain injury. However, after LPS injection brain blood flow was attenuated in the 
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ovine fetus during both hypoxia and the recovery phase, while cerebral blood flow in control 
animals immediately recovered after acute asphyxia (Garnier et al, 2001) and was increased in 
comparison to control levels. Thus it seems that LPS attenuates the post-hypoxia rise in cerebral 
blood flow, which might indicate an increased susceptibility to moderate hypoxia. 
In conclusion, LPS injection in our study lead to changes in MAP (+20%) in combination with a 
reduction in umbilical blood flow (-30%). Histological investigation of the brain showed an 
inflammatory response with an increased periventricular cell count, clustered microglia and 
macrophages in this region, as well as an increase in apoptosis and mitosis. 
Since the introduction of LPS as a paradigm to induce brain damage, several studies have 
observed brain damage after LPS, while others have not. From our results, it is not conclusive 
whether endotoxin leads to changes in brain histology due to mild hypoperfusion, or due to an 
inflammatory response in the brain after LPS.  
It seems likely that brain damage induced by LPS is a combination of a direct inflammatory 
reaction in the brain, and also an inflammatory response in the fetal circulation leading to a 
redistribution in organ blood flow with placental hypoperfusion and decreased oxygen delivery. 
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Despite the improvements in obstetric care, the number of children suffering from perinatal 
brain damage has not been decreased over the past two decades. On the contrary, 
epidemiological data show an increase in the number of children affected by cerebral palsy. The 
assumption that asphyxia is the major cause of perinatal brain damage has recently been 
questioned since several studies showed that other factors are as significant in solving the puzzle 
of perinatal brain damage, one of the most prominent being intrauterine infection. 
 
The objective of this thesis is to investigate the role of endotoxins (LipoPolySaccharides, LPS) 
as a paradigm for fetoplacental infection on the fetal circulation and the brain, as well as to 
elucidate some of the underlying mechanisms. 
 
In Chapter 1, perinatal brain damage is linked to asphyxia, preterm birth and intrauterine 
infection. It has been assumed that asphyxia is the major cause of perinatal brain damage. 
However, pregnant women with fever and bacteriuria have a higher incidence of giving birth to 
infants with neurological defects at 1 year of age, than do mothers free of urinary tract infection. 
Recent studies have investigated the role of intrauterine infection in causing cerebral palsy and 
concluded that fetuses with a prenatal exposure to infection have an increased risk of developing 
brain damage. Thus it appears that maternal endotoxemia is associated with fetal central nervous 
system damage.  
Clinical chorioamnionitis is defined as an infection of the uterus and its contents during 
pregnancy. Its diagnosis is based on the presence of fever (T > 38°C) plus two or more of the 
following conditions: maternal tachycardia, fetal tachycardia, uterine tenderness, foul smelling 
of the amniotic fluid, or maternal leukocytosis. Its incidence varies between 10% and 20%. 
Antenatal exposure to intra-amniotic inflammation and evidence of a systemic fetal 
inflammatory response are strong and independent risk factors for the subsequent development 
of cerebral palsy at the age of three years.  
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Documented intrauterine infection, with associated maternal and fetal inflammatory responses, 
may account for up to 30% of preterm birth. Intrauterine infection is associated with increased 
interleukin levels, which lead to higher prostaglandin concentrations and thus may cause 
preterm birth.  
 
In Chapter 2, the objectives of this study are summarized and placed in a clinical context. Since 
endotoxin can mimic a clinical infection we decided to use LPS in our experimental setting. The 
relation between intrauterine infection and fetal brain damage is incompletely understood. Two 
pathways seem to be likely. First, brain injury might result from a direct neurotoxic effect of 
increased cytokine production during chorioamnionitis. Second, cerebral damage might be 
caused by endotoxemic alterations of the fetal cardiovascular system resulting in placental and 
cerebral hypoperfusion.  
Based on these facts, we hypothesized that endotoxemia can affect fetal circulatory 
centralization, a vital mechanism that enables the fetus to maintain cerebral blood flow during 
asphyxia and thus protect its brain from hypoxic-ischemic injury. Therefore, we combined LPS 
and acute hypoxia in the first four experiments. 
 
In Chapter 3, we wanted to determine whether endotoxins affect the fetal cardiovascular system 
in a way likely to cause brain damage. Thirteen fetal sheep were chronically instrumented at a 
mean gestational age of 107 ± 1 days. The ewe's abdominal wall was opened in the midline, and 
a snare was placed around the descending aorta below the renal artery, which was then used to 
arrest uterine and ovarian blood flow during the experiment for 2 minutes. Polyvinyl catheters 
were inserted into a tibial fetal vein and artery of each hindleg and were advanced into the 
caudal vena cava and abdominal aorta respectively. Furthermore, catheters were placed into 
both brachial arteries. A recovery period of 72 hours followed the operation before experiments 
started. After control measurements of organ blood flow (microsphere method), blood gases, 
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and acid base balance were obtained, 7 out of 13 fetuses received LPS (53 ± 3 g/kg fetal 
weight) intravenously. Sixty minutes later, asphyxia was induced by occlusion of the maternal 
aorta for 2 minutes. Measurements of organ blood flows were made at -60, -1, +2, +4, +30, and 
+60 minutes, with timepoint zero being the start of asphyxia.  
In the LPS group, there was a significant decrease in arterial oxygen saturation (-46%; P < 
0.001) and in pH (P <0 .001), unlike in the control group. In LPS-treated fetuses the portion of 
combined ventricular output directed to the placenta decreased significantly (76%; P<0.001), 
whereas output to the fetal body (+60%; P<0.001), heart (+167%; P<0.05), and adrenals 
(+229%; P<0.01) increased. Furthermore during asphyxia, circulatory centralization was 
considerably impaired in LPS-treated fetuses, and there was clear evidence of circulatory 
decentralization. This decentralization caused a severe decrease in cerebral oxygen delivery of 
70%. Within 30 minutes after induction of asphyxia five out of seven LPS-treated fetuses died, 
whereas all control fetuses recovered completely.  
From this study we conclude that endotoxemia severely impairs fetal cardiovascular control 
during normoxia and asphyxia, resulting in a considerable decrease in cerebral oxygen delivery. 
Our findings also indicate that this impaired fetal cardiovascular control and organ blood flow is 
caused by the interference of LPS with the centralisation mechanism during hypoxia-ischemia.  
 
Since LPS leads to an increased production of NO, this vasodilator might mediate the 
mechanism of decentralization after LPS. The role of nitric oxide in the control of fetal 
cardiovascular functions and of cerebral blood flow during normoxia and acute hypoxia is only 
partially known. In Chapter 4, the results of a study regarding the effects of nitric oxide synthase 
inhibition on the distribution of cardiac output in preterm sheep, during normoxia and acute 
hypoxia using L-NAME (a NOS inhibitor), are presented.  
We used the same experimental set-up as described before. Three days later, fetuses received L-
NAME (n=7) or vehicle infusion (n=6). At timepoint zero, acute hypoxia was induced by 
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occlusion of the maternal aorta for 2 min. Organ blood flows (microsphere method) and 
physiological variables (fetal heart rate, mean arterial pressure, oxygen saturation, pH) were 
measured at -75,-1,+2,+4 and +30 minutes.  
L-NAME caused bradycardia and a rise in MAP. Combined fetal cardiac output declined by 
64%. Blood flow to the fetal body, placenta and cerebrum decreased by 62 %, 66 %, and 55%, 
respectively. During acute hypoxia, L-NAME did not change the redistribution of cardiac output 
towards the central organs. In the L-NAME group, MAP rose and FHR was maintained in 
contrast to controls where MAP initially decreased and then returned to control value while 
FHR decreased. After hypoxia, L-NAME delayed the recovery of cardiac output and blunted the 
increase in blood flow to the brain and heart.  
From this study we concluded that NO plays a role in fetal cardiovascular control during 
normoxia and acute hypoxia. It also mediates the increase in blood flow to the brain and heart 
immediately after hypoxia.    
Recently, Morrison and co-workers have described a technique called the NO clamp to test the 
hypothesis that enhanced NO opposes fetal peripheral vasoconstrictor responses to acute 
hypoxemia via actions involving carotid chemoreflex and adrenal medulla. This technique 
combines treatment of the animal with L-NAME and the NO-donor, sodium nitroprusside (NP). 
In contrast to treatment with L-NAME alone, combined treatment with L-NAME and NP 
prevents generalized vasoconstriction and pronounced hypertension, not only maintaining basal 
cardiovascular function, but also permitting blockade of the de novo synthesis of NO during 
acute hypoxaemia while compensating for the tonic production of the gas (Morrison et al, J 
Physiol 2003;547:283-291). In the future, this technique could aid to investigations describing 
the effects of NO on the fetal circulation.   
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Since we established that circulatory centralization during hypoxia is blunted by LPS, we 
wanted to further investigate the mediators in this process in Chapter 5. As stated before, 
endotoxin leads to an increased production of NO, which might influence the effects of LPS on 
the fetal circulation. Fifteen fetal sheep were instrumented as previously described. After three 
days, eight fetuses received 30 mg L-NAME (t-75) followed by a continuous infusion. All 
fetuses received LPS at-60. At timepoint zero, hypoxia was induced by occlusion of the 
maternal aorta for 2 minutes. Organ blood flows (microsphere method) and physiological 
variables were measured at t-75, -1, +2, +4 and +30 minutes.  
After LPS administration there was a significant decrease in the percentage cardiac output to the 
placenta and cerebral oxygen delivery and an increase to the fetal body, heart, and adrenals. 
These changes were further enhanced during hypoxia. In the L-NAME + LPS group, fetal body 
and adrenal blood flow were lower than in the LPS group, while cerebral and placental blood 
flows were in the same range in both groups. These changes occurred during normoxia and 
continued during hypoxia and recovery phase. 
In conclusion, endotoxemia severely impaired fetal cardiovascular control, leading to peripheral 
vasodilation. NOS inhibition partially overruled the LPS-induced peripheral vasodilation. 
 
In the study presented in Chapter 6, we investigated the changes in cardiac output distribution to 
the fetal lung, following a fetal intravenous LPS injection, during normoxia and asphyxia. We 
also aimed at analysing the role of NO and endothelin in this process, pretreating one group of 
animals with L-NAME, and another group of animals with BQ 123, an endothelin A selective 
antagonist, before the injection of LPS. 
Experiments were performed 3 days after the surgical procedure at 110 ± 1 days. Fetuses were 
randomized into 4 groups: group1, the control group (n=6), group 2 the LPS group (n=7) with 
LPS injection at t-60 (52 ± 6 µg/kg), group 3, the L-NAME+LPS group (n=8) with L-NAME 
pre-treatment at t -75 and LPS administration at t-60 as described above and group 4, the 
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BQ123+LPS group (n=4) with BQ123 pre-treatment at t-75 minutes and LPS injection at t-60 as 
described above. All groups started with 75 minutes normoxia, then received a 2 minute period 
of acute asphyxia at timepoint zero, with 30 minutes recovery thereafter.  
Under normal conditions, the amount of blood flow through the lungs is only approximately 4 % 
of cardiac output. In the control group there was a low percentage cardiac output directed to the 
lungs which was not altered during fetal asphyxia. However, a marked elevation in the 
percentage microspheres after LPS was observed during normoxia, which was even further 
increased during asphyxia. This increase was partially blocked by BQ 123, an endothelin 
antagonist and completely abolished by pretreatment with L-NAME, an eNOS inhibitor.  
Therefore we conclude that during endotoxemia, cardiac output to the fetal lung is increased by 
LPS and this seems to be in part NO and in part endothelin dependent. 
 
Two pathways seem likely to explain the relation between infection and perinatal brain damage. 
First, brain injury might be caused by the substantial changes in fetal organ blood flow 
distiribution and the concomitant considerable decrease in oxygen delivery to the brain, caused 
by decentralization as we observed in Chapter 3, Chapter 5 and Chapter 6. On the other hand, 
LPS induces cytokine production in the brain and may thus lead to cytotoxic brain damage.  
 
Therefore, we used a different route of LPS administration, the intracisternal application, which 
has only minimal side-effects on the cardiovascular system, in order to bypass hemodynamic 
changes. We wanted to assess whether intracisternal LPS injection could cause brain damage, in 
combination with and without a subsequent hypoxic-ischemic insult. 
In chapter 7, we studied seven-day-old Wistar rats, which were subjected to intracisternal 
application of NaCl or LPS (5 µg/pup). One hour later the left common carotid artery was 
exposed through a midline neck incision and ligated. After another hour of recovery the pups 
were subjected to a hypoxic gas mixture for 60 min. The animals were randomized to four 
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experimental groups. Sham control group (1): left common carotid artery exposed, but not 
ligated. LPS group (2): subjected to intracisternal application of LPS. Hypoxic-ischemic study 
group (3): intracisternally injected with NaCl and exposed to hypoxia after ligation of the left 
carotid artery. Hypoxic-ischemic / LPS study group (4): intracisternally injected with LPS and 
exposed to hypoxia after ligation of the left carotid artery. Seven days later the neonatal brains 
were assessed for neuronal cell damage. In a second set of experiments, rat pups were injected 
with LPS and evaluated for TNF-α expression by immunohistochemistry. 
Neuronal cell damage could not be observed in the sham control or in the LPS group. In the 
hypoxic-ischemic/LPS group, neuronal injury in the cerebral cortex was significantly higher 
than in animals subjected to hypoxia/ischemia after application of NaCl. Injecting LPS 
intrathecally caused a marked expression of TNF-α in the leptomeninges. 
Thus, applying LPS intrathecally sensitizes the immature rat brain to a subsequent hypoxic-
ischemic insult. 
 
In order to study the long-term effects of LPS on umbilico-placental blood flow and to assess 
whether a relationship exists between fetal endotoxemia and histological brain injury, we 
administered a low dose LPS to fetal sheep intravenously. 
In chapter 8 we present the data on continuously recorded umbilical blood flow after LPS 
administration. Fetal sheep were catheterized at a gestational age of 107 ± 1 days. A flow probe 
was placed around either the common umbilical artery or one single umbilical artery. Three days 
later fetuses received either 100 or 500 nanogram LPS or saline i.v.. Six fetuses died within 12 
hours after LPS. FHR, MAP, and umbilical blood flow were monitored for three consecutive 
days.  
FHR increased by 25% at approximately 4-5 hours after LPS and remained high for 15 hrs after 
LPS. MAP increased by 18% one hour after LPS and returned to control value 4-5 hrs after LPS. 
Umbilical blood flow began to fall one hour after LPS, it was minimal (-30%) at 4-5 hours after 
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LPS injection, but slowly returned to control values 12 hours after LPS. Placental vascular 
resistance rose by 73% (p<0.01), while pH did not appreciably change. 
Thus, intravenous application of endotoxin caused a substantial and longlasting decrease in 
umbilical blood flow, resulting in sustained fetal hypoxemia without acidemia.  
 
In the appendix of Chapter 8 we present the data on brain histology of fetal sheep after LPS 
injection. We wanted to address the question if, and to what degree endotoxemia could cause 
histological brain injury. Histological investigation of the brain showed an inflammatory 
response with an increased periventricular cell count, with clustered microglia and macrophages 
in this region, as well as an increase in apoptosis and mitosis.  
Thus, LPS leads to a distinct inflammatory reaction in the brain with an increased 
periventricular white cell count, which seem to be activated microglia. These findings indicate 
that LPS contributes to the development of histological brain damage. 
 
Several conclusions can be drawn as to the harmful effects of endotoxemia on the fetal 
circulation and the brain. 
Endotoxemia severely impaired fetal cardiovascular control during normoxia and asphyxia, 
resulting in a considerable decrease in cerebral oxygen delivery. This is caused by the 
interference with the centralisation mechanism during hypoxia-ischemia. The impaired fetal 
cardiovascular control leads to peripheral vasodilation which can be partially overruled by NOS 
inhibition.  
Due to this decentralisation, endotoxemia also leads to increased cardiac output to the fetal lung 
which seems to be in part NO- and in part endothelin- dependent.  
The long-term effects of intravenous application of endotoxin are a substantial and longlasting 
decrease in umbilical blood flow, resulting in sustained fetal hypoxemia without acidemia. 
These hemodynamic changes are followed by a distinct inflammatory reaction in the brain with 
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an increased periventricular white cell count, caused by an increase of macrophages and 
microglia. Furthermore, the intracisternal injection of LPS sensitizes the immature rat brain to a 
subsequent hypoxic-ischemic insult, while endotoxin injection alone does not result in 
histological brain damage. 
These findings indicate that LPS contributes to the development of histological brain damage. 
 
The effort to understand the effects of endotoxin on the fetal circulation and brain is by no 
means complete.  
Several topics for future research are obvious.  
1. Possible sensitization of the brain by repeated doses of endotoxin with and without the effect 
of additional hypoxic events e.g. induced by repeated brief umbilical cord occlusions is a 
subject for fetal sheep studies.  
2. The mechanisms by which the decrease in umbilico-placental blood flow after LPS is 
established is a challenging research topic. 
3. The relationship between infection and preterm birth and the role of the hypothalamic-
pituitary-adrenal axis in the initiation of labour can be addressed in the fetal sheep model. 
4. The chicken embryo is an established model in perinatal research and is suitable for study of 
the long-term effects of LPS on brain histology after application of LPS on the chorio-
allantoic membrane.  
5. Intervention strategies with drugs in order to prevent or ameliorate the deleterious effects of  
perinatal infection can be tested in various animal models. 
6. Doppler blood flow velocity waveform analysis in the fetal pulmonary artery and the 
umbilical artery as a potential tool for detection of intrauterine infection is a subject for 
studies in the human fetus. 
7. Endotoxemia and effects on brain function by means of behavioural studies in a rat model. 
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Research usually generates more questions than answers and this is also the case for this thesis. 
For the future, we should bear in mind the mythological Hydra. On many an occasion, the route 
to finding a solution gives birth to more problems, which nevertheless need to be afforded 
copious amounts of research. 
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Perinatale hersenschade heeft, ondanks alle technologische vooruitgang, nog steeds een zeer 
hoge incidentie en leidt tot een aanzienlijke mortaliteit en morbiditeit. 
Tijdens de laatste jaren is er een omslag gekomen in de zoektocht naar oorzaken van 
hersenschade. Het werd langzaamaan duidelijk dat meerdere problemen, niet alleen perinatale 
asfyxie, kunnen leiden tot perinatale hersenschade en spasticiteit. Van deze oorzaken wordt 
intra-uteriene infectie als een van de belangrijkste factoren genoemd. 
 
Het doel van dit proefschrift is het onderzoeken van de effecten van endotoxines 
(lipopolysaccharides, LPS) die afkomstig zijn van gram negatieve bacteriën, op de foetale 
cardiovasculaire functie en het foetale brein, alsmede enkele onderliggende mechanismen te 
bestuderen.  
 
In Hoofdstuk 1  wordt er een relatie gelegd tussen asfyxie, vroeggeboorte en intra-uteriene 
infectie. Er werd vroeger gedacht dat asfyxie tijdens de perinatale periode de belangrijkste 
oorzaak was van perinatale hersenschade. Toch is gebleken dat zwangere vrouwen met koorts 
en een urineweginfectie, een hogere incidentie van kinderen met neurologische afwijkingen op 
een leeftijd van een jaar hebben dan vrouwen zonder urineweginfectie. Recent werden in 
verschillende studies de rol van een intra-uteriene infectie in het ontstaan van spasticiteit 
aangetoond en werd geconcludeerd dat een foetus met prenatale blootstelling aan infectie een 
verhoogd risico heeft op het krijgen van hersenschade. Dus lijkt er een associatie tussen 
maternale endotoxemie en foetale hersenschade te bestaan.  
Klinische chorioamnionitis is gedefinieerd als een infectie van de uterus en uterusinhoud tijdens 
zwangerschap. De diagnose wordt gebaseerd op de aanwezigheid van koorts (temperatuur boven 
de 38°C) in combinatie met twee of meer van de volgende symptomen: maternale tachycardie, 
fetal tachycardie, gevoeligheid van de uterus en riekend vruchtwater, of maternale leukocytose. 
De incidentie van chorioamnionitis varieert van 10% tot 20%. Antenatale blootstelling aan intra 
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amniotische infectie en bewijs van een systemische foetale inflammatoire respons, zijn 
duidelijke risicofactoren voor het ontstaan van spasticiteit op drie-jarige leeftijd. 
Gedocumenteerde intra-uteriene infecties, met een maternale of foetale inflammatoire respons, 
kunnen leiden tot 30% van vroeggeboorten. Een intra-uteriene infectie kan leiden tot 
vroeggeboorte door verhoogde interleukine spiegels, welke een hogere prostaglandine 
concentratie, en dus vroeggeboorte tot gevolg kunnen hebben.  
 
In Hoofdstuk 2 worden de doelstellingen van dit proefschrift samengevat en in een klinische 
context geplaatst. Daar endotoxines een klinische infectie kunnen nabootsen, werd LPS gebruikt 
in onze experimentele opstelling.  
Er zijn klinische aanwijzingen dat neonaten die geboren worden na blootstelling aan een intra 
uteriene infectie, een hoger risico hebben op hersenschade. Hoe een intra-uteriene infectie leidt 
tot perinatale hersenschade is niet bekend, wel zijn er twee plausibele mogelijkheden. Enerzijds 
kan een infectie leiden tot direct cytotoxische hersenschade door de aanwezigheid van 
cytokines, die in grote hoeveelheden in de hersenen worden geproduceerd tijdens een infectie. 
Anderzijds kan een intra-uteriene infectie leiden tot een verstoord afweermechanisme, 
centralisatie, dat de foetus gebruikt als bescherming tegen zuurstofgebrek. Als dit mechanisme 
verstoord wordt, treedt er hypoperfusie van de placentaire circulatie op met cerebraal 
zuurstofgebrek dat tot hersenschade kan leiden. 
Naar aanleiding van deze mogelijkheden was onze hypothese dat endotoxemie de foetale 
circulatoire centralisatie, een vitaal beschermingsmechanisme dat de foetus in staat stelt de 
cerebrale doorbloeding te handhaven tijdens asfyxie en dus bescherming geeft tegen 
hypoxische-ischemische schade, kan beïnvloeden. Derhalve gebruikten we LPS in combinatie 
met acute hypoxie in de eerste vier experimenten.  
In Hoofdstuk 3 hebben we onderzocht of endotoxine de foetale circulatie beïnvloedt op een 
manier die kan leiden tot hersenschade. Dertien foetale schapen werden geïnstrumenteerd bij 
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een zwangerschapsduur van 107 ± 1 dagen. Het abdomen van de ooi werd geopend en een draad 
werd om de aorta descendens, onder het niveau van de arteria renalis,  geplaatst. Deze draad 
werd vervolgens gebruikt om uteriene en ovariële bloeddoorstroming gedurende 2 minuten te 
onderbreken. Polyvinyl catheters werden ingebracht in de arteria en vene tibialis van iedere 
achterpoot en werden opgeschoven in de vena cava and abdominale aorta, respectievelijk. Ook 
werden catheters geplaatst in beide arteriae brachiales. Na een herstelperiode van 72 uur werd 
gestart met de experimenten. Na controle meting van orgaandoorbloeding (microsfeer methode), 
bloed gassen en zuur-	
	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foetaal gewicht) toegediend. Na 60 minuten werd asfyxie geïnduceerd door occlusie van de 
maternale aorta gedurende 2 minuten. Metingen van de orgaandoorbloeding werden verricht op t 
-60, -1, +2, +4, +30 en +60 minuten met tijdpunt 0 de start van de asfyxie. 
Na LPS werd er een significante daling gezien in de zuurstofsaturatie (-46%; P < 0.001) en pH 
(P <0 .001), welke niet in de controle groep optrad. In de LPS groep daalde de hoeveelheid 
cardiac output naar de placenta significant (-76%; P<0.001), terwijl de cardiac output naar het 
karkas (+60%; P<0.001), hart (+167%; P<0.05), en bijnieren (+229%; P<0.01) steeg. Ook was 
de centralisatie tijdens asfyxie duidelijk aangetast in de LPS groep en waren er zelfs 
aanwijzingen voor circulatoire decentralisatie. Deze decentralisatie leidde tot een daling van 
70% van het cerebraal zuurstofaanbod. Binnen 30 minuten na asfyxie waren vijf van de zeven 
foetus in de LPS groep overleden terwijl in de controle groep alle dieren overleefden. 
Uit deze studie concluderen we dat endotoxemie de foetale cardiovasculaire funktie tijdens 
normoxie en asfyxie aantast en dat dit een aanzienlijke daling in cerebraal zuurstofaanbod 
veroorzaakt. Verder duiden deze resultaten aan dat het verlies van cardiovasculaire functie en 
veranderingen in orgaandoorbloeding veroorzaakt worden door verstoring van het centralisatie 
mechanisme tijdens normoxie en hypoxie-ischemie.  
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Daar LPS leidt tot een verhoogde productie van Nitric Oxide (NO), kan deze vasodilatator de 
verstoring van de centralisatie beïnvloeden. De rol van NO in het handhaven van de foetale 
circulatie en cerebrale bloeddoorstroming tijdens normoxie en acute hypoxie is slechts 
gedeeltelijk bekend. In hoofdstuk 4 worden de resultaten van het onderzoek naar de rol van NO 
in het onderhoud van cardiovasculaire functie in foetale schapen tijdens normoxische en 
hypoxische omstandigheden gepresenteerd. Dezelfde experimentele opstelling zoals eerder 
beschreven, werd gebruikt. Na drie dagen herstelperiode, kregen de foetus L-NAME (een NOS 
inhibitor) (n=7) of NaCl (n=6) toegediend. Op t =0, werd acute hypoxie geïnduceerd. 
Orgaandoorbloeding (d.m.v. microsfeer methode) en fysiologische parameters (gemiddelde 
arteriele druk (MAP), foetale hartslag (FHR) en bloedgasanalyse) werden gemeten op -75, -
1,+2,+4 and +30 minuten.  Na L-NAME trad er bradycardie en hypertensie op. De cardiac 
output daalde met 64%. De doorbloeding van het karkas, de placenta en cerebrum na L-NAME 
injectie waren verminderd met 62 %, 66 %, and 55%, respectievelijk. Na L-NAME toediening 
veranderde de redistributie van cardiac output naar de centrale organen tijdens acute hypoxie 
niet. In de L-NAME groep steeg MAP en bleef de FHR gelijk, in tegenstelling tot de controle 
groep waar de MAP aanvankelijk daalde en vervolgens terugkeerde naar de uitgangswaarde 
terwijl de FHR daalde. Na hypoxie vertraagde L-NAME het herstel van cardiac output en 
verminderde de toename van doorbloeding naar de hersenen en het hart.  
Uit deze resultaten concluderen we dat NO een rol speelt in het handhaven van de 
cardiovasculaire functie tijdens normoxie en acute hypoxie. NO speelt ook een rol in de stijging 
van hersen- en hart-doorbloeding na hypoxie.  
 
Nadat was gebleken dat de circulatoire centralisatie tijdens hypoxie wordt aangetast door LPS, 
was de volgende stap het onderzoeken van de rol van NO in dit proces. Zoals eerder gezegd 
leidt LPS tot een verhoogde productie van NO, dat derhalve de effecten van LPS op de foetale 
circulatie kan beïnvloeden.  In het vijfde hoofdstuk gebruikten we dezelfde experimentele 
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opstelling. Vijftien foetale schapen werden chronisch geïnstrumenteerd zoals voorheen 
beschreven. Na drie dagen kregen 8 foetus een bolus van 30 mg L-NAME (t-75) gevolgd door 
een continu infuus. Alle foetus kregen op -60 LPS toegediend. Op t 0 werd acute hypoxie 
geïnduceerd door occlusie van de maternale aorta gedurende 2 minuten. De orgaandoorbloeding 
(microsfeer methode) en fysiologische parameters (FHR, MAP en  bloedgasanalyse) werden 
gemeten op t-75, -1, +2, +4 and +30 minuten.  
Na LPS was er een significante daling in het percentage cardiac output naar de placenta en 
zuurstof aanbod aan de hersenen, en een stijging naar het karkas, hart en bijnieren. Deze 
veranderingen werden versterkt tijdens hypoxie. In de L-NAME + LPS groep waren de 
doorbloeding naar het karkas en bijnieren lager dan in de LPS groep terwijl de doorbloeding 
naar de hersenen en placenta in beide groepen gelijk was. Deze veranderingen traden reeds op 
tijdens de normoxische periode en bleven voortduren tijdens hypoxie- en herstel-fase. 
Concluderend leidt endotoxemie tot een ernstige aantasting van de cardiovasculaire functie en 
perifere vasodilatatie. NOS inhibitie vermindert de LPS-geïnduceerde vasodilatatie.   
 
In de studie beschreven in hoofdstuk 6 hebben we de veranderingen in cardiac output naar de 
foetale longen onderzocht na toediening van LPS, tijdens normoxie en asphyxie. Ook werd de 
rol van NO en endotheline in dit proces onderzocht, door een groep schapen met L-NAME, en 
een andere groep schapen met  BQ-123, een endotheline A selectieve antagonist, te injecteren, 
alvorens LPS toe te dienen.  
De experimenten werden 3 dagen na de operatie uitgevoerd bij een zwangerschapsduur van 110 
± 1 dagen. De foetus werden in 4 groepen gerandomiseerd: groep 1, de controle groep (n=6), 
groep 2, de LPS groep (n=7) met LPS injectie op t-60 (52 ± 6 µg/kg), groep 3, de L-NAME + 
LPS groep (n=8) met L-NAME injectie op t -75 en LPS toediening op t-60 zoals eerder 
beschreven, en groep 4, de BQ123 + LPS groep (n=4) met BQ 123 injectie op t-75 minutes en 
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LPS toediening op t-60. Alle groepen startten met 75 minuten normoxie waarna een periode van 
2 minuten hypoxie volgde met een 30 minuten durende herstelperiode.  
Onder normale omstandigheden is de hoeveelheid cardiac output naar de longen slechts 4% van 
de totale cardiac output. In de controle groep was er in de longen een laag percentage cardiac 
output. Dit veranderde niet tijdens de periode van foetale asfyxie in de controle groep. 
Daarentegen was er een duidelijke toename in het percentage cardiac output in de LPS groep 
reeds tijdens normoxie, welke nog verder toenam tijdens hypoxie. Deze toename werd 
gedeeltelijk geblokkeerd door BQ 123, een endotheline antagonist en werd geheel tegengegaan 
door injectie met L-NAME, een NOS inhibitor.  
Concluderend leidt endotoxemie tot een stijging in het percentage cardiac output naar de foetale 
long, welke gedeeltelijk NO- en endotheline- afhankelijk lijkt.  
 
Twee mechanismen lijken de relatie tussen infectie en perinatale hersenschade te kunnen 
verklaren. Allereerst kan hersenschade veroorzaakt worden door de aanzienlijke veranderingen 
in foetale orgaandoorbloeding en de begeleidende aanzienlijke daling in zuurstof aanbod aan de 
hersenen, veroorzaakt door decentralisatie zoals beschreven in Hoofdstuk 3, 5 en 6. Aan de 
andere kant kan LPS cytokine productie stimuleren en aldus tot cytotoxische hersenschade 
leiden. Daarom kozen we voor een andere toegangsroute om LPS toe te dienen, de 
intracisternale methode, welke minimale bijwerkingen heeft op het cardiovasculaire systeem, 
zodat de hemodynamische veranderingen konden worden omzeild.  
 
In hoofdstuk 7 werden 7-dagen oude Wistar ratten intracisternaal geïnjecteerd met of NaCl of 
LPS (5 µg/pup). Na een uur werd de linker A. Carotis Communis vrijgeprepareerd en geligeerd 
door een incisie in het midden van de hals. Na opnieuw een uur herstelperiode werden de pups 
hypoxisch door inademing van een gasmengsel gedurende 60 minuten. De dieren werden 
gerandomiseerd in 4 groepen. Sham controle groep (1): linker arteria carotis communis werd 
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vrijgeprepareerd maar niet geligeerd. LPS groep (2): intracisternale LPS toediening. Hypoxie-
ischemie studie groep (3): intracisternale injectie met NaCl en later hypoxie na ligatie. 
Hypoxie-ischemie / LPS studie groep (4): intracisternale injectie met LPS en hypoxie-ischemie 
na ligatie. Zeven dagen later werden de neonatale hersenen onderzocht op neuronale celschade. 
In een tweede set experimenten werden ratten pups geïnjecteerd met LPS en onderzocht op 
TNF-α expressie door middel van immunohistochemie. 
Er was geen neuronale celschade in de sham of LPS groep zichtbaar. In de hypoxie-ischemie/ 
LPS groep was er significant meer neuronale schade in de cerebrale cortex in vergelijking met 
de dieren in de NaCl met hypoxie groep. Intracisternale LPS toediening leidde tot een 
verhoogde TNF-α expressie in de leptomeningen, maar niet tot hersenschade. 
Concluderend sensibiliseert intracisternale LPS toediening de immature ratten hersenen voor 
een later hypoxisch-ischemisch insult.  
 
Om de langetermijn effecten van LPS op de placentaire doorbloeding te meten en te 
onderzoeken of er een relatie bestaat tussen foetale endotoxemie en histologische 
veranderingen in de hersenen, werd een lage dosis LPS intraveneus toegediend in foetale 
lammeren.  
In hoofdstuk 8 werden de effecten van LPS op de umbilicoplacentaire doorbloeding en de 
cardiovasculaire functie onderzocht. De umbilicale doorbloeding werd continu gemeten 
gedurende 3 dagen. Foetale lammeren werden geïnstrumenteerd bij een zwangerschapsduur van 
107+1 dagen. Een flow probe werd ofwel om de Arteria Umbilicalis Communis, danwel om een 
enkele Arteria Umbilicalis geplaatst. Na een drie dagen durende herstelperiode kregen de fetus 
of 100 of 500 nanogram LPS of NaCl toegediend. Zes foetus stierven binnen 12 uur na LPS 
toediening. Foetale hartslag, gemiddelde arteriële druk en umbilicale doorbloeding werden 
gedurende 3 dagen gemeten.  
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De foetale hartslag steeg met 25% ongeveer 4-5 uur na LPS toediening en bleef verhoogd 
gedurende 15 uur na LPS. De arteriële bloeddruk steeg met 18% een uur na LPS toediening en 
keerde langzaam terug naar controle waarden 4-5 uur na LPS. De placentaire doorbloeding 
verminderde een uur na LPS en verminderde tot 70 % van de controle waarde ongeveer 4-5 uur 
na LPS maar herstelde langzaam naar de uitgangswaarde 12 uur na LPS. De weerstand in de 
placenta steeg met 73% terwijl de pH niet veranderde. Concluderend leidt intraveneuze injectie 
van endotoxine tot een langdurige en significante daling in placentaire doorbloeding, resulterend 
in een ononderbroken hypoxemie zonder acidemie.  
In de appendix van Hoofdstuk 8 worden de data van de histologie van de hersenen na LPS 
injectie gepresenteerd. Met deze studie wilden we de vraag beantwoorden of endotoxemie in het 
foetale lam kan leiden tot histologische afwijkingen in de hersenen. Histologisch onderzoek liet 
een inflammatoire respons zien in de hersenen met een stijging in het aantal periventriculair 
gelokaliseerde cellen, welke geactiveerde microglia leken te zijn. Deze bevindingen duiden aan 
dat LPS bijdraagt tot het ontstaan van histologische hersenschade. 
 
Verschillende conclusies kunnen gemaakt worden ten aanzien van de effecten van LPS op de 
foetale circulatie en de hersenen.  
Endotoxemie tast de foetale cardiovasculaire functie aan tijdens normoxie en hypoxie, leidend 
tot een daling in zuurstof aanbod aan de hersenen. Deze aantasting van foetale cardiovasculaire 
functie en verdeling in orgaandoorbloeding wordt veroorzaakt door de verstoring van het 
centralisatie mechanisme tijdens hypoxie-ischemie. De verstoorde cardiovasculaire functie leidt 
tot een perifere vasodilatatie welke gedeeltelijk kan worden tegengegaan door NOS inhibitie. 
Door bovengenoemde decentralisatie na LPS injectie onstaat er een stijging in het percentage 
cardiac output naar de foetale longen welke gedeeltelijk NO- en endotheline-afhankelijk lijkt.   
De langetermijn effecten van intraveneuze toediening zijn een aanzienlijke en aanhoudende 
daling in placentaire doorbloeding resulterend in foetale hypoxemie zonder acidose. Deze 
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hemodynamische veranderingen worden gevolgd door een inflammatoire reactie in de hersenen 
met een verhoging van de periventriculaire witte cellen, welke blijkt te berusten op een toename 
van geactiveerde microglia. 
Intracisternale toediening van LPS leidt tot een verhoogde gevoeligheid van immature 
rattenhersenen voor een later hypoxisch-ischemisch insult.  
Deze bevindingen duiden aan dat LPS bijdraagt aan de ontwikkeling van histologische 
hersenschade. 
 
Het beschreven onderzoek heeft verschillende vragen opgeworpen; de krachtsinspanning om de 
effecten van endotoxine op de foetale circulatie en de hersenen te onderzoeken is dan ook niet 
voorbij. 
Verschillende onderwerpen zijn een logische stap voor verder onderzoek. 
1. De mogelijkheid van sensibilisering van de hersenen door herhaaldelijke toediening van LPS 
met en zonder het effect van gesuperponeerde hypoxie zoals bijvoorbeeld door korte 
herhaalde navelstrengocclusies is een onderwerp voor onderzoek in foetale schapen. 
2. De mechanismen waardoor de daling in placentaire doorbloeding na LPS onstaat is een 
interessant onderwerp. 
3. De relatie tussen infectie en vroeggeboorte en de rol van de hypofyse-hypothalamus-bijnier 
as in het begin van de baring kan worden onderzocht in het foetale schapen model.   
4. Het kippenembryo is een goed onderzocht model in perinataal onderzoek en is geschikt om, 
na LPS toediening op de chorion-allantois membraan, de lange-termijn effecten van LPS op 
histologie van hersenweefsel te onderzoeken.  
5. Interventie strategieën met medicatie om de schadelijke effecten van LPS te voorkomen of 
op te heffen.  
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6. Doppler flow analyse in de foetale arteria pulmonalis en de arteria umbilicalis als een 
mogelijk hulpmiddel om intrauteriene infectie op te sporen is een onderwerp voor onderzoek 
in de menselijke foetus.   
7. Endotoxemie kan ook een effect hebben op hersenfunctie; dit kan onderzocht worden door 
gedragsstudies in het rattenmodel.  
 
Onderzoek leidt meestal tot meer vragen dan antwoorden en dat is ook het geval voor dit 
proefschrift.  
Voor de toekomst is het belangrijk om aan de mythologische Hydra te denken.  
Meermaals creëert de weg naar het vinden van een oplossing aanleiding tot vragen, waar 
desondanks uitvoerig onderzoek naar moet worden verricht.  
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Vele mensen hebben hun steentje dan wel steen bijgedragen aan dit proefschrift. Enkele van hen 
wil ik persoonlijk bedanken. 
 
Dr T.H.M. Hasaart, co-promotor, beste Tom. Nog altijd is het lastig om je baas bij de voornaam 
te noemen, maar het gaat me steeds beter af. Bedankt voor je vertrouwen; nog voor ik mijn 
artsexamen had gehaald mocht ik bij je beginnen. Een vrouwelijke promovendus die met 
schapen gaat slepen zal niet makkelijk voor je zijn geweest, toch stond je deur altijd open. 
Bedankt. 
 
Prof. Dr. J. de Haan, promotor. Dankzij U is het contact met de Duitse collega’s gelegd, zonder 
dat was het ”boekje” niet gelukt. Dank voor uw interesse gedurende de jaren. 
Prof. Dr. Berger, dear Richard, your patience is admirable. You were there from the beginning, 
guiding me through this scientific adventure, thank you. 
Dr. Y. Garnier, dear Yves. Thanks for your cooperation the past years. The first time I saw the 
meat-grinder I wasn’t so happy to be your colleague, but it turned out very well after all.  
Dr. J. Middelanis, dear Johannes. We had a lot of fun during the experiments in Bochum, even 
when we were breathing in a bit too much halothane. Thanks for your dedication. 
De mensen van de centrale proefdieren voorziening, Joyce Suyk en May Bost, bedankt voor 
jullie expertise, gezelligheid en hulp. Frans Slangen en Monique de Jong, jullie leefden mee als 
het weer eens mis ging en hielpen mee waar nodig. 
Jan Geilen zorgde altijd weer dat het HDAS optimaal functioneerde nadat ik weer eens met de 
verkeerde knopjes had gespeeld.  
Rob van Sebille. Bedankt voor je flexibele hulp toen mijn computer crashte, er zijn momenten 
die ik niet wil overdoen, dat was er een van.  
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De onderzoekers van PERIM: Olivier, onderzoeker vanaf het eerste uur, nu dan ook in de 
kliniek, succes met je opleiding. Robert, jouw speciale humor maakt het onderzoek iedere dag 
weer een uitdaging, sterkte met je boekje. De rest van de PERIM- club: Marc, Hugo, Timo en 
Inez, bedankt en succes voor de toekomst. 
Dorette, samen hebben we heel wat geklaagd, gerookt (in de goeie ouwe tijd) en vooral 
gelachen. Bedankt dat je op deze dag mijn paranimf wil zijn. 
 
De gynaecologen, en verpleegkundigen en medewerkers van het secretariaat uit het 
Maaslandziekenhuis Sittard, jullie hebben me opgevangen en wegwijs gemaakt in de wondere 
wereld van de gynaecologie. Het was een leuke tijd die ik niet zal vergeten.  
 
Alle collega-assistenten, gynaecologen en medewerkers van de afdeling Obstetrie en 
Gynaecologie uit het Academisch Ziekenhuis Maastricht, bedankt voor de fijne samenwerking 
sinds de start van mijn opleiding. 
 
Dhr A.P.C. Smit, bedankt voor het maken en vermaken van het ontwerp. 
Mijn oom, Willem K. Coumans, voor het corrigeren van de nederlandse vertaling. 
 
Tenslotte mijn ouders, pap en mam, wat zullen jullie wel gedacht hebben toen ik kwam vertellen 
dat ik onderzoek met schapen ging doen. Na 2 jaar vonden jullie dat “het nu wel eens klaar 
mocht zijn dat boekje”. Bedankt voor jullie steun, ook toen het wat langer duurde… 
 
 ! r eens niet liep zoals ik wilde. De schapen en ik waren 
blij als jij er bij was ’s nachts in het lab. De afgelopen jaren maak jij iedere dag tot vakantie. Je 
bent de rustgevende factor in mijn leven, hopelijk nog heel lang.
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